<SEC-DOCUMENT>0001459839-19-000021.txt : 20190430
<SEC-HEADER>0001459839-19-000021.hdr.sgml : 20190430
<ACCEPTANCE-DATETIME>20190430163747
ACCESSION NUMBER:		0001459839-19-000021
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20190613
FILED AS OF DATE:		20190430
DATE AS OF CHANGE:		20190430
EFFECTIVENESS DATE:		20190430

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SI-BONE, Inc.
		CENTRAL INDEX KEY:			0001459839
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				262216351
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38701
		FILM NUMBER:		19782395

	BUSINESS ADDRESS:	
		STREET 1:		471 EL CAMINO REAL, SUITE 101
		CITY:			SANTA CLARA
		STATE:			CA
		ZIP:			95050
		BUSINESS PHONE:		4082070700

	MAIL ADDRESS:	
		STREET 1:		471 EL CAMINO REAL, SUITE 101
		CITY:			SANTA CLARA
		STATE:			CA
		ZIP:			95050

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SI-Bone Inc.
		DATE OF NAME CHANGE:	20090326
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>sibn2019proxystatement.htm
<DESCRIPTION>DEF 14A
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2019 Workiva -->
		<title>Document</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s894A79A42A99345AC61E5656500ED92D"></a></div><div></div><div><br></div><div style="line-height:130%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SCHEDULE 14A INFORMATION</font></div><div style="line-height:130%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934</font></div><div style="line-height:130%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Amendment No.__)</font></div><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Filed by the Registrant&#160;&#160;&#160;&#160;</font><font style="font-family:Wingdings;font-size:10pt;">&#254;</font></div><div style="line-height:130%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Filed by a Party other than the Registrant&#160;&#160;&#160;&#160;</font><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div><div style="line-height:130%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Check the appropriate box:</font></div><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Preliminary Proxy Statement</font></div><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</font></div><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#254;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Definitive Proxy Statement</font></div><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Definitive Additional Materials</font></div><div style="line-height:130%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Soliciting Material Pursuant to &#167; 240.14a-12</font></div><div style="line-height:130%;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">SI-BONE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:33.13492063492063%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:130%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Name of Registrant as Specified In Its Charter)</font></div><div style="line-height:130%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">N/A</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:33.53174603174603%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:130%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Name of Person(s) Filing Proxy Statement if Other Than the Registrant)</font></div><div style="line-height:130%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Payment of Filing Fee (Check the appropriate box)</font></div><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#254;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;No fee required.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.</font></div><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title of each class of securities to which transaction applies:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.20634920634922%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:130%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Aggregate number of securities to which transaction applies:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.20634920634922%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:130%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.20634920634922%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:130%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Proposed maximum aggregate value of transaction:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.20634920634922%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:130%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total fee paid:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.20634920634922%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:130%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Fee paid previously with preliminary materials.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously.  Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.</font></div><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amount Previously Paid:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.20634920634922%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Form, Schedule or Registration Statement No.:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.20634920634922%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Filing Party:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.20634920634922%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date Filed:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.20634920634922%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div><br></div><div></div><hr style="page-break-after:always"><div><a name="sb66dea48fd434ad886f71d1f30c31b27"></a></div><div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">INVITATION TO 2019 ANNUAL MEETING OF STOCKHOLDERS</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DATE: Thursday, June 13, 2019</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">TIME: 10:00&#160;a.m., local time</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">PLACE: The Offices of Cooley LLP</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">3175 Hanover Street, Palo Alto, CA 94304</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:right;padding-left:336px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">April 30, 2019</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dear Stockholders:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Please join me at the Annual Meeting of Stockholders of SI-BONE, Inc. on June 13, 2019. At the annual meeting, we will ask you to:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(i) elect the Board of Directors&#8217; nominees Timothy E. Davis, Jr., Heyward R. Donigan and Mark J. Foley as directors serving in Class I of the Board of Directors of SI-BONE, each to serve until the next annual meeting in which directors in Class I shall be elected, or until a successor is duly elected and qualified;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(ii) ratify the selection by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2019; and</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(iii) conduct any other business properly brought before the meeting.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Members of the Board of Directors will also be present.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Whether or not you are able to attend the annual meeting in person, it is important that your shares be represented.  We have provided in the accompanying proxy statement instructions on how to vote your shares.  Please vote as soon as possible.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:288px;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sincerely yours,</font></div><div style="line-height:120%;text-align:left;padding-left:288px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:288px;text-indent:48px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:39.48412698412698%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Jeffrey W. Dunn</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Jeffrey W. Dunn</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chairman and Chief Executive Officer</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;padding-left:288px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div></div><hr style="page-break-after:always"><div><a name="sEB8B53D31CEA5D4DCB225656502E6465"></a></div><div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:130%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SI-BONE, INC.</font></div><div style="line-height:130%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">471 El Camino Real, Suite 101</font></div><div style="line-height:130%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Santa Clara, California 95050</font></div><div style="line-height:130%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTICE OF ANNUAL MEETING OF STOCKHOLDERS</font></div><div style="line-height:130%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">To Be Held on June 13, 2019</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dear Stockholder:</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">You are cordially invited to attend the Annual Meeting of Stockholders of </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SI-BONE, INC.</font><font style="font-family:inherit;font-size:10pt;">, a Delaware corporation.  The meeting will be held on Thursday, June 13, 2019 at 10:00 a.m. local time at the offices of Cooley LLP at 3175 Hanover Street, Palo Alto, CA 94304 for the following purposes: </font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">1.&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;">To elect the Board of Director&#8217;s three nominees for director to serve until the 2022 Annual Meeting of Stockholders or until their successors are elected and qualified.  </font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2.&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;">To ratify the selection by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2019.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">3.&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;">To conduct any other business properly brought before the meeting.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These items of business are more fully described in the Proxy Statement accompanying this Notice.</font></div><div style="line-height:130%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The record date for the Annual Meeting is April 15, 2019.  Only stockholders of record at the close of business on that date may vote at the meeting or any adjournment thereof. </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.20634920634922%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Important Notice Regarding the Availability of Proxy Materials for the Stockholders&#8217; Meeting to Be Held on June 13, 2019 at the offices of Cooley LLP at 3175 Hanover Street, Palo Alto, CA 94304.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The proxy statement and annual report to stockholders </font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">are available at  </font><a style="font-family:inherit;font-size:10pt;" href="#"><font style="font-family:inherit;font-size:10pt;">www.proxyvote.com</font></a><font style="font-family:inherit;font-size:10pt;">.</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:130%;padding-bottom:8px;padding-top:8px;text-align:justify;padding-left:336px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By Order of the Board of Directors</font></div><div style="line-height:120%;text-align:justify;padding-left:336px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:39.48412698412698%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Michael A. Pisetsky</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Michael A. Pisetsky</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Secretary and General Counsel</font></div></td></tr></table></div></div><div style="line-height:130%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Santa Clara, California</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">April 30, 2019</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">You are cordially invited to attend the meeting in person.  Whether or not you expect to attend the meeting, please complete, date, sign and return the enclosed proxy, or vote over the telephone or the internet as instructed in these materials, as promptly as possible in order to ensure your representation at the meeting.  A return envelope (which is postage prepaid if mailed in the United States) has been provided for your convenience.  Even if you have voted by proxy, you may still vote in person if you attend the meeting.  Please note, however, that if your shares are held of record by a broker, bank or other nominee and you wish to vote at the meeting, you must obtain a proxy issued in your name from that record holder.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:130%;padding-bottom:10px;text-align:left;text-indent:312px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><a name="s75EC9241FF746FD68E3C5656505F72F9"></a></div><div><div style="line-height:130%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Table of Contents</font></div><div style="line-height:130%;padding-bottom:10px;text-align:right;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:95.43650793650794%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:91%;"></td><td style="width:9%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:10px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Page</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sF9D5629C875FB22B195A565650B45376"><font style="font-family:inherit;font-size:10pt;">QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sF9D5629C875FB22B195A565650B45376">1</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s6C826F9B8884B334C7DF565650EB3D46"><font style="font-family:inherit;font-size:10pt;">PROPOSAL NO. 1  ELECTION OF DIRECTORS</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s6C826F9B8884B334C7DF565650EB3D46">6</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s6D6028D4908A29BB73AC5656510DB23F"><font style="font-family:inherit;font-size:10pt;">INFORMATION REGARDING THE BOARD OF DIRECTORS AND CORPORATE GOVERNANCE</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s6D6028D4908A29BB73AC5656510DB23F">9</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s861BAB4C35A7C888F63F5656512995F8"><font style="font-family:inherit;font-size:10pt;">Family Relationships</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s861BAB4C35A7C888F63F5656512995F8">9</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s57FE019D6B50F5F69D885656515A0D25"><font style="font-family:inherit;font-size:10pt;">Independence of the Board of Directors</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s57FE019D6B50F5F69D885656515A0D25">9</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s4EBF8EC7D5DDD7034BB05656517B2F5A"><font style="font-family:inherit;font-size:10pt;">Board Leadership Structure</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s4EBF8EC7D5DDD7034BB05656517B2F5A">10</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sDB647A818DE3B71EA3A8565651AEDFF5"><font style="font-family:inherit;font-size:10pt;">Role of the Board in Risk Oversight</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sDB647A818DE3B71EA3A8565651AEDFF5">10</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sE789503A62D771514143565651CEB0C0"><font style="font-family:inherit;font-size:10pt;">Meetings of The Board of Directors</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sE789503A62D771514143565651CEB0C0">10</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s726F73E2D3204620A0A15656520070F5"><font style="font-family:inherit;font-size:10pt;">Board Committees and Meetings</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s726F73E2D3204620A0A15656520070F5">11</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:76px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s3721A00B3815EAC6533E56565222445E"><font style="font-family:inherit;font-size:10pt;">Audit Committee</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s3721A00B3815EAC6533E56565222445E">11</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:76px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sF4AFA3333128B2C09790565652523280"><font style="font-family:inherit;font-size:10pt;">Compensation Committee</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sF4AFA3333128B2C09790565652523280">12</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:76px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sC05E519B58169715CE2C56565274A13C"><font style="font-family:inherit;font-size:10pt;">Nominating and Corporate Governance Committee</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sC05E519B58169715CE2C56565274A13C">14</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s33B01C5C708C5D6468C6565652A9FC3C"><font style="font-family:inherit;font-size:10pt;">Stockholder Communications With The Board Of Directors</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s33B01C5C708C5D6468C6565652A9FC3C">15</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s0E0670040C6AFE659500565652CA8D55"><font style="font-family:inherit;font-size:10pt;">Code of Business Conduct and Ethics</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s0E0670040C6AFE659500565652CA8D55">15</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sA614E7A312979C5D7C47565652FB9FFA"><font style="font-family:inherit;font-size:10pt;">Corporate Governance Guidelines</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sA614E7A312979C5D7C47565652FB9FFA">16</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sC59AE993C3C018B66D515656531D0873"><font style="font-family:inherit;font-size:10pt;">PROPOSAL NO. 2  RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sC59AE993C3C018B66D515656531D0873">16</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sAFA145225470A3D4EF8F5656534D2638"><font style="font-family:inherit;font-size:10pt;">Principal Accountant Fees and Services</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sAFA145225470A3D4EF8F5656534D2638">16</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s271F5516EB605BA3937656565386CA35"><font style="font-family:inherit;font-size:10pt;">Pre-Approval Policies and Procedures</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s271F5516EB605BA3937656565386CA35">17</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sB8EEDE2B78297D11C1EF565653A28994"><font style="font-family:inherit;font-size:10pt;">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sB8EEDE2B78297D11C1EF565653A28994">18</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s8A89EF2627B0C99284F8565653C2C339"><font style="font-family:inherit;font-size:10pt;">Section 16(a) Beneficial Ownership Reporting Compliance</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s8A89EF2627B0C99284F8565653C2C339">20</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sE73854E9AA355B395D8C565653F503D0"><font style="font-family:inherit;font-size:10pt;">MANAGEMENT</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sE73854E9AA355B395D8C565653F503D0">20</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s754488FF158726FA7A13565654144BEE"><font style="font-family:inherit;font-size:10pt;">EXECUTIVE COMPENSATION</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s754488FF158726FA7A13565654144BEE">22</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s14C90E6CD8BE4AADA183565654461041"><font style="font-family:inherit;font-size:10pt;">Summary Compensation Table</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s14C90E6CD8BE4AADA183565654461041">22</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s640AF01A45C20B21D55E56565469C76E"><font style="font-family:inherit;font-size:10pt;">Outstanding Equity Awards at December 31, 2018</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s640AF01A45C20B21D55E56565469C76E">23</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sF807541C6D8C1076C0495656549BEF0C"><font style="font-family:inherit;font-size:10pt;">401(k) Plan</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sF807541C6D8C1076C0495656549BEF0C">23</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sAAF7A7229B02AC478D2D565654BD857B"><font style="font-family:inherit;font-size:10pt;">Emerging Growth Company Status</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sAAF7A7229B02AC478D2D565654BD857B">24</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s176182b6a7bf41328fc431f0d1a59063"><font style="font-family:inherit;font-size:10pt;">Pension Benefits</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s176182b6a7bf41328fc431f0d1a59063">24</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sEABEBE6B34D81F4C65D8565654EFDABC"><font style="font-family:inherit;font-size:10pt;">Nonqualified Deferred Compensation</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sEABEBE6B34D81F4C65D8565654EFDABC">24</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sA190A0D77503942E6E375656550F1A1B"><font style="font-family:inherit;font-size:10pt;">Employment Severance and Change in Control Agreements</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sA190A0D77503942E6E375656550F1A1B">24</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sC9FA6D726293C17A3A515656554329D6"><font style="font-family:inherit;font-size:10pt;">Securities Authorized for Issuance under Equity Compensation Plans</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sC9FA6D726293C17A3A515656554329D6">27</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;background-color:#ffffff;" href="#s7B13BAB515ED3A9E615F5656556402EA"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">Compensation of Non-Employee Board Members</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s7B13BAB515ED3A9E615F5656556402EA">27</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s11F8689F1551D70DE1AB565655953C0E"><font style="font-family:inherit;font-size:10pt;">Non-Employee Director Compensation Policy</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s11F8689F1551D70DE1AB565655953C0E">28</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s866a65a415d44e04bf69c9ab7cadaa84"><font style="font-family:inherit;font-size:10pt;">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s866a65a415d44e04bf69c9ab7cadaa84">29</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s77eb485cab1d492d9a992d3e5787420e"><font style="font-family:inherit;font-size:10pt;">Related-Person Transactions Policy and Procedures</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s77eb485cab1d492d9a992d3e5787420e">29</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sd9d57f6cb3204d0fa932afb5b0a631f6"><font style="font-family:inherit;font-size:10pt;">Certain Related-Person Transactions</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sd9d57f6cb3204d0fa932afb5b0a631f6">29</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s14289904beaa49e4b5c6104dbfe33461"><font style="font-family:inherit;font-size:10pt;">INDEMNIFICATION AGREEMENTS</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s14289904beaa49e4b5c6104dbfe33461">30</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s97582b9700cb48c6b85af549cd52eef5"><font style="font-family:inherit;font-size:10pt;">HOUSEHOLDING OF PROXY MATERIALS</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s97582b9700cb48c6b85af549cd52eef5">30</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s8518e08d9c614a8b9bf6503f1e1daadc"><font style="font-family:inherit;font-size:10pt;">OTHER MATTERS</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s8518e08d9c614a8b9bf6503f1e1daadc">31</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s3e7864d3af6545f99d991dfcd5138387"><font style="font-family:inherit;font-size:10pt;">PROXY CARD</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s3e7864d3af6545f99d991dfcd5138387">32</a></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:130%;padding-bottom:8px;text-align:left;padding-left:48px;text-indent:624px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><br></div><div><div style="line-height:130%;padding-bottom:10px;text-align:left;text-indent:312px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><a name="sF83476FBCC3316BC475D5656508436AF"></a></div><div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:130%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SI-BONE, INC. </font></div><div style="line-height:130%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">471 El Camino Real, Suite 101</font></div><div style="line-height:130%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Santa Clara, California 95050</font></div><div style="line-height:130%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">PROXY STATEMENT</font></div><div style="line-height:130%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">FOR THE 2019 ANNUAL MEETING OF STOCKHOLDERS</font></div><div style="line-height:130%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">June 13, 2019</font></div><div><a name="sF9D5629C875FB22B195A565650B45376"></a></div><div style="line-height:130%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Why am I receiving these materials?</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have sent you these proxy materials because our Board of Directors (the &#8220;Board&#8221;) is soliciting your proxy to vote at the 2019 Annual Meeting of Stockholders, including at any adjournments or postponements of the meeting.  You are invited to attend the annual meeting to vote on the proposals described in this proxy statement.  However, you do not need to attend the meeting to vote your shares.  Instead, you may simply complete, sign and return the enclosed proxy card, or follow the instructions below to submit your proxy over the telephone or through the internet.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We intend to mail these proxy materials on or about May 7, 2019 to all stockholders of record entitled to vote at the annual meeting.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">How do I attend the annual meeting?</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The meeting will be held on Thursday, June 13, 2019 at 10:00 a.m. local time at the offices of Cooley LLP at 3175 Hanover Street, Palo Alto, California 94304.  Directions to the annual meeting may be found at </font><a style="font-family:inherit;font-size:10pt;" href="#"><font style="font-family:inherit;font-size:10pt;">www.proxyvote.com</font></a><font style="font-family:inherit;font-size:10pt;">.</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">Information on how to vote in person at the annual meeting is discussed below.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Who can vote at the annual meeting?</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Only stockholders of record at the close of business on April 15, 2019, will be entitled to vote at the annual meeting.  On this record date, there were 24,502,484 shares of common stock outstanding and entitled to vote. </font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Stockholder of Record:  Shares Registered in Your Name</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If on April 15, 2019, your shares were registered directly in your name with our transfer agent, American Stock Transfer &amp; Trust Company, LLC, then you are a stockholder of record.  As a stockholder of record, you may vote in person at the meeting or vote by proxy.  Whether or not you plan to attend the meeting, we urge you to fill out and return the enclosed proxy card or vote by proxy over the telephone or on the internet as instructed below to ensure your vote is counted. </font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Beneficial Owner:  Shares Registered in the Name of a Broker or Bank</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If on April 15, 2019,</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:10pt;">your shares were held, not in your name, but rather in an account at a brokerage firm, bank or other similar organization, then you are the beneficial owner of shares held in &#8220;street name&#8221; and these proxy materials are being forwarded to you by that organization.  The organization holding your account is considered to be the stockholder of record for purposes of voting at the annual meeting.  As a beneficial owner, you have the right to direct your broker, bank or other agent regarding how to vote the shares in your account.  You are also invited to attend the annual meeting.  However, since you are not the stockholder of record, you may not vote your shares in person at the meeting unless you request and obtain a valid proxy from your broker, bank or other agent. </font></div><div><br></div><div><div style="line-height:130%;padding-bottom:10px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1</font></div></div><hr style="page-break-after:always"><div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">What am I voting on?</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">There are two matters scheduled for a vote: </font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Election of three directors (Proposal No. 1); and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ratification of selection by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as independent registered public accounting firm of SI-BONE for its fiscal year ending December 31, 2019 (Proposal No. 2).</font></div></td></tr></table><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">What if another matter is properly brought before the meeting?</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Board of Directors knows of no other matters that will be presented for consideration at the Annual Meeting.  If any other matters are properly brought before the meeting, it is the intention of the persons named in the accompanying proxy to vote on those matters in accordance with their best judgment.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">How do I vote?</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">You may either vote &#8220;For&#8221; all the nominees to the Board of Directors or you may &#8220;Withhold&#8221; your vote for any nominee you specify.  For the ratification of selection by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as independent registered public accounting firm of SI-BONE for its fiscal year ending December 31, 2019, you may vote &#8220;For&#8221; or &#8220;Against&#8221; or abstain from voting. </font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The procedures for voting are fairly simple:</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Stockholder of Record: Shares Registered in Your Name</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If you are a stockholder of record, you may vote in person at the annual meeting, vote by proxy using the enclosed proxy card, vote by proxy over the telephone, or vote by proxy through the internet.  Whether or not you plan to attend the meeting, we urge you to vote by proxy to ensure your vote is counted.  You may still attend the meeting and vote in person even if you have already voted by proxy.</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">To vote in person, come to the annual meeting and we will give you a ballot when you arrive. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">To vote using the proxy card, simply complete, sign and date the enclosed proxy card and return it promptly in the envelope provided.  If you return your signed proxy card to us before the annual meeting, we will vote your shares as you direct.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">To vote over the telephone, dial toll-free 1-800-690-6903 using a touch-tone phone and follow the recorded instructions.  You will be asked to provide the company number and control number from the enclosed proxy card.  Your telephone vote must be received by 11:59 p.m., Eastern Time on June 12, 2019, to be counted.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">To vote through the internet, go to www.proxyvote.com</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:10pt;">to complete an electronic proxy card.  You will be asked to provide the company number and control number from the enclosed proxy card.  Your internet vote must be received by 11:59 p.m. Eastern Time on June 12, 2019 to be counted. </font></div></td></tr></table><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Beneficial Owner:  Shares Registered in the Name of Broker or Bank</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If you are a beneficial owner of shares registered in the name of your broker, bank or other agent, you should have received a voting instruction form with these proxy materials from that organization rather than from us.  Simply complete and mail the voting instruction form to ensure that your vote is counted.  Alternatively, you may vote by telephone or over the internet as instructed by your broker or bank.  To vote in person at the annual meeting, you must obtain a valid proxy from your broker, bank or other agent.  Follow the instructions from your broker, bank or other agent included with these proxy materials, or contact that organization to request a proxy form. </font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:130%;padding-bottom:10px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2</font></div></div><hr style="page-break-after:always"><div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.20634920634922%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Internet proxy voting may be provided to allow you to vote your shares online, with procedures designed to ensure the authenticity and correctness of your proxy vote instructions.  However, please be aware that you must bear any costs associated with your internet access, such as usage charges from internet access providers and telephone companies. </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.20634920634922%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">How many votes do I have?</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On each matter to be voted upon, you have one vote for each share of common stock you own as of April 15, 2019.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">If I am a stockholder of record and I do not vote, or if I return a proxy card or otherwise vote without giving specific voting instructions, what happens?</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If you are a stockholder of record and do not vote by completing your proxy card, by telephone, through the internet</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:10pt;">or in person at the annual meeting, your shares will not be voted.  </font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If you return a signed and dated proxy card or otherwise vote without marking voting selections, your shares will be voted, as applicable, &#8220;For&#8221; the election of all three nominees for director, and &#8220;For&#8221; the ratification of selection by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as independent registered public accounting firm of SI-BONE for its fiscal year ending December 31, 2019.  If any other matter is properly presented at the meeting, your proxyholder (one of the individuals named on your proxy card) will vote your shares using his or her best judgment.</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">If I am a beneficial owner of shares held in street name and I do not provide my broker or bank with voting instructions, what happens?</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If you are a beneficial owner of shares held in street name and you do not instruct your broker, bank or other agent how to vote your shares, your broker, bank or other agent may still be able to vote your shares in its discretion.  In this regard, under the rules of the New York Stock Exchange (&#8220;NYSE&#8221;), brokers, banks and other securities intermediaries that are subject to NYSE rules may use their discretion to vote your &#8220;uninstructed&#8221; shares with respect to matters considered to be &#8220;routine&#8221; under NYSE rules, but not with respect to &#8220;non-routine&#8221; matters. In this regard, Proposal 1, the election of directors, is considered to be &#8220;non-routine&#8221; under NYSE rules meaning that your broker may not vote your shares on that proposals in the absence of your voting instructions. However, Proposal 2 is considered to be a &#8220;routine&#8221; matter under NYSE rules meaning that if you do not return voting instructions to your broker by its deadline, your shares may be voted by your broker in its discretion on Proposal 2</font><font style="font-family:inherit;font-size:10pt;color:#7030a0;">.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">If you a beneficial owner of shares held in street name, in order to ensure your shares are voted in the way you would prefer, you </font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">must</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">&#32;provide voting instructions to your broker, bank or other agent by the deadline provided in the materials you receive from your broker, bank or other agent.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Who is paying for this proxy solicitation?</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We will pay for the entire cost of soliciting proxies.  In addition to these proxy materials, our directors and employees may also solicit proxies in person, by telephone, or by other means of communication.  Directors and employees will not be paid any additional compensation for soliciting proxies.  We may also reimburse brokerage firms, banks and other agents for the cost of forwarding proxy materials to beneficial owners.</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">What does it mean if I receive more than one set of proxy materials?</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If you receive more than one set of proxy materials, your shares may be registered in more than one name or in different accounts.  Please follow the voting instructions on the proxy cards in the proxy materials to ensure that all of your shares are voted.</font></div><div><br></div><div><div style="line-height:130%;padding-bottom:10px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3</font></div></div><hr style="page-break-after:always"><div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Can I change my vote after submitting my proxy?</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Stockholder of Record: Shares Registered in Your Name</font></div><div style="line-height:130%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Yes.  You can revoke your proxy at any time before the final vote at the meeting.  If you are the record holder of your shares, you may revoke your proxy in any one of the following ways:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">You may submit another properly completed proxy card with a later date.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">You may grant a subsequent proxy by telephone or through the internet.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">You may send a timely written notice that you are revoking your proxy to our Secretary at 471 El Camino Real, Suite 101, Santa Clara, California 95050.</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">You may attend the annual meeting and vote in person.  Simply attending the meeting will not, by itself, revoke your proxy.</font></div></td></tr></table><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Your most current proxy card or telephone or internet proxy is the one that is counted.  </font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Beneficial Owner:  Shares Registered in the Name of Broker or Bank</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If your shares are held by your broker, bank or other agent, you should follow the instructions provided by your broker, bank or other agent.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">When are Stockholder proposals due for next year&#8217;s annual meeting?</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">To be considered for inclusion in next year&#8217;s proxy materials, your proposal must be submitted in writing by January 8, 2020, to SI-BONE, Inc., Attn: Michael A. Pisetsky, General Counsel, 471 El Camino Real, Suite 101, Santa Clara, California 95050.  </font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If you wish to submit a proposal (including a director nomination) at the meeting that is not to be included in next year&#8217;s proxy materials, your proposal must be submitted in writing and </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">received by our Secretary at our executive offices located at</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">471 El Camino Real, Suite 101, Santa Clara, California 95050, </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">not later than the close of business on March 15, 2020, nor earlier than the close of business on February 14, 2020;&#160;</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-style:italic;">provided, however,</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">&#160;that in the event that the date of the annual meeting is held earlier than May 14, 2020, or held later than July 13, 2020, notice by the stockholder to be timely must be so received not earlier than the close of business on the one hundred twentieth (120</font><font style="font-family:inherit;font-size:8.5pt;background-color:#ffffff;"><sup style="vertical-align:top;line-height:120%;background-color:#ffffff; font-size:pt">th</sup></font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">) day prior to such annual meeting and not later than the close of business on the later of the ninetieth (90</font><font style="font-family:inherit;font-size:8.5pt;background-color:#ffffff;"><sup style="vertical-align:top;line-height:120%;background-color:#ffffff; font-size:pt">th</sup></font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">) day prior to such annual meeting or the tenth (10</font><font style="font-family:inherit;font-size:8.5pt;background-color:#ffffff;"><sup style="vertical-align:top;line-height:120%;background-color:#ffffff; font-size:pt">th</sup></font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">) day following the day on which public announcement of the date of such meeting is first made.</font><font style="font-family:inherit;font-size:10pt;">&#32;</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stockholders wishing to make stockholder proposals or nominations for directors should consult our bylaws, which contain additional requirements and information regarding these matters.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">How are votes counted?</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Votes will be counted by the inspector of election appointed for the meeting, who will separately count, (a) for the proposal to elect directors, votes &#8220;For,&#8221; votes &#8220;Withheld&#8221; and broker non-votes, and (b) with respect to the ratification of selection by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as independent registered public accounting firm of SI-BONE for its fiscal year ending December 31, 2019, or any other proposals, votes  &#8220;For&#8221; and &#8220;Against,&#8221; abstentions and, if applicable, broker non-votes.</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Abstentions will be counted towards the vote total for Proposal No. 2, and will have the same effect as &#8220;Against&#8221; votes. Broker non-votes have no effect and will not be counted towards the vote total for any proposal.</font></div><div><br></div><div><div style="line-height:130%;padding-bottom:10px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4</font></div></div><hr style="page-break-after:always"><div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">What are &#8220;broker non-votes&#8221;? </font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As discussed above, when a beneficial owner of shares held in street name does not give voting instructions to his or her broker, bank or other securities intermediary holding his or her shares as to how to vote on matters deemed to be &#8220;non-routine&#8221; under NYSE rules, the broker, bank or other such agent cannot vote the shares. These un-voted shares are counted as &#8220;broker non-votes.&#8221;  </font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">As a reminder, if you </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-style:italic;font-weight:bold;">a beneficial owner of shares held in street name</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">, in order to ensure your shares are voted in the way you would prefer, you </font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">must</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">&#32;provide voting instructions to your broker, bank or other agent by the deadline provided in the materials you receive from your broker, bank or other agent.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">How many votes are needed to approve each proposal? </font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the minimum vote needed to approve each proposal and the effect of abstentions and broker non-votes.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.20634920634922%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:12%;"></td><td style="width:2%;"></td><td style="width:31%;"></td><td style="width:2%;"></td><td style="width:27%;"></td><td style="width:2%;"></td><td style="width:12%;"></td><td style="width:2%;"></td><td style="width:10%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;padding-left:1px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Proposal Number</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;padding-left:1px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Proposal Description</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;padding-left:1px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Vote Required for Approval</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;padding-left:1px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Effect of Abstentions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;padding-left:1px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Effect of Broker Non-Votes</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;padding-left:1px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:12px;"><div style="text-align:left;padding-left:1px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Election of Directors</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:5px;"><div style="text-align:left;padding-left:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nominees receiving the most &#8220;For&#8221; votes; withheld votes will have no effect</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:5px;"><div style="text-align:left;padding-left:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Not applicable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:1px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">No effect</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;padding-left:1px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:12px;"><div style="text-align:left;padding-left:1px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ratification of the selection of PricewaterhouseCoopers LLP as SI-BONE&#8217;s independent registered public accounting firm for the fiscal year ending December 31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:5px;"><div style="text-align:left;padding-left:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8220;For&#8221; votes from the holders of a majority of shares present in person or represented by proxy and entitled to vote on the matter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:5px;"><div style="text-align:left;padding-left:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Against</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:1px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">No effect</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">What is the quorum requirement?</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A quorum of stockholders is necessary to hold a valid meeting.  A quorum will be present if stockholders</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:10pt;">holding</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:10pt;">at least a majority of the outstanding shares entitled to vote are present at the meeting in person or represented by proxy.  On the record date, there were 24,502,484 shares</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:10pt;">outstanding and entitled to vote.</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt"> </sup></font><font style="font-family:inherit;font-size:10pt;">Thus, the holders of 12,251,243 shares must be present in person or represented by proxy at the meeting to have a quorum.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Your shares will be counted towards the quorum only if you submit a valid proxy (or one is submitted on your behalf by your broker, bank or other nominee) or if you vote in person at the meeting.  Abstentions and broker non-votes will be counted towards the quorum requirement.  If there is no quorum, the chairman of the meeting or the holders of a majority of shares present at the meeting in person or represented by proxy may adjourn the meeting to another date.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">How can I find out the results of the voting at the annual meeting?</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Preliminary voting results will be announced at the annual meeting.  In addition, final voting results will be published in a current report on Form 8-K that we expect to file within four business days after the annual meeting.  If final voting results are not available to us in time to file a Form&#160;8-K within four business days after the meeting, we intend to file a Form&#160;8&#8209;K to publish preliminary results and, within four business days after the final results are known to us, file an additional Form&#160;8-K to publish the final results.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">What proxy materials are available on the internet? </font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The proxy statement and Annual Report to</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;S</font><font style="font-family:inherit;font-size:10pt;">tockholders are available at </font><a style="font-family:inherit;font-size:10pt;" href="#"><font style="font-family:inherit;font-size:10pt;">www.proxyvote.com</font></a><font style="font-family:inherit;font-size:10pt;font-weight:bold;">. </font></div><div><br></div><div><div style="line-height:130%;padding-bottom:10px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5</font></div></div><hr style="page-break-after:always"><div><a name="s6C826F9B8884B334C7DF565650EB3D46"></a></div><div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:130%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">PROPOSAL NO. 1</font><font style="font-family:inherit;font-size:10pt;">&#32;<br> <br></font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ELECTION OF DIRECTORS</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our Board of Directors currently consists of nine members and is divided into three classes.  Each class consists, as nearly as possible, of one-third of the total number of directors, and each class has a three-year term.  Vacancies on the Board may be filled only by persons elected by a majority of the remaining directors.  A director elected by the Board to fill a vacancy in a class, including vacancies created by an increase in the number of directors, shall serve for the remainder of the full term of that class and until the director&#8217;s successor is duly elected and qualified. </font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our Board of Directors was elected pursuant to the provision of a voting agreement and the related provisions of our amended and restated certificate of incorporation as in effect prior to the initial public offering of our common stock. Under the terms of this voting agreement, the stockholders party thereto agreed to vote their respective shares to elect: (1)&#160;two directors designated by the holders of a majority of the then outstanding shares of Series 2 common, which were Jeffrey W. Dunn and Dr.&#160;Mark A. Reiley; (2)&#160;one director designated by Skyline Venture Partners Qualified Purchaser Fund V, L.P., Dr.&#160;John G. Freund; (3)&#160;one director designated by Montreux Equity Partners IV, LP (which was not filled); (4)&#160;four directors approved by a majority of the members of our Board and at least one of whom has relevant industry experience relating to our business, Gregory K. Hinckley, Timothy E. Davis, Jr., Karen A. Licitra, and Keith C. Valentine; (5)&#160;one director designated by OrbiMed Advisors LLC or OrbiMed Private Investments V, LP, Dr.&#160;Bonita; and (6)&#160;one director designated by Arboretum IV, LP, Timothy&#160;Petersen.  The provisions of this voting agreement terminated upon the closing of our initial public offering.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our Board of Directors currently has nine</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:10pt;">members.  There are three directors in the class the term of which office expires in 2019:  Dr. Bonita, Dr. Reiley and Mr. Davis.  Mr. Davis is currently a member of our Board and has served as a member of our Board since our inception in 2008. Each of Dr. Bonita and Dr. Reiley have declined to stand for reelection at the upcoming annual meeting.  The two nominees to replace Dr. Bonita and Dr. Reiley, Heyward R. Donigan and Mark J. Foley were recommended by our Nominating and Corporate Governance Committee, following a thorough search process led by Korn Ferry, a third-party search firm.</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:10pt;">If elected at the annual meeting, each of the three nominees would serve until the 2022 annual meeting and until his or her successor has been duly elected and qualified, or, if sooner, until the director&#8217;s death, resignation or removal.  It is our policy to encourage directors and nominees for director to attend the Annual Meeting.  We did not hold an annual meeting of our stockholders in 2018.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Directors are elected by a plurality of the votes of the holders of shares present in person or represented by proxy and entitled to vote on the election of directors.  Accordingly, the three nominees receiving the highest number of affirmative votes will be elected.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following is a brief biography of each nominee and each director whose term will continue after the annual meeting.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOMINEES FOR ELECTION FOR A THREE-YEAR TERM EXPIRING AT THE 2022 ANNUAL MEETING</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-style:italic;font-weight:bold;">Timothy E. Davis, Jr.</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">, age 49,</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">has served as a member of our Board of Directors since our inception in April 2008. Mr. Davis has served as President and Chief Executive Officer of Active Implants, LLC, a company that provides orthopedic implant solutions, since February 2017. From January 2014 through September 2015, Mr. Davis served as Chief Executive Officer of MicroPort Orthopedics, Inc., a multinational producer of orthopedic products, following the purchase of Wright Medical Group&#8217;s OrthoRecon Business in January 2014. From December 2006 to January 2014, Mr. Davis served in a number of executive positions for Wright Medical Technology, Inc., a subsidiary of Wright Medical Group, Inc., including President of the OrthoRecon business. From 2004 to 2006, Mr. Davis was a Partner with MB Venture Partners, LLC, a medical technology and life sciences venture capital firm. From 1997 to 2004, Mr. Davis held various positions, ultimately serving as Vice President, with Vector Fund Management, a healthcare and life sciences focused venture capital fund. Early in his career, Mr. Davis worked in the healthcare management consulting and pharmaceutical industries. Mr. Davis received a B.E. degree in Biomedical Engineering from Vanderbilt University and an M.B.A. from the J.L. Kellogg Graduate School of Management at Northwestern University. We believe Mr. Davis&#8217; experience in the industry and his knowledge of our company enable him to make valuable contributions to our Board of Directors.</font></div><div><br></div><div><div style="line-height:130%;padding-bottom:10px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6</font></div></div><hr style="page-break-after:always"><div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-style:italic;font-weight:bold;">Heyward R. Donigan</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">, age 58, has served as President, Chief Executive Officer and director&#160;of Sapphire Digital, formerly, Vitals, a leading consumer transparency company, since March 2015. From 2010 to 2014, Ms.&#160;Donigan served as President, Chief Executive Officer and a director of ValueOptions, Inc., a health improvement company specializing in mental and emotional well-being and recovery, which merged with Beacon Health Strategies during 2014. Previously, Ms.&#160;Donigan was Executive Vice President and Chief Marketing Officer of Premera Blue Cross, an insurer doing business in Washington, Alaska, and Oregon, from 2003 to 2010. Ms.&#160;Donigan is director of Kindred Healthcare, Inc., a healthcare services company, and was a director of NxStage Medical, Inc., a medical technology company, until it was acquired by Fresenius Medical Care Holdings, Inc. in February 2019. With over 30 years of experience in all facets of the health plan business, including network management, contracting, sales and marketing, product development, and operations, Ms.&#160;Donigan brings extensive knowledge of the healthcare sector, strategic insight and leadership to our</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">Board of Directors</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Mark J. Foley</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">, age 53,</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">has more than 25 years of operational and investment experience in the healthcare arena. He was a Managing Director at RWI Ventures, a venture capital firm focused on life sciences, networking, semiconductor and software investments from 2004 to 2018. Previously, Mr. Foley was Chairman, director, President and CEO of ZELTIQ Aesthetics (ZLTQ), a medical technology company, serving from 2012 through the company&#8217;s acquisition by Allergan (AGN) in April 2017. Prior to ZELTIQ, Mr. Foley held a variety of senior operating roles in large public companies and venture-backed startups, including U.S. Surgical Corporation, Guidant Corporation, Devices for Vascular Intervention (acquired by Eli Lilly), Perclose (acquired by Abbott) and Ventrica (acquired by Medtronic), where he was the founder and CEO. He is a board member at Glaukos Corporation (GKOS) where he chairs the nominating, governance and compensation committee and Revance Therapeutics, Inc. (RVNC) where he chairs the audit committee. Additionally, he serves as Chairman of uLAB, HintMD and Arrinex which was acquired by Stryker Corporation (SYK) in 2019. Mr. Foley received a Bachelor of Arts degree from the University of Notre Dame. Our Board of Directors believes that Mr. Foley&#8217;s financial expertise, experience at multiple public healthcare companies and his expertise with the development and commercialization in medical device and biotechnology industries make him qualified to serve on our Board of Directors.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">THE BOARD OF DIRECTORS RECOMMENDS</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">A VOTE IN FAVOR OF EACH NAMED NOMINEE.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DIRECTORS CONTINUING IN OFFICE UNTIL THE 2020 ANNUAL MEETING</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Jeffrey W. Dunn</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">, age 64,</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">has served as our President and Chief Executive Officer and as the Chairman of our Board of Directors since our inception in April 2008. Prior to joining us, Mr. Dunn served as Chief Executive Officer of INBONE Technologies, Inc., an ankle replacement and small bone fusion medical device company, from December 2006 to April 2008, until its sale to Wright Medical Technology, Inc. in April 2008. From August 2000 to June 2006, Mr. Dunn was the Chief Executive Officer of Active Decisions, Inc., a software as a service business, until its sale to Knova Software, Inc. From December 1999 to June 2000, Mr. Dunn was the Chief Executive Officer of Velogic, Inc., an internet performance testing software company, until its sale to Keynote Systems Inc. From June 1999 to December 1999, Mr. Dunn was the Chief Executive Officer of EnterpriseLink Inc., a provider of enterprise Internet enablement software, until its sale to Merant, Inc. From November 1994 to June 1998, Mr. Dunn was Chief Executive Officer of AccelGraphics Inc., a 3D graphics system supplier, until its sale to Evans and Sutherland Computer Corporation. As well, during his career, Mr. Dunn held executive positions with Evans and Sutherland, Cygnet Systems, Inc., Avnet, Inc. and Xerox Corporation. Mr. Dunn received a B.A. from Colgate University and an M.B.A. from Babson College. We believe Mr. Dunn&#8217;s experience in the industry, his role as our President and Chief Executive Officer, and his knowledge of our company enable him to make valuable contributions to our Board of Directors.</font></div><div><br></div><div><div style="line-height:130%;padding-bottom:10px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7</font></div></div><hr style="page-break-after:always"><div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">John G. Freund, M.D.</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">, age 65,</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">has served as a member of our Board of Directors since January 2013. Dr. Freund founded Skyline Ventures, a venture capital firm, in October 1997 and has served as a Managing Director of Skyline since then. Prior to joining Skyline, Dr. Freund served as Managing Director in the private equity group of Chancellor Capital Management, a private capital investment firm. In November 1995, Dr. Freund co-founded Intuitive Surgical, Inc., a medical device company, and served on its board of directors until March 2000. From 1988 to 1994, he held various positions at Acuson Corporation, a maker of ultrasound equipment that is now part of Siemens, most recently as Executive Vice President. Prior to joining Acuson, Dr. Freund was a general partner of Morgan Stanley Venture Partners from 1987 to 1988. From 1982 to 1988, Dr. Freund was at Morgan Stanley &amp; Co., an investment banking company, where he co-founded the Healthcare Group in the Corporate Finance Department in 1983. Dr. Freund has served on the board of directors of Collegium Pharmaceuticals, Inc., a biotechnology company, since 2014, Tetraphase Pharmaceuticals, Inc., medical technology company, since 2012, and Proteon Therapeutics, Inc., a biotechnology company, since 2014, Sutro Biopharma, Inc., a biotechnology company, since 2014. Dr. Freund also serves on the board of directors of six U.S. registered investment funds managed by affiliates of the Capital Group, Inc. He also previously served on the board of directors of four publicly traded companies, Map Pharmaceuticals, Inc., a biopharmaceutical company, MAKO Surgical Corp., a medical device company, Concert Pharmaceuticals, Inc., a biopharmaceutical company and was Chairman of XenoPort, Inc., a biopharmaceutical company. Dr. Freund is a member of the Advisory Board for the Harvard Business School Healthcare Initiative. Dr. Freund received a B.A. in History from Harvard College, an M.D. from Harvard Medical School, and an M.B.A. from Harvard Business School, where he was a Baker Scholar. We believe Dr. Freund&#8217;s experience with medical device companies, his role in the venture capital industry, and his knowledge of our company enable him to make valuable contributions to our Board of Directors. </font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-style:italic;font-weight:bold;">Gregory K. Hinckley</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">, age 72, has served as a member of our</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">Board of Directors</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">since January 2011. Mr.&#160;Hinckley served as President of Mentor Graphics Corporation, an electronic design automation company, from January 1999 until his retirement in July 2017, and served on the board of directors from January 1999 to June 2016. From January 1997 to January 1999, he served as Executive Vice President. He has also served as the Chief Financial Officer of Mentor Graphics, first from January 1997 to July 2007 and again from December 2008 to July 2017. Previously, he served on the board of directors of Super Micro Computer, Inc., a manufacturer of servers, from January 2009 to February 2015 and Intermec, Inc., a developer of automated identification and data collection solutions, from July 2004 to September 2013. From August 1992 to January 1997, Mr.&#160;Hinckley served as Senior Vice President, Finance of VLSI Technology, Inc., a designer and manufacturer of custom and semi-custom integrated circuits. From January 1989 to November 1991, he served as Senior Vice President and Chief Financial Officer of Crowley Maritime Corporation, a marine solutions, transportation, and logistics company. From February 1983 to January 1989, Mr.&#160;Hinckley served as Vice President and Chief Financial Officer, and since April 2017, Mr.&#160;Hinckley has served on the board of directors of&#160;Bio-Rad&#160;Laboratories, a manufacturer and supplier of products and systems for the life science research and healthcare markets. Previously, Mr.&#160;Hinckley held a number of senior officer positions with Raychem Corporation, a developer of products and services for the aerospace, automotive and telecommunications industries. Hinckley received a B.A. in Physics from Claremont McKenna College and was a Fulbright Scholar in applied mathematics at Nottingham University. He received an M.S. in Applied Physics from the University of California, San Diego and an M.B.A. from Harvard Business School. We believe Mr.&#160;Hinckley&#8217;s financial experience, his familiarity of serving on the boards of public companies, and his knowledge of our company enable him to make valuable contributions to our</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">Board of Directors</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DIRECTORS CONTINUING IN OFFICE UNTIL THE 2021 ANNUAL MEETING</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-style:italic;font-weight:bold;">Karen A. Licitra</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">, age 59, has served as a member of our</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">Board of Directors</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">since August 2015. From January 2014 through August 2015, Ms.&#160;Licitra served as Corporate Vice President, Worldwide Government Affairs&#160;&amp; Policy at Johnson&#160;&amp; Johnson, a medical devices, pharmaceutical, and consumer packaged goods manufacturer. From December 2011 to December 2013, Ms.&#160;Licitra served as the Worldwide Chairman, Global Medical Solutions at Johnson&#160;&amp; Johnson. From July 2002 to November 2011, she served as the Company Group Chairman and Worldwide Franchise Chairman at Ethicon Endo-Surgery, Inc., a Johnson&#160;&amp; Johnson medical device company. From January 2001 to June 2002, she served as the President of Ethicon Endo-Surgery. Ms. Licitra previously served on the board of directors of Novadaq Technologies Inc., a provider of proven comprehensive fluorescence imaging solutions, until the company was acquired by Stryker Corporation in 2017. Ms.&#160;Licitra received a B.S. in Commerce from Rider College. We believe Ms.&#160;Licitra&#8217;s experience working for medical device companies and her knowledge of our company enable her to make valuable contributions to our</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">Board of Directors</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">.</font></div><div><br></div><div><div style="line-height:130%;padding-bottom:10px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8</font></div></div><hr style="page-break-after:always"><div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-style:italic;font-weight:bold;">Timothy B. Petersen</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">, age 55, has served as a member of our</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">Board of Directors</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">since June 2016. Since April 2002, Mr.&#160;Petersen has been employed by Arboretum Ventures, Inc. As a Managing Partner of the firm, his investments primarily target capital-efficient medical device, health IT and services companies. Mr.&#160;Petersen has led investments and held board seats for Arboretum in more than fifteen companies, including HealthMedia (acquired by Johnson&#160;&amp; Johnson), Accuri Cytometers Inc. (acquired by Becton Dickinson), IntelliCyt Corporation (acquired by Sartorius AG) and Inogen. Mr.&#160;Petersen currently serves on the boards of several private companies in addition to our Company. Mr.&#160;Petersen holds a B.A. in Economics from Williams College, an M.S. in Economics from the University of Wisconsin-Madison, and an M.B.A. from the Ross School of Business at the University of Michigan. We believe Mr.&#160;Petersen&#8217;s extensive investment experience in the healthcare industry and his experience as a public company director enable him to make valuable contributions to our</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">Board of Directors</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-style:italic;font-weight:bold;">Keith C. Valentine</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">, age 51, has served as a member of our</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">Board of Directors</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">since August 2015. Since June 2015, Mr.&#160;Valentine has also served as President, Chief Executive Officer and a member of the board of directors of SeaSpine Holdings Corporation, a</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">global medical technology company</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">. From January 2007 to January 2015, he served as President and Chief Operating Officer of NuVasive, Inc., a medical device company. From December 2004 to January 2007, he served as President of NuVasive. From January 2001 to December 2004, he held various senior executive roles in marketing, development and operations at NuVasive. Previously, Mr.&#160;Valentine served as Vice President of Marketing at ORATEC Interventions, Inc., a medical device company acquired by Smith&#160;&amp; Nephew PLC, and spent eight years in various roles with Medtronic including Vice President of Marketing for the Thoracolumbar Division and Group Director for the BMP Biologics program, Interbody Sales Development, and International Sales and Marketing. Mr.&#160;Valentine received a B.B.A. in Management and Biomedical Sciences from Western Michigan University. We believe Mr.&#160;Valentine&#8217;s experience working for medical device companies and his knowledge of our company enable him to make valuable contributions to our Board of Directors.</font><font style="font-family:inherit;font-size:10pt;">&#32;</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Each of our directors, other than Mr. Dunn and Dr. Reiley, is independent as defined under the Nasdaq Global Market listing standards. See &#8220;Independence of the Board of Directors&#8221; immediately below, which information is incorporated by reference here.</font></div><div><a name="s6D6028D4908A29BB73AC5656510DB23F"></a></div><div style="line-height:130%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">INFORMATION REGARDING THE BOARD OF DIRECTORS AND CORPORATE GOVERNANCE</font></div><div><a name="s861BAB4C35A7C888F63F5656512995F8"></a></div><div style="line-height:130%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">FAMILY RELATIONSHIPS </font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">There are no family relationships among the directors and executive officers. </font></div><div><a name="s57FE019D6B50F5F69D885656515A0D25"></a></div><div style="line-height:130%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">INDEPENDENCE OF THE BOARD OF DIRECTORS</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As required under the Nasdaq Global Market (&#8220;Nasdaq&#8221;)</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:10pt;">listing standards, a majority of the members of a listed company&#8217;s Board of Directors must qualify as &#8220;independent,&#8221; as affirmatively determined by the Board. The Board consults with SI-BONE&#8217;s counsel to ensure that the Board&#8217;s determinations are consistent with relevant securities and other laws and regulations regarding the definition of &#8220;independent,&#8221; including those set forth in pertinent listing standards of Nasdaq, as in effect from time to time. </font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consistent with these considerations, after review of all relevant identified transactions or relationships between each director, or any of his or her family members, and SI-BONE, its senior management and its independent auditors, the Board has affirmatively determined that the following seven directors are independent directors within the meaning of the applicable Nasdaq</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:10pt;">listing standards: Dr. Bonita, Mr. Davis, Dr. Freund, Mr. Hinckley, Ms. Licitra, Mr. Petersen, and Mr. Valentine. In making this determination, the Board found that none of the directors or nominees for director other than Mr. Dunn and Dr. Reiley had a material or other disqualifying relationship with SI-BONE </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">and that each of these directors is &#8220;independent&#8221; as that term is defined under the rules of the Nasdaq Global Market</font><font style="font-family:inherit;font-size:10pt;">.  </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">Mr. Dunn is not independent given his position as our President and Chief Executive Officer, and Dr. Reiley is not independent given his status as the Chief Medical Officer of Reiley Pharmaceuticals, Inc., where Mr. Dunn and Mr. Valentine are members of the board of directors, and where Mr. Dunn also serves on the compensation committee. Accordingly, a majority of our directors are independent, as required under applicable Nasdaq listing rules.&#160;</font><font style="font-family:inherit;font-size:10pt;">Each of Ms. Donigan and Mr. Foley will be independent directors within the meaning of the applicable Nasdaq listing standards upon their election.  </font></div><div><br></div><div><div style="line-height:130%;padding-bottom:10px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9</font></div></div><hr style="page-break-after:always"><div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In making those independence determinations, the Board took into account certain relationships and transactions that occurred in the ordinary course of business between SI-BONE and entities with which some of our directors are or have been affiliated.  The Board considered the fact that each of </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">Arboretum Ventures, OrbiMed and Skyline Venture Partners participated in or initial public offering of our common stock, with which Mr. Petersen, Dr. Bonita and Dr. Freund, respectively, are affiliated, and</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">determined that these transactions were not transactions or relationships that would interfere with their exercise of independent judgment in carrying out their responsibilities as directors.</font></div><div><a name="s4EBF8EC7D5DDD7034BB05656517B2F5A"></a></div><div style="line-height:130%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">BOARD LEADERSHIP STRUCTURE</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our Board of Directors is currently chaired by the President and Chief Executive Officer of SI-BONE, Mr. Dunn.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We believe that combining the positions of Chief Executive Officer and Chairman helps to ensure that the Board and management act with a common purpose. In our view, separating the positions of Chief Executive Officer and Chairman has the potential to give rise to divided leadership, which could interfere with good decision-making or weaken SI-BONE&#8217;s ability to develop and implement strategy.  Instead, we believe that combining the positions of Chief Executive Officer and Chairman provides a single, clear chain of command to execute SI-BONE&#8217;s strategic initiatives and business plans. In addition, we believe that a combined Chief Executive Officer/Chairman is better positioned to act as a bridge between management and the Board, facilitating the regular flow of information. We also believe that it is advantageous to have a Chairman with an extensive history with and knowledge of SI-BONE (as is the case with our Chief Executive Officer).</font></div><div><a name="sDB647A818DE3B71EA3A8565651AEDFF5"></a></div><div style="line-height:130%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ROLE OF THE BOARD IN RISK OVERSIGHT</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">One of the key functions of our</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">Board of Directors</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">is informed oversight of our risk management process. In particular, our</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">Board</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">is responsible for monitoring and assessing strategic risk exposure. Our executive officers are responsible for the&#160;day-to-day&#160;management of the material risks we face. Our</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">Board</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">administers its oversight function directly as a whole, as well as through various standing committees of our</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">Board</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">that address risks inherent in their respective areas of oversight. For example, our Audit Committee is responsible for overseeing the management of risks associated with our financial reporting, accounting and auditing matters; our Compensation Committee oversees the management of risks associated with our compensation policies and programs; and our Nominating and Corporate Governance Committee oversees the management of risks associated with director independence, conflicts of interest, composition and organization of our</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">Board</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">, director succession planning, and oversight of healthcare, regulatory, and fraud and abuse compliance.</font></div><div><a name="sE789503A62D771514143565651CEB0C0"></a></div><div style="line-height:130%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">MEETINGS OF THE BOARD OF DIRECTORS</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our Board of Directors met six</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:10pt;">times during 2018.  Each Board member attended 75% or more of the aggregate number of meetings of the Board and of the committees on which he or she</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:10pt;">served, held during the portion of the last fiscal year for which he or she</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:10pt;">was a director or committee member.</font></div><div><br></div><div><div style="line-height:130%;padding-bottom:10px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10</font></div></div><hr style="page-break-after:always"><div><a name="s726F73E2D3204620A0A15656520070F5"></a></div><div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:130%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">BOARD COMMITTEES AND MEETINGS</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our Board of Directors has three standing committees:</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:10pt;">an Audit Committee, a Compensation Committee and a Nominating and Corporate Governance Committee.  The following table provides membership and meeting information for fiscal 2018 for each of the Board committees (Mr. Dunn did not serve on any committees in 2018 or to date): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:94.04761904761905%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td style="width:41%;"></td><td style="width:3%;"></td><td style="width:14%;"></td><td style="width:4%;"></td><td style="width:18%;"></td><td style="width:3%;"></td><td style="width:17%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:8px;"><div style="padding-bottom:8px;text-align:left;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Name</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:8px;"><div style="padding-bottom:8px;text-align:center;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Audit</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:8px;"><div style="padding-bottom:8px;text-align:center;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Compensation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:8px;"><div style="padding-bottom:8px;text-align:center;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nominating and Corporate Governance</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:8px;"><div style="text-align:left;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Jeffrey W. Dunn</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:8px;"><div style="text-align:left;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">David P. Bonita, M.D.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:8px;"><div style="text-align:center;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">X</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:8px;"><div style="text-align:left;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Timothy E. Davis</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:8px;"><div style="text-align:center;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">X</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:8px;"><div style="text-align:center;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">X*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:8px;"><div style="text-align:left;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">John G. Freund, M.D.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:8px;"><div style="text-align:center;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">X</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:8px;"><div style="text-align:left;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gregory K. Hinckley</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:8px;"><div style="text-align:center;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">X*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:8px;"><div style="text-align:left;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Karen A. Licitra</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:8px;"><div style="text-align:center;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">X</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:8px;"><div style="text-align:left;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Timothy B. Petersen</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:8px;"><div style="text-align:center;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">X</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:8px;"><div style="text-align:left;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Keith C. Valentine</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:8px;"><div style="text-align:center;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">X*</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:8px;"><div style="padding-bottom:16px;text-align:left;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total meetings in fiscal 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:8px;"><div style="padding-bottom:16px;text-align:center;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:8px;"><div style="padding-bottom:16px;text-align:center;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:8px;"><div style="padding-bottom:16px;text-align:center;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:17.857142857142858%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*&#160;&#160;&#160;&#160;Committee Chairperson</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Below is a description of each committee of the Board.  </font></div><div><a name="s3721A00B3815EAC6533E56565222445E"></a></div><div style="line-height:130%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Audit Committee</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our Audit Committee consists of&#160;Messrs. Davis, Hinckley, and Petersen, each of whom satisfies the independence requirements under the Nasdaq Global Market listing standards and Rule&#160;10A-3(b)(1)&#160;of the Exchange Act. The chairman of our Audit Committee is Mr.&#160;Hinckley. Our Board has determined that each of&#160;Messrs. Davis, Hinckley, and Petersen&#160;is an &#8220;audit committee financial expert&#8221; within the meaning of SEC regulations. Our Board has also determined that each member of our Audit Committee has the requisite financial expertise required under the applicable requirements of the Nasdaq Global Market. In arriving at this determination, the Board has examined each audit committee member&#8217;s scope of experience and the nature of their employment in the corporate finance sector.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The primary purpose of the Audit Committee is to discharge the responsibilities of our Board with respect to our accounting, financial, and other reporting and internal control practices and to oversee our independent registered public accounting firm. Specific responsibilities of our Audit Committee include:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">selecting a qualified firm to serve as the independent registered public accounting firm to audit our financial statements;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">helping to ensure the independence and performance of the independent registered public accounting firm;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">discussing the scope and results of the audit with the independent registered public accounting firm, and reviewing, with management and the independent accountants, our interim and year-end operating results;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">developing procedures for employees to submit concerns anonymously about questionable accounting or audit matters;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">reviewing our policies on risk assessment and risk management;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">reviewing related party transactions;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">obtaining and reviewing a report by the independent registered public accounting firm at least annually, that describes our internal quality-control procedures, any material issues with such procedures, and any steps taken to deal with such issues when required by applicable law; and</font></div></td></tr></table><div><br></div><div><div style="line-height:130%;padding-bottom:10px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11</font></div></div><hr style="page-break-after:always"><div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">approving (or, as permitted, pre-approving) all audit and all permissible non-audit service to be performed by the independent registered public accounting firm.</font></div></td></tr></table><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Audit Committee met five times during 2018.  Our Board has adopted a written Audit Committee charter that is available to stockholders</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:10pt;">on SI-BONE&#8217;s website at www.si-bone.com.</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our Board reviews the Nasdaq listing standards definition of independence for Audit Committee members on an annual and has determined that all members of SI-BONE&#8217;s Audit Committee are independent (as independence is currently defined in Rule 5605(c)(2)(A)(i) and (ii) of the Nasdaq listing standards).</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Report of the Audit Committee of the Board of Directors</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our Audit Committee has reviewed and discussed the audited financial statements for the fiscal year ended December 31, 2018</font><font style="font-family:inherit;font-size:10pt;color:#800080;">&#32;</font><font style="font-family:inherit;font-size:10pt;">with management of SI-BONE.  The Audit Committee has discussed with the independent registered public accounting firm the matters required to be discussed by Auditing Standard No. 1301, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Communications with Audit Committees,</font><font style="font-family:inherit;font-size:10pt;">&#32;as adopted by the Public Company Accounting Oversight Board (&#8220;PCAOB&#8221;). The Audit Committee has also received the written disclosures and the letter from the independent registered public accounting firm required by applicable requirements of the PCAOB regarding the independent accountants&#8217; communications with the audit committee concerning independence, and has discussed with the independent registered public accounting firm the accounting firm&#8217;s independence.  Based on the foregoing, the Audit Committee has recommended to the Board of Directors that the audited financial statements be included in SI-BONE&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2018.</font></div><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">Gregory K. Hinckley&#160;</font><font style="font-family:inherit;font-size:10pt;">(Chairperson)</font></div><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Timothy E. Davis</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Timothy B. Petersen</font></div><div style="line-height:130%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">The material in this report is not &#8220;soliciting material,&#8221; is not deemed &#8220;filed&#8221; with the Commission and is not to be incorporated by reference in any filing of SI-BONE under the Securities Act or the Exchange Act, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing.</font></div><div><a name="sF4AFA3333128B2C09790565652523280"></a></div><div style="line-height:130%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Compensation Committee</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our Compensation Committee consists of&#160;Dr. Bonita, Mr. Davis, and Ms. Licitra, each of whom our Board has determined to be independent under the Nasdaq Global Market listing standards and the rules and regulations of the SEC, a&#160;&#8220;non-employee&#160;director&#8221; as defined in Rule&#160;16b-3&#160;promulgated under the Exchange Act. The chairman of our Compensation Committee is Mr. Davis.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The primary purpose of our Compensation Committee is to discharge the responsibilities of our Board to oversee our compensation policies, plans, and programs and to review and determine the compensation to be paid to our executive officers, directors, and other senior management, as appropriate. Specific responsibilities of our Compensation Committee include:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">reviewing and approving, or recommending that our Board approve, the compensation of our executive officers;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">reviewing and recommending to our Board the compensation of our directors;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">reviewing and approving, or recommending that our Board approve, the terms of compensatory arrangements with our executive officers;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">administering our stock and equity incentive plans;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">selecting independent compensation consultants and assessing whether there are any conflicts of interest with any of the committee&#8217;s compensation advisors;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">reviewing and approving, or recommending that our Board approve, incentive compensation and equity plans, severance agreements, change-of-control protections, and any other compensatory arrangements for our executive officers and other senior management, as appropriate;</font></div></td></tr></table><div><br></div><div><div style="line-height:130%;padding-bottom:10px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12</font></div></div><hr style="page-break-after:always"><div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">reviewing and establishing general policies relating to compensation and benefits of our employees; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">reviewing our overall compensation philosophy.</font></div></td></tr></table><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Compensation Committee met five</font><font style="font-family:inherit;font-size:10pt;color:#800080;">&#32;</font><font style="font-family:inherit;font-size:10pt;">times during 2018.  The Board has adopted a written Compensation Committee charter that is available to stockholders on SI-BONE&#8217;s website at www.si-bone.com</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Compensation Committee Processes and Procedures </font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Typically, our Compensation Committee meets at least four times annually and with greater frequency if necessary.  The agenda for each meeting is usually developed by the chair of the Compensation Committee, in consultation with the General Counsel.  The Compensation Committee meets regularly in executive session.  However, from time to time, various members of management and other employees as well as outside advisors or consultants</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:10pt;">may be invited by the Compensation Committee to make</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:10pt;">presentations, to provide financial or other</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:10pt;">background information or advice or to otherwise participate in Compensation Committee meetings.  The Chief Executive Officer may not participate in, or be present during, any deliberations or determinations of the Compensation Committee regarding his or her compensation or individual performance objectives. The charter of the Compensation Committee grants the Compensation Committee full access to all books, records, facilities and personnel of SI-BONE. In addition, under the charter, the Compensation Committee has the authority to obtain, at the expense of SI-BONE, advice and assistance from compensation consultants and internal and external legal, accounting or other advisors and other external resources that the Compensation Committee considers necessary or appropriate in the performance of its duties. The Compensation Committee has direct responsibility for the oversight of the work of any consultants or advisers engaged for the purpose of advising the Committee.  In particular, the Compensation Committee has the sole authority to retain, in its sole discretion, compensation consultants to assist in its evaluation of</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:10pt;">executive</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:10pt;">and director compensation, including the authority to approve the consultant&#8217;s reasonable fees and other retention terms. Under the charter, the Compensation Committee may select, or receive advice from, a compensation consultant, legal counsel or other adviser to the compensation committee, other than in-house legal counsel and certain other types of advisers, only after taking into consideration six factors, prescribed by the SEC and Nasdaq, that bear upon the adviser&#8217;s independence; however, there is no requirement that any adviser be independent. </font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the past fiscal year,</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:10pt;">after taking into consideration the six factors prescribed by the SEC and Nasdaq described above, the Compensation Committee engaged Compensia as compensation consultants.</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:10pt;">The Compensation Committee requested that Compensia:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">evaluate the efficacy of SI-BONE&#8217;s existing compensation strategy and practices in supporting and reinforcing SI-BONE&#8217;s long-term strategic goals; and </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">assist in refining SI-BONE&#8217;s compensation strategy and in developing and implementing an executive compensation program to execute that strategy.</font></div></td></tr></table><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As part of its engagement, the Compensation Committee requested Compensia to develop a comparative group of companies and to perform analyses of competitive performance and compensation levels for that group.  Compensia also conducted individual interviews with members of the Compensation Committee and senior management to learn more about SI-BONE&#8217;s business operations and strategy, key performance metrics and strategic goals, as well as the labor markets in which SI-BONE competes.  Compensia ultimately developed recommendations that were presented to the Compensation Committee for its consideration.  Following an active dialogue with Compensia the Compensation Committee approved the recommendations of Compensia. </font></div><div><br></div><div><div style="line-height:130%;padding-bottom:10px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13</font></div></div><hr style="page-break-after:always"><div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Historically, the Compensation Committee has made most of the significant adjustments to annual compensation, determined bonus and equity awards and established new performance objectives at one or more meetings held during the first quarter of the year. However, the Compensation Committee also considers matters related to individual compensation, such as compensation for new executive hires, as well as high-level strategic issues, such as the efficacy of SI-BONE&#8217;s compensation strategy, potential modifications to that strategy and new trends, plans or approaches to compensation, at various meetings throughout the year. Generally, the Compensation Committee&#8217;s process comprises two related elements: the determination of compensation levels and the establishment of performance objectives for the current year.  For executives other than the Chief Executive Officer, the Compensation Committee solicits and considers evaluations and recommendations submitted to the Committee by the Chief Executive Officer.  In the case of the Chief Executive Officer, the evaluation of his performance is conducted by the Compensation Committee, which determines any adjustments to his compensation as well as awards to be granted.  For all executives and directors as part of its deliberations, the Compensation Committee may review and consider, as appropriate, materials such as financial reports and projections, operational data, tax and accounting information, tally sheets that set forth the total compensation that may become payable to executives in various hypothetical scenarios, executive and director stock ownership information, company stock performance data, analyses of historical executive compensation levels and current Company-wide compensation levels and recommendations of the Compensation Committee&#8217;s compensation consultant, including analyses of executive and director compensation paid at other companies identified by the consultant.  </font></div><div><a name="sC05E519B58169715CE2C56565274A13C"></a></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nominating and Corporate Governance Committee</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our Nominating and Corporate Governance Committee consists of Dr.&#160;Freund and Mr.&#160;Valentine, each of whom our Board of Directors has determined to be independent under the Nasdaq Global Market listing standards. The chairman of our Nominating and Corporate Governance Committee is Mr.&#160;Valentine.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Specific responsibilities of our Nominating and Corporate Governance Committee include:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">identifying, evaluating, and selecting, or recommending that our Board approve, nominees for election to our Board;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">evaluating the performance of our Board and of individual directors;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">reviewing developments in corporate governance practices;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">evaluating the adequacy of our corporate governance practices and reporting;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">reviewing management succession plans;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">developing and making recommendations to our Board regarding corporate governance guidelines and matters, and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">overseeing administration of our healthcare compliance program.</font></div></td></tr></table><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Nominating and Corporate Governance Committee met two times during 2018. The Board has adopted a written Nominating and Corporate Governance Committee charter that is available to stockholders on SI-BONE&#8217;s website and www.si-bone.com.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Nominating and Corporate Governance Committee believes that candidates for director should have certain minimum qualifications, including the ability to read and understand basic financial statements, being over 21 years of age and having the highest personal integrity and ethics.  The Nominating and Corporate Governance Committee also intends to consider such factors as possessing relevant expertise upon which to be able to offer advice and guidance to management, having sufficient time to devote to the affairs of SI-BONE, demonstrated excellence in his or her field, having the ability to exercise sound business judgment and having the commitment to rigorously represent the long-term interests of SI-BONE&#8217;s stockholders.  However, the Nominating and Corporate Governance Committee retains the right to modify these qualifications from time to time. Candidates for director nominees are reviewed in the context of the current composition of the Board, the operating requirements of SI-BONE and the long-term interests of its stockholders.  In conducting this assessment, the Nominating and Corporate Governance Committee typically considers diversity (including gender, racial and ethnic diversity), age, skills and such other factors as it deems appropriate, given the current needs of the Board and SI-BONE, to maintain a balance of knowledge, experience and capability.</font></div><div><br></div><div><div style="line-height:130%;padding-bottom:10px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">14</font></div></div><hr style="page-break-after:always"><div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Nominating and Corporate Governance Committee appreciates the value of thoughtful Board refreshment, and regularly identifies and considers qualities, skills and other director attributes that&#8217;s would enhance the composition of the Board. In the case of incumbent directors whose terms of office are set to expire, the Committee reviews these directors&#8217; overall service to SI-BONE during their terms, including the number of meetings attended, level of participation, quality of performance and any other relationships and transactions that might impair the directors&#8217; independence. In the case of new director candidates, the Nominating and Corporate Governance Committee also determines whether the nominee is independent for Nasdaq purposes, which determination is based upon applicable Nasdaq listing standards, applicable SEC rules and regulations and the advice of counsel, if necessary.  The Nominating and Corporate Governance Committee then uses its network of contacts to compile a list of potential candidates, but may also engage, if it deems appropriate, a professional search firm.  The Nominating and Corporate Governance Committee conducts any appropriate and necessary inquiries into the backgrounds and qualifications of possible candidates after considering the function and needs of the Board.  The Nominating and Corporate Governance Committee meets to discuss and consider the candidates&#8217; qualifications and then selects a nominee for recommendation to the Board by majority vote. In fiscal 2018 and 2019, the Nominating and Corporate Governance Committee paid fees to Korn Ferry to assist in the process of identifying or evaluating director candidates.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Nominating and Corporate Governance Committee will consider director candidates recommended by stockholders. The Nominating and Corporate Governance Committee does not intend to alter the manner in which it evaluates candidates, including the minimum criteria set forth above, based on whether or not the candidate was recommended by a stockholder. Stockholders who wish to recommend individuals for consideration by the Nominating and Corporate Governance Committee to become nominees for election to the Board may do so by delivering a written recommendation to the Nominating and Corporate Governance Committee at the following address: 471 El Camino Real, Suite 101, Santa Clara, CA 95050 at least 120 days prior to the anniversary date of the mailing of SI-BONE&#8217;s proxy statement for the last Annual Meeting of Stockholders and no later than the 90</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">th</sup></font><font style="font-family:inherit;font-size:10pt;">&#32;day prior to this year&#8217;s annual meeting.  Submissions must include the full name of the proposed nominee, a description of the proposed nominee&#8217;s business experience for at least the previous five years, complete biographical information, a description of the proposed nominee&#8217;s qualifications as a director and a representation that the nominating stockholder is a beneficial or record holder of SI-BONE&#8217;s stock and has been a holder for at least one year.  Any such submission must be accompanied by the written consent of the proposed nominee to be named as a nominee and to serve as a director if elected.</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font></div><div><a name="s33B01C5C708C5D6468C6565652A9FC3C"></a></div><div style="line-height:130%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">STOCKHOLDER COMMUNICATIONS WITH THE BOARD OF DIRECTORS</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Historically, we have not provided a formal process related to stockholder communications with our Board of Directors.  Nevertheless, every effort has been made to ensure that the views of stockholders are heard by the Board or individual directors, as applicable, and that appropriate responses are provided to stockholders in a timely manner.  We believe our responsiveness to stockholder communications to our directors has been excellent.  Stockholders may communicate with the Board or any of our directors. Stockholders who wish to communicate with the Board may do so by sending written communications addressed as follows: SI-BONE, Inc. Board Communication, 471 El Camino Real, Suite 101, Santa Clara, CA 95050. Any communication sent must state the number of shares owned by the stockholder making the communication. The communications will be reviewed by the Chair of the Board. The Chair of the Board will forward such communication to the Board or to any individual director to whom the communication is addressed unless the communication is unduly frivolous, hostile, threatening or similarly inappropriate, in which case, the Chair of the Board shall discard the communication.</font></div><div><a name="s0E0670040C6AFE659500565652CA8D55"></a></div><div style="line-height:130%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CODE OF BUSINESS CONDUCT AND ETHICS</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have adopted the SI-BONE, Inc.</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:10pt;">Code of Business Conduct and Ethics that applies to all officers, directors and employees.  The Code of Business Conduct and Ethics is available on SI-BONE&#8217;s website at www.si-bone.com.</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">If SI-BONE makes any substantive amendments to the Code of Business Conduct and Ethics or grants any waiver from a provision of the Code to any executive officer or director, SI-BONE will promptly disclose the nature of the amendment or waiver on its website.  </font></div><div><br></div><div><div style="line-height:130%;padding-bottom:10px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">15</font></div></div><hr style="page-break-after:always"><div><a name="sA614E7A312979C5D7C47565652FB9FFA"></a></div><div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:130%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CORPORATE GOVERNANCE GUIDELINES</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In July 2018, the Board of Directors documented the governance practices followed by SI-BONE by adopting Corporate Governance Guidelines to assure that the Board will have the necessary authority and practices in place to review and evaluate SI-BONE&#8217;s business operations as needed and to make decisions that are independent of SI-BONE&#8217;s management.  The guidelines are also intended to align the interests of directors and management with those of SI-BONE&#8217;s stockholders.  The Corporate Governance Guidelines set forth the practices the Board intends to follow with respect to board composition and selection, board meetings and involvement of senior management, Chief Executive Officer performance evaluation and succession planning, and board committees and compensation.  The Corporate Governance Guidelines, as well as the charters for each committee of the Board, may be viewed at www.si-bone.com. </font></div><div><a name="sC59AE993C3C018B66D515656531D0873"></a></div><div style="line-height:130%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">PROPOSAL NO. 2</font><font style="font-family:inherit;font-size:10pt;">&#32;<br> <br></font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Audit Committee of the Board of Directors has selected PricewaterhouseCoopers LLP as SI-BONE&#8217;s independent registered public accounting firm for the fiscal year ending December 31, 2019, and has further directed that management submit the selection of its independent registered public accounting firm for ratification by the stockholders at the annual meeting. PricewaterhouseCoopers LLP has audited SI-BONE&#8217;s financial statements since our inception in 2008. Representatives of PricewaterhouseCoopers LLP are expected to be present at the Annual Meeting.  They will have an opportunity to make a statement if they so desire and will be available to respond to appropriate questions.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Neither our Bylaws nor other governing documents or law require stockholder ratification of the selection of PricewaterhouseCoopers LLP as SI-BONE&#8217;s independent registered public accounting firm.  However, the Audit Committee of the Board is submitting the selection of PricewaterhouseCoopers LLP to the stockholders for ratification as a matter of good corporate practice.  If the stockholders fail to ratify the selection, the Audit Committee of the Board will reconsider whether or not to retain that firm.  Even if the selection is ratified, the Audit Committee of the Board in its discretion may direct the appointment of different independent auditors at any time during the year if they determine that such a change would be in the best interests of SI-BONE and its stockholders.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The affirmative vote of the holders of a majority of the shares present in person or represented by proxy and entitled to vote on the matter at the annual meeting will be required to ratify the selection of PricewaterhouseCoopers LLP. </font></div><div><a name="sAFA145225470A3D4EF8F5656534D2638"></a></div><div style="line-height:130%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">PRINCIPAL ACCOUNTANT FEES AND SERVICES </font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table represents aggregate fees billed to SI-BONE for the fiscal years ended December 31, 2017 and 2018 by PricewaterhouseCoopers LLP, our independent registered public accounting firm.  </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:88.29365079365078%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:66%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fiscal Year Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:8px;"><div style="text-align:center;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:8px;"><div style="text-align:center;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:8px;"><div style="text-align:left;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Audit Fees</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$1,017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$686</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:8px;"><div style="text-align:left;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Audit-related Fees (specifically describe audit-related fees incurred)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:8px;"><div style="text-align:left;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tax Fees (specifically describe tax fees incurred)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:8px;"><div style="text-align:left;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All Other Fees (specifically describe all other fees incurred)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:8px;"><div style="text-align:left;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Fees</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$1,110</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$839</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All fees described above were pre-approved by the Audit Committee.</font></div><div><br></div><div><div style="line-height:130%;padding-bottom:10px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16</font></div></div><hr style="page-break-after:always"><div><a name="s271F5516EB605BA3937656565386CA35"></a></div><div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:130%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">PRE-APPROVAL POLICIES AND PROCEDURES. </font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our Audit Committee has adopted a policy and procedures for the pre-approval of audit and non-audit services rendered by SI-BONE&#8217;s independent registered public accounting firm, PricewaterhouseCoopers LLP.  The policy generally pre-approves specified services in the defined categories of audit services, audit-related services and tax services up to specified amounts.  Pre-approval may also be given as part of the Audit Committee&#8217;s approval of the scope of the engagement of the independent auditor or on an individual, explicit, case-by-case basis before the independent auditor is engaged to provide each service.  The pre-approval of services may be delegated to one or more of the Audit Committee&#8217;s members, but the decision must be reported to the full Audit Committee at its next scheduled meeting.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Audit Committee has determined that the rendering of services other than audit services by PricewaterhouseCoopers LLP is compatible with maintaining the principal accountant&#8217;s independence.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">THE BOARD OF DIRECTORS RECOMMENDS</font></div><div style="line-height:120%;padding-bottom:32px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">A VOTE IN FAVOR OF PROPOSAL NO. 2</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div><br></div><div><div style="line-height:130%;padding-bottom:10px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">17</font></div></div><hr style="page-break-after:always"><div><a name="sB8EEDE2B78297D11C1EF565653A28994"></a></div><div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:130%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SECURITY OWNERSHIP OF <br>CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth certain information regarding the ownership of SI-BONE&#8217;s common stock as of April 1, 2019, by: (i) each director and nominee for director; (ii) each of the executive officers named in the Summary Compensation Table; (iii) all executive officers and directors of SI-BONE as a group; and (iv) all those known by SI-BONE to be beneficial owners of more than five percent of its common stock.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This table is based upon information supplied by officers, directors and principal stockholders</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:10pt;">and Schedules 13G filed with the SEC.</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">Unless otherwise indicated in the footnotes to this table and subject to community property laws where applicable, SI-BONE believes that each of the stockholders named in this table has sole voting and investment power with respect to the shares indicated as beneficially owned. Applicable percentages are based on 24,497,566 shares outstanding on April 1, 2019, adjusted as required by rules promulgated by the SEC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:93.25396825396825%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:40%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total Beneficial Ownership</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:8px;"><div style="padding-bottom:6px;text-align:center;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Name of Beneficial Owner</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:6px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Shares Owned</font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:6px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Right to Acquire Shares Within 60 days</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:8px;"><div style="padding-bottom:6px;text-align:center;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Number of Shares</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:8px;"><div style="padding-bottom:6px;text-align:center;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Percent of Total</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:8px;"><div style="text-align:left;padding-left:13px;text-indent:-14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Named Executive Officers and Directors:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:13px;text-indent:-14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">David P. Bonita, M.D.</font><font style="font-family:inherit;font-size:8.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(1)</sup></font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">985,368</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,222</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,007,590</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:8px;"><div style="text-align:left;padding-left:13px;text-indent:-14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Timothy E. Davis, Jr.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,426</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55,397</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61,823</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:13px;text-indent:-14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Jeffrey W. Dunn</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">547,540</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">631,902</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,179,442</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:13px;text-indent:-14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">John G. Freund, M.D.</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,419,985</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,222</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,442,207</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:13px;text-indent:-14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gregory K. Hinckley</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(4)</sup></font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">116,394</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,222</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">138,616</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:8px;"><div style="text-align:left;padding-left:13px;text-indent:-14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Karen A. Licitra</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,630</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,630</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:13px;text-indent:-14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Timothy B. Petersen</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(5)</sup></font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,695,036</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,222</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,717,258</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:13px;text-indent:-14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Mark A. Reiley, M.D.</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(6)</sup></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">542,624</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">542,624</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:13px;text-indent:-14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Keith C. Valentine</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(7)</sup></font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,374</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,222</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53,596</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:8px;"><div style="text-align:left;padding-left:13px;text-indent:-14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Heyward R. Donigan</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:8px;"><div style="text-align:left;padding-left:13px;text-indent:-14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Mark J. Foley</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:13px;text-indent:-14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Laura A. Francis</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(8)</sup></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44,515</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">212,067</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">256,582</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:8px;"><div style="text-align:left;padding-left:13px;text-indent:-14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Anthony J. Recupero</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">184,322</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">184,322</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:13px;text-indent:-14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All executive officers and directors as a group (16 persons)</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(9)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,602,656</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,464,519</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,067,175</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38.8</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:8px;"><div style="text-align:left;padding-left:13px;text-indent:-14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">5% Stockholders:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:13px;text-indent:-14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Skyline Venture Partners V, L.P.</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(10)</sup></font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,419,985</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,419,985</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:13px;text-indent:-14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Entities affiliated with Montreux Equity Partners</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(11)</sup></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,035,814</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,035,814</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:13px;text-indent:-14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Arboretum Ventures IV, LP</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(12)</sup></font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,695,036</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,695,036</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:13px;text-indent:-14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">RTW Investments, LP</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(13)</sup></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">1,234,118</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">1,234,118</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:24.00793650793651%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less than one percent.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The outstanding shares consist of shares held by OrbiMed Private Investments V, LP. (&#8220;OPI V&#8221;). Dr. Bonita is an employee of OrbiMed Advisors LLC, which exercises investment and voting power over the securities held by OPI V. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The outstanding shares consist of shares of common stock held by Jeffrey W. Dunn as Trustee of the Jeffrey W. Dunn Living Trust Dated May 17, 2012. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The outstanding shares consist of the shares held by the Skyline Venture Partners V, L.P. as set forth in footnote 10 below. </font></div></td></tr></table><div><br></div><div><div style="line-height:130%;padding-bottom:10px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18</font></div></div><hr style="page-break-after:always"><div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(4)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The outstanding shares include (i) 3,765 shares of common stock that are unvested and subject to our right of repurchase as of April 1, 2019 and (ii) 75,603 shares of common stock held by Gregory K. Hinckley and Mary C. Hinckley as Community Property with the Right of Survivorship. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(5)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The outstanding shares consist of the shares held by Arboretum Ventures IV, L.P. as set forth in footnote 12 below.  </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(6)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The outstanding shares include (i) 11,934 shares of common stock that are unvested and subject to our right of repurchase as of April 1, 2019 and (ii) 19,444 shares of common stock held by The Mark and Muriel Reiley Charitable Remainder Unitrust. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(7)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The outstanding shares include 4,365 shares of common stock that are unvested and subject to our right of repurchase as of April 1, 2019.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(8)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The outstanding shares include 13,694 shares of common stock that are unvested and subject to our right of repurchase as of April 1, 2019.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(9)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consists of (i) 8,389,262 shares of common stock beneficially owned by our directors and Named Executive Officers as listed in the table, as well as 213,394 shares of common stock beneficially owned by our other three executive officers not listed in the table, of which 59,193 shares of common stock are unvested and subject to our right of repurchase as of April 1, 2019, (ii) the right to acquire 1,238,428 shares of common stock within 60 days of April 1, 2019 by our directors and Named Executive Officers listed in the table, as well as the right to acquire 226,091 shares of common stock by our other three executive officers, of which 367,781 shares would be unvested as of such date.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(10)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based on a Schedule 13G filed February 14, 2019, reporting beneficial ownership as of December 31, 2018.  Each of Skyline Venture Partners V, L.P. (&#8220;SVP V&#8221;), Skyline Venture Management V, LLC (&#8220;SVM V&#8221;), John G. Freund, M.D. and Yasunori Kaneko (collectively, the &#8220;Skyline Entities&#8221;) has shared voting and investment power over these shares. Dr. Freund, a member of our Board, is Managing Director of SVP V and Managing Member of SVM V.  The address of the principal place of business of each of the entities and individuals is 525 University Avenue, Suite 1350, Palo Alto, CA 94301.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(11)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based on a Schedule 13G filed February 14, 2019, reporting beneficial ownership as of December 31, 2018.  Montreux Equity Partners IV, L.P. (&#8220;MEP IV&#8221;) has sole voting and investment power over 1,733,494 of these shares, and shared voting and investment power over 302,320 of these shares; Montreux IV Associates, L.L.C. (&#8220;Associates&#8221;) has sole voting and investment power over 130,391 of these shares, and shared voting and investment power over 1,905,423 of these shares; Montreux IV Associates IV, L.L.C. (&#8220;Associates IV&#8221;) has sole voting and investment power over 171,929 of these shares, and shared voting and investment power over 1,863,885 of these shares; and Daniel K. Turner III has shared voting and investment power over all of these Shares.  Montreux Equity Management IV, L.L.C. (&#8220;MEM IV&#8221;) is the sole general partner of MEP IV and the manager of Associates and Associates IV. Mr. Turner is the Managing Director of MEM IV. Each of MEM IV and Mr. Turner disclaim beneficial ownership of such securities, except to the extent of their respective pecuniary interests therein. The address of the principal place of business of each of the entities and Mr. Turner is Four Embarcadero Center, Suite 3720, San Francisco, California 94111.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(12)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based on a Schedule 13G filed February 14, 2019, reporting beneficial ownership as of December 31, 2018.  Each of Arboretum Ventures IV, L.P. (&#8220;IV LP&#8221;), Arboretum Investment Manager IV, LLC (&#8220;IV GP&#8221;), Jan L. Garfinkle, Timothy B. Petersen and Paul McCreadie has shared voting and investment power over these shares. The shares are held by IV LP, for which IV GP serves as the sole general partner.  Messrs. Garfinkle, Petersen and McCreadie are Managing Partners of IV LLC. The address of the principal place of business of each of the entities and individuals 303 Detroit Street, Suite 301, Ann Arbor, Michigan 48104.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(13)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based on a Schedule 13G filed February 15, 2019, reporting beneficial ownership as of February 6, 2019.  These shares of common stock are held by one or more private funds managed by RTW Investments, LP (the "RTW"). RTW, in its capacity as the investment manager of the funds, has shared voting and investment power over these shares. Roderick Wong is the Managing Partner of RTW, and therefore also has shared voting and investment power over these shares. The address for each of RTW and Mr. Wong is RTW Investments, LP, 412 West 15th Street, Floor 9, New York, New York 10011.</font></div></td></tr></table><div><br></div><div><div style="line-height:130%;padding-bottom:10px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">19</font></div></div><hr style="page-break-after:always"><div><a name="s8A89EF2627B0C99284F8565653C2C339"></a></div><div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:130%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Section 16(a) of the Exchange Act requires SI-BONE&#8217;s directors and executive officers, and persons who own more than ten percent of a registered class of SI-BONE&#8217;s equity securities, to file with the SEC initial reports of ownership and reports of changes in ownership of common stock and other equity securities of SI-BONE.  Officers, directors and greater than ten percent stockholders are required by SEC regulation to furnish SI-BONE with copies of all Section 16(a) forms they file.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">To SI-BONE&#8217;s knowledge, based solely on a review of the copies of such reports furnished to SI-BONE and written representations that no other reports were required, during the fiscal year ended December 31, 2018, all Section 16(a) filing requirements applicable to its officers, directors and greater than ten percent beneficial owners were complied with.</font></div><div><a name="sE73854E9AA355B395D8C565653F503D0"></a></div><div style="line-height:130%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">MANAGEMENT</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth certain information with respect to our executive officers as of April 1, 2019.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:88.4920634920635%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:26%;"></td><td style="width:4%;"></td><td style="width:10%;"></td><td style="width:4%;"></td><td style="width:56%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Name</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Age</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Position</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Jeffrey W. Dunn   </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">President, Chief Executive Officer and Chairman</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Laura A. Francis   </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">52</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chief Financial Officer</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Michael A. Pisetsky   </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">General Counsel and Chief Compliance Officer</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">W. Carlton Reckling, M.D.   </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chief Medical Officer and Vice President, Medical Affairs</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Anthony J. Recupero.   </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chief Commercial Officer</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Scott A. Yerby, Ph.D.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chief Technology Officer</font></div></td></tr></table></div></div><div style="line-height:130%;padding-bottom:16px;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For Mr. Dunn&#8217;s biography, see &#8220;Proposal No. 1 - Election of Directors - Directors Continuing in Office Until the 2020 Annual Meeting&#8221; above.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Laura A. Francis </font><font style="font-family:inherit;font-size:10pt;">has served as our Chief Financial Officer since May 2015. Prior to joining us, Ms.&#160;Francis was the Chief Financial Officer for Auxogyn, Inc., a women&#8217;s health company, from December 2012 to September 2014. From September 2004 to December 2012, Ms.&#160;Francis served as Vice President of Finance, Chief Financial Officer and Treasurer for Promega Corporation, a life science reagent company. From March 2002 to September 2004, Ms.&#160;Francis served as the Chief Financial Officer of Bruker BioSciences Corporation, a public life science instrumentation company. From May 2001 to March 2002, Ms.&#160;Francis served as Chief Operating Officer and Chief Financial Officer of Nutra-Park Inc., an agricultural biotechnology company. From April 1999 to May 2001, Ms.&#160;Francis was Chief Financial Officer of Hypercosm, Inc., a software company. From October 1995 to April 1999, Ms.&#160;Francis was an engagement manager with McKinsey&#160;&amp; Company, a consulting firm. Early in her career, Ms.&#160;Francis was an audit manager with Coopers&#160;&amp; Lybrand, an accounting firm. Since January 2019, Ms. Francis has served as a member of the board of directors of ShockWave Medical, Inc, a medical device company.   Ms.&#160;Francis received a B.B.A. from the University of Wisconsin and an M.B.A. from Stanford University. She is a Certified Public Accountant (inactive) in the State of California.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Michael A. Pisetsky </font><font style="font-family:inherit;font-size:10pt;">has served as our General Counsel and Chief Compliance Officer since August 2016. Mr. Pisetsky joined us in March 2015 as our Director of Legal. From August 2011 to March 2015, Mr. Pisetsky practiced law privately advising a number of companies in the medical technology, healthcare services and real estate industries. From August 2008 to July 2011, Mr. Pisetsky was an Associate in the Business Department at Cooley LLP in Palo Alto, representing a number of medical technology, biotech, healthcare services and general technology clients, from inception to public offering or sale. Mr. Pisetsky received his B.A. with Honors from Harvard College. Mr. Pisetsky received his J.D. (magna cum laude) and M.B.A., including a certificate in Health Sector Management, concurrently from Duke University.</font></div><div><br></div><div><div style="line-height:130%;padding-bottom:10px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20</font></div></div><hr style="page-break-after:always"><div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">W. Carlton Reckling, M.D.&#160;</font><font style="font-family:inherit;font-size:10pt;">has served as our Vice President, Medical Affairs since April 2012 and our Chief Medical Officer since February 2017. From July 1994 to April 2012, Dr.&#160;Reckling was a spine surgeon at the Spine Center in Loveland, Colorado, Rocky Mountain Orthopedic Specialists in Cheyenne, Wyoming, the Center for Spine&#160;&amp; Orthopedic Surgery in Cheyenne, Wyoming, Associates in Orthopedic Surgery in Cheyenne, Wyoming, and Ramsey Hospital and Clinics in St. Paul, Minnesota. Dr.&#160;Reckling received a B.S. in Chemical Engineering from Northwestern University, an M.D. from Creighton University, and an M.B.A. from the University of Wyoming. He completed his internship and his residency in orthopedic surgery at the University of Minnesota. While in the Minnesota program, he spent time at the Twin Cities Scoliosis Center. He completed his fellowship in spine surgery at Queen&#8217;s University Medical Centre in Nottingham, England. Dr.&#160;Reckling also underwent additional training in general surgery at the University of Minnesota Hospitals and Clinics in Minneapolis, Minnesota. Dr.&#160;Reckling is a board-certified orthopedic spine surgeon.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Anthony J. Recupero</font><font style="font-family:inherit;font-size:10pt;">&#160;has served as our Chief Commercial Officer since July 2016. Prior to joining us, Mr.&#160;Recupero was the President of Catalyst Performance Advisors, LLC, where he advised leading medical device companies on commercial strategy from June 2013 to July 2016. In July 2008, Mr.&#160;Recupero joined Baxano, Inc., a medical device company with minimally invasive products to treat degenerative conditions of the spine affecting the lumbar region, initially as Vice President of Sales and Marketing and was promoted in February 2009 to President and Chief Executive Officer until its acquisition by TranS1 in June 2013. From January 2005 to July 2008, Mr.&#160;Recupero was President of Recupero Consulting Group, LLC, where he advised leading medical device companies on commercial strategy. From October 1999 to December 2004, Mr.&#160;Recupero was the Vice President of Sales for Kyphon. Early in his career, Mr.&#160;Recupero progressed to senior sales </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">management roles at United States Surgical Corporation and Sulzer Spine-Tech, Inc. Mr.&#160;Recupero received a B.A. in Communications from State University of New York at Albany.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-style:italic;font-weight:bold;">Scott A. Yerby, Ph.D.&#160;</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">has served as our Chief Technology Officer since January 2011. Prior to joining us, Dr.&#160;Yerby served as Vice President, Research and Development for ProMed, Inc., a medical supply company, from June 2009 to January 2011. From May 2007 to June 2009, Dr.&#160;Yerby sat on the board of several&#160;non-profit&#160;organizations. From June 2000 to May 2007, Dr.&#160;Yerby served as Vice President of Research and Development for St. Francis Medical Technologies, Inc., a spinal manufacturing company, until its acquisition by Kyphon, Inc. From June 1997 to June 2000, Dr.&#160;Yerby served as Director of Experimental Biomechanics at the Palo Alto VA Hospital. Early in his career, Dr.&#160;Yerby held appointments as Consulting Assistant Professor at Stanford University in the Department of Mechanical Engineering, Division of Biomechanical Engineering, and the Department of Functional Restoration, Division of Orthopedic Surgery. Dr.&#160;Yerby received B.S. and M.S. degrees in Mechanical Engineering and a Ph.D. in Biomedical Engineering, all from the University of California, Davis.</font></div><div><br></div><div><div style="line-height:130%;padding-bottom:10px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">21</font></div></div><hr style="page-break-after:always"><div><a name="s754488FF158726FA7A13565654144BEE"></a></div><div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:130%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">EXECUTIVE COMPENSATION</font></div><div><a name="s14C90E6CD8BE4AADA183565654461041"></a></div><div style="line-height:130%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SUMMARY COMPENSATION TABLE</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table shows for the fiscal years ended 2018 and 2017, compensation awarded to or paid to, or earned by, our Chief Executive Officer, Chief Financial Officer and our other most highly compensated executive officers at</font><font style="font-family:inherit;font-size:10pt;color:#800080;">&#32;</font><font style="font-family:inherit;font-size:10pt;">December 31, 2018 (the &#8220;Named Executive Officers&#8221;).</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SUMMARY COMPENSATION TABLE FOR FISCAL 2018</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.03174603174604%;border-collapse:collapse;text-align:left;"><tr><td colspan="33"></td></tr><tr><td style="width:8%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Name and Principal Position</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Year</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Salary</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Bonus</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)(2)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="4" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Stock</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Awards</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Option Awards</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">All Other</font><font style="font-family:inherit;font-size:9pt;">&#160;<br></font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Compensation</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(4)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total</font></div></td></tr><tr><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:13px;text-indent:-14px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Jeffrey W. Dunn</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">466,095</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">262,546</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">696,327</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">245,692</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,670,660</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:13px;text-indent:-14px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">President and Chief Executive Officer</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">437,750</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">249,518</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">251,618</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">239,889</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,178,775</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:13px;text-indent:-14px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Laura A. Francis</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">318,512</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">319,418</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">77,356</font></div></td><td style="vertical-align:bottom;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">19,044</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">734,330</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:13px;text-indent:-14px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Chief Financial Officer</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">302,315</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">120,624</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">77,073</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18,458</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">518,470</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:13px;text-indent:-14px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Anthony J. Recupero</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">323,911</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">145,911</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">19,204</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">489,026</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:13px;text-indent:-14px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Chief Commercial Officer</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">315,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">142,924</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">107,503</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18,468</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">583,895</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:19.444444444444446%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Represents payments upon the achievement of 2018 and 2017 corporate goals, as applicable, as well as individual objectives, which were paid in January 2019 and January 2018, respectively. Our corporate goals included revenue growth, cash flow, expense, profitability management, reimbursement progress and clinical milestones.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts reported in 2018 for Ms. Francis and Mr. Recupero include bonus paid in connection with the completion of our initial public offering in the amounts of $200,000 and $25,000, respectively.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Represents the aggregate grant date fair value of restricted stock units and option awards granted to the officer and, with respect to 2017, the incremental fair value of stock options repriced in December 2017, computed in accordance with FASB ASC Topic 718. See Note 11 to our financial statements in our Annual Report on Form 10-K, filed with the SEC on March 14, 2019.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(4)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts reported include medical and life insurance premiums paid by us on behalf of our Named Executive Officers and, with respect to our Chief Executive Officer, forgiveness of a note payable to us in 2017 ($231,914) and 2018 ($231,914).</font></div></td></tr></table><div><br></div><div><div style="line-height:130%;padding-bottom:10px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">22</font></div></div><hr style="page-break-after:always"><div><a name="s640AF01A45C20B21D55E56565469C76E"></a></div><div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:130%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">OUTSTANDING EQUITY AWARDS AT DECEMBER 31, 2018</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table shows, certain information regarding outstanding equity awards at December 31, 2018, for our Named Executive Officers: </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="22"></td></tr><tr><td style="width:11%;"></td><td style="width:8%;"></td><td style="width:2%;"></td><td style="width:13%;"></td><td style="width:2%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:3%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Option Awards</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Stock Awards</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Grant Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Vesting Commencement Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number of Securities Underlying Unexercised Options Vested (#)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number of Securities Underlying Unexercised Options Unvested (#)</font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Option Exercise Price <br>($)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Option Expiration Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number of Shares or Units of Stock That Have Not Vested</font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(5)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Market Value of Shares or Units of Stock That Have Not Vested</font></div></td></tr><tr><td rowspan="5" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Jeffrey W. Dunn</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">07/21/14</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">07/21/14</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">272,753</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3.42</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">07/20/24</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">05/26/15</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">04/15/15</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">92,988</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,452</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.32</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">05/25/25</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">07/26/16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">06/02/16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">71,818</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">43,083</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.32</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">07/25/26</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">03/01/17</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">09/06/17</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">39,460</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">86,800</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.68</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(4)</sup>&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">03/01/27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">08/17/17</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">33,333</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">696,327</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td rowspan="4" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Laura A. Francis</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">05/26/15</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">05/26/15</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">158,017</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">19,840</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.32</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">05/25/25</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">07/26/16</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">06/02/16</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11,361</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.32</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">07/25/26</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">03/01/17</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">09/06/17</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">17,307</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.68</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(4)</sup>&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">03/01/27</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">08/17/17</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,703</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">77,356</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td rowspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Anthony J. Recupero</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">07/26/16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">07/05/16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">75,886</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49,704</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.32</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">07/25/26</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">03/01/17</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">09/06/17</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16,860</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">37,083</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.68</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(4)</sup>&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">03/01/27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:19.047619047619047%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares subject to the option vests in equal monthly installments over four years commencing on the vesting commencement date specified above, subject to the continued service with us through each relevant vesting date. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The unvested shares subject to these options are subject to accelerated vesting as described in &#8220;Equity Acceleration&#8221; below. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This stock option was repriced in July 2016. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(4)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This stock option was repriced in December 2017. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(5)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Represents a restricted stock unit granted outside of our equity compensation plans. </font></div></td></tr></table><div><a name="sF807541C6D8C1076C0495656549BEF0C"></a></div><div style="line-height:130%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">401(K) PLAN </font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We maintain a tax-qualified retirement plan that provides eligible employees with an opportunity to save for retirement on a tax advantaged basis. Eligible employees are able to defer eligible compensation up to certain Code limits, which are updated annually. We have the ability to make matching and discretionary contributions to the 401(k) plan, but have not done so to date. Employee contributions are allocated to each participant&#8217;s individual account and are then invested in selected investment alternatives according to the participants&#8217; directions. Employees are immediately and fully vested in their own contributions. The 401(k) plan is intended to be qualified under Section 401(a) of the Code, with the related trust intended to be tax exempt under Section 501(a) of the Code. As a tax-qualified retirement plan, contributions to the 401(k) plan are deductible by us when made, and contributions and earnings on those amounts are not taxable to the employees until withdrawn or distributed from the 401(k) plan. </font></div><div><br></div><div><div style="line-height:130%;padding-bottom:10px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">23</font></div></div><hr style="page-break-after:always"><div><a name="sAAF7A7229B02AC478D2D565654BD857B"></a></div><div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:130%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">EMERGING GROWTH COMPANY STATUS </font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are an &#8220;emerging growth company,&#8221; as defined in the JOBS Act. As an emerging growth company we are exempt from certain requirements related to executive compensation, including the requirements to hold a nonbinding advisory vote on executive compensation and to provide information relating to the ratio of total compensation of our President and Chief Executive Officer to the median of the annual total compensation of all of our employees, each as required by the Investor Protection and Securities Reform Act of 2010, which is part of the Dodd-Frank Act. </font></div><div><a name="s176182b6a7bf41328fc431f0d1a59063"></a></div><div style="line-height:130%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">PENSION BENEFITS </font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our Named Executive Officers did not participate in, or otherwise receive any benefits under, any pension or retirement plan sponsored by us during 2018. </font></div><div><a name="sEABEBE6B34D81F4C65D8565654EFDABC"></a></div><div style="line-height:130%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NONQUALIFIED DEFERRED COMPENSATION </font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our Named Executive Officers did not participate in, or earn any benefits under, a nonqualified deferred compensation plan sponsored by us during 2018. </font></div><div><a name="sA190A0D77503942E6E375656550F1A1B"></a></div><div style="line-height:130%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">EMPLOYMENT SEVERANCE AND CHANGE IN CONTROL AGREEMENTS</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have offer letters with each of our executive officers. The offer letters generally provide for at-will employment and set forth the executive officer&#8217;s initial base salary, eligibility for employee benefits and confirmation of the terms of previously issued equity grants, including in some cases severance benefits on a qualifying termination of employment. In addition, each of our executive officers has executed our standard proprietary information and inventions agreement. The key terms of employment with our Named Executive Officers are described below. See &#8220;Executive Compensation&#8212;Outstanding Equity Awards as of December&#160;31, 2018&#8221; for information on outstanding options as of December&#160;31, 2018 for our Named Executive Officers.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Jeffrey W. Dunn </font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In December 2009, we entered into an offer letter with Jeffrey W. Dunn, our President and Chief Executive Officer. Mr. Dunn&#8217;s annual base salary as of January 1, 2017 was $437,750 and Mr. Dunn was eligible for annual variable compensation up to 50% of his base salary. As of April 1, 2018, Mr. Dunn&#8217;s annual base salary was increased to $451,320. Upon the closing of our initial public offering, Mr. Dunn&#8217;s annual base salary was increased to $540,000 and Mr. Dunn became eligible for annual variable compensation up to 75% of his base salary. Under the terms of Mr. Dunn&#8217;s offer letter, if he is subject to an &#8220;involuntary termination,&#8221; then we will continue to pay his base salary and reimburse his COBRA premiums for up to 12 months. An involuntary termination occurs if Mr. Dunn&#8217;s employment is terminated by us without &#8220;cause&#8221; at any time or if he resigns for &#8220;good reason&#8221; within 12 months after a &#8220;change in control&#8221; (as such terms are defined in the offer letter). These severance benefits are contingent on Mr. Dunn&#8217;s return of all of our property, execution of a release of claims, and resignation from our Board, if applicable. </font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2017, Mr.&#160;Dunn was granted an option to purchase 126,260 shares of common stock with an exercise price of $5.94 per share vesting in equal monthly installments over four years commencing upon the closing of our initial public offering of our common stock, subject to Mr.&#160;Dunn&#8217;s continued service with us through each relevant vesting date. In December 2017, this option was repriced with an exercise price of $4.68 per share and the vesting commencement date was set at September&#160;6, 2017.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2018, Mr. Dunn was granted 33,333 restricted stock units, 50% of which will vest on the first day of the first open trading window (as determined under our insider trading policy) that occurs after the one-year anniversary of the closing of our initial public offering, and 50% of which will vest on the first day of the first open trading window (as determined under our insider trading policy) that occurs after the two-year anniversary of the closing of our initial public offering, subject to Mr. Dunn&#8217;s continued service with us through each relevant vesting date. </font></div><div><br></div><div><div style="line-height:130%;padding-bottom:10px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24</font></div></div><hr style="page-break-after:always"><div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">Mr.&#160;Dunn&#8217;s options to purchase 114,901 shares granted in July 2016 and 126,260 shares granted in March 2017 will fully vest if we are subject to a change in control before Mr.&#160;Dunn&#8217;s service terminates, provided he agrees to provide services to the acquiring company for a period not to exceed six months. Mr.&#160;Dunn&#8217;s option for 101,440 shares granted in May 2015, will vest as to 50% of the option shares if we are subject to a change in control.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Laura A. Francis </font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In April 2015, we entered into an offer letter with Laura A. Francis, our Chief Financial Officer. Ms. Francis&#8217; annual base salary as of January 1, 2017 was $302,315 and Ms. Francis was eligible for annual variable compensation up to 35% of her base salary. As of April 1, 2018, Ms. Francis&#8217; annual base salary was increased to $314,106. Upon the closing of our initial public offering, Ms. Francis&#8217;s annual base salary was increased to $350,000 and Ms. Francis became eligible for annual variable compensation up to 45% of her base salary. </font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under the terms of her offer letter, Ms.&#160;Francis was granted an option to purchase 190,483 shares, with an exercise price of $7.92 per share. Twenty-five percent of the shares subject to this option vested on May&#160;26, 2016, and 1/36</font><font style="font-family:inherit;font-size:8.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">th</sup></font><font style="font-family:inherit;font-size:10pt;">&#160;of the balance of the shares began vesting each month thereafter, subject to Ms.&#160;Francis&#8217; continued service with us through each relevant vesting date. Ms.&#160;Francis&#8217; offer letter provides that she will vest in 50% of the unvested option shares if (a)&#160;we are subject to a change in control (as defined in the offer letter) before her service with us terminates and (b)&#160;she is subject to an involuntary termination (as defined in the offer letter) within 12 months after the change in control. In addition, in the event of Ms.&#160;Francis&#8217; termination for any reason other than for cause (as defined in the offer letter) we will make a lump sum payment to her equal to three months of her then-current base salary. These severance benefits are contingent on Ms.&#160;Francis&#8217; return of all of our property and execution of a release of claims.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2016, we entered into a severance letter agreement with Ms.&#160;Francis. This agreement provides that in the event we terminate her for any reason other than for cause (as defined in the letter agreement), we will provide her the following benefits within 60&#160;calendar days of her termination date:</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A lump sum payment equal to three months of her then-current base salary; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A lump sum payment in the amount of $5,700.</font></div></td></tr></table><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This agreement further provides that in the event we terminate Ms. Francis for any reason other than for cause or if she resigns for good reason (as defined in the letter agreement) within three months prior to or 12 months following the consummation of a change in control (as defined in the letter agreement), we will provide her the following benefits within 60 calendar days of her termination date: </font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A lump sum payment equal to six months of her then-current base salary; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A lump sum payment in the amount of $11,300; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accelerated vesting of any unvested option shares such that 100% of the unvested option shares shall vest as of her termination date; and </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A lump sum equal to her target annual bonus, prorated for partial months of service prior to her termination date. </font></div></td></tr></table><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These severance benefits are contingent on Ms. Francis returning all of our property, continued adherence to the terms and condition of the proprietary information and inventions agreement between us and Ms. Francis, resigning from our Board, if applicable, and executing and not revoking a release of claims. The severance letter agreement for Ms. Francis supersedes the acceleration provisions set forth in her offer letter. </font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2017, we entered into an amended and restated letter agreement with Ms.&#160;Francis that provides that she will be eligible to receive a bonus of $200,000 if we complete a qualified IPO (as defined in the letter agreement) and she remains an employee in good standing through the date that is 30&#160;trading days after such qualified IPO, which will be paid 60&#160;days thereafter.</font></div><div><br></div><div><div style="line-height:130%;padding-bottom:10px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">25</font></div></div><hr style="page-break-after:always"><div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2017, Ms.&#160;Francis was granted an option to purchase 38,675 shares of common stock with an exercise price of $5.94 per share vesting in equal monthly installments over four years commencing upon the closing of our initial public offering, subject to Ms.&#160;Francis&#8217; continued service with us through each relevant vesting date. In December 2017, this option was repriced with an exercise price of $4.68 per share and the vesting commencement date was set at September&#160;6, 2017.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2018, Ms. Francis was granted 3,703 restricted stock units, 50% of which will vest on the first day of the first open trading window (as determined under our insider trading policy) that occurs after the one-year anniversary of the closing of an initial public offering, and 50% of which will vest on the first day of the first open trading window (as determined under our insider trading policy) that occurs after the two-year anniversary of the closing of our initial public offering, subject to Ms. Francis&#8217; continued service with us through each relevant vesting date. </font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Anthony J. Recupero </font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2016, we entered into an offer letter with Anthony J. Recupero, our Chief Commercial Officer. Mr. Recupero&#8217;s annual base salary as of January 1, 2017 was $315,000 and Mr. Recupero was eligible for annual variable compensation up to 40% of his base salary. As of April 1, 2018, Mr. Recupero&#8217;s annual base salary was increased to $325,710. Upon the closing of our initial public offering, Mr. Recupero&#8217;s annual base salary was increased to $330,000 and Mr. Recupero became eligible for annual variable compensation up to 45% of his base salary. </font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under the terms of his offer letter, Mr.&#160;Recupero was granted an option to purchase a number of shares of common stock equal to 0.7% of the fully-diluted capitalization as of his first day of employment, or 125,590 shares, with an exercise price of $4.32 per share. Twenty-five percent of the shares subject to this option vested on the July&#160;5, 2017 and 1/36</font><font style="font-family:inherit;font-size:8.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">th</sup></font><font style="font-family:inherit;font-size:10pt;">&#160;of the balance of the shares began vesting each month thereafter, subject to Mr.&#160;Recupero&#8217;s continued service with us through each relevant vesting date. Mr.&#160;Recupero&#8217;s offer letter provides that in the event we terminate him for any reason other than for cause (as defined in the letter agreement), we will provide him with the following benefits within 60&#160;calendar days of his termination date:</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A lump sum payment equal to three months of his then-current base salary; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A lump sum payment in the amount of $4,000.</font></div></td></tr></table><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Mr. Recupero&#8217;s offer letter further provides that in the event we terminate him for any reason other than for cause or if he resigns for good reason (as defined in the letter agreement) either three months prior to or 12 months following the consummation of a change in control (as defined in the letter agreement), we will provide him with the following benefits within 60 calendar days of his termination date: </font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A lump sum payment equal to six months of his then-current base salary; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A lump sum payment in the amount of $8,000; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accelerated vesting of any unvested option shares such that 100% of the unvested option shares shall vest as of his termination date; and </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A lump sum equal to his target annual bonus, prorated for partial months of service prior to his termination date. </font></div></td></tr></table><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These severance benefits are contingent on Mr. Recupero returning all of our property, continued adherence to the terms and condition of the proprietary information and inventions agreement between us and Mr. Recupero, resignation from our Board, if applicable, and execution and non-revocation of a release of claims.</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">In March 2017, we granted to Mr.&#160;Recupero an option to purchase for 53,944 shares of common stock with an exercise price of $5.94 per share vesting in equal monthly installments over four years commencing upon the closing of our initial public offering, subject to Mr.&#160;Recupero&#8217;s continued service with us through each relevant vesting date. In December 2017, this option was repriced with an exercise price of $4.68 per share and the vesting commencement date was set at September&#160;6, 2017.</font></div><div><br></div><div><div style="line-height:130%;padding-bottom:10px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">26</font></div></div><hr style="page-break-after:always"><div><a name="sC9FA6D726293C17A3A515656554329D6"></a></div><div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:130%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS </font></div><div style="line-height:130%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table shows certain information with respect to all of our equity compensation plans in effect as of December&#160;31, 2018.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.40476190476191%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"></td></tr><tr><td style="width:46%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:16%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:1px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:1px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:1px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:1px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:1px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:1px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:1px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:1px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:1px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:1px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Plan&#160;Category</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Number&#160;of securities&#160;to&#160;be issued&#160;upon exercise&#160;of outstanding&#160;</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">stock options  <br>(a)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted-average exercise&#160;price&#160;of outstanding&#160;</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">stock options  <br>(b)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Number&#160;of securities&#160;remaining available for issuance&#160;under equity&#160;</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">compensation plans&#160;(excluding securities&#160;reflected in&#160;column&#160;(a)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity compensation plans approved by stockholders</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,657,598</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.24</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,049,425</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)(4)</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity compensation plans not approved by stockholders</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,036</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total   </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,694,634</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.24</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,049,425</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:19.246031746031747%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The equity compensation plans approved by security holders are described in Note 11 to our financial statements included in our Annual Report on Form 10 K for the year ended December 31, 2018.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The weighted-average exercise price includes 16,400 shares issuable upon vesting of outstanding awards of restricted stock units, which have no exercise price.  Excluding these awards of restricted stock units, the weighted-average exercise price would be $4.27.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Includes 2,534,118 and 515,307 shares of common stock available for issuance under the 2018 Equity Incentive Plan, or the 2018 Plan, and the 2018 Employee Stock Purchase Plan, or the ESPP, respectively, as of December 31, 2018. As of December 31, 2018, up to a maximum of 74,019 shares of our common stock may be purchased in the current purchase period. The shares issuable pursuant to our ESPP are not included in the number of shares to be issued pursuant to rights outstanding and the weighted-average exercise price of such rights as of December 31, 2018, as those numbers are not known. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(4)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The reserve for shares available under the 2018 Plan automatically increases on January 1st each year, through and including January 1, 2028, in an amount equal to 5% of the total number of shares of our capital stock outstanding on the last day of the preceding fiscal year, or a lesser number of shares as determined by the Board of Directors. The reserve for shares available under the ESPP automatically increases on January 1st of each year through and including January 1, 2028, in an amount equal to the lesser of (i) 1% of the total number of shares of common stock outstanding on such December 31, (ii) 555,000 shares of common stock, or (iii) a number of shares as determined by the Board prior to the beginning of each year, which shall be the lesser of (i) or (ii) above.</font></div></td></tr></table><div><a name="s7B13BAB515ED3A9E615F5656556402EA"></a></div><div style="line-height:130%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-weight:bold;">COMPENSATION OF NON-EMPLOYEE BOARD MEMBERS</font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">The following table shows for the fiscal year ended December 31, 2018, certain information with respect to the compensation of all non-employee directors of</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">SI-BONE</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">:</font><font style="font-family:inherit;font-size:10pt;">&#32;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:86.30952380952381%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"></td></tr><tr><td style="width:35%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:16%;"></td><td style="width:1%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:17%;"></td><td style="width:1%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:17%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Name</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fees&#160;Earned&#160;or</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Paid in Cash</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Option</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Awards</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">David P. Bonita, M.D.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,522</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,522</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Timothy E. Davis, Jr.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,073</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,073</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">John G. Freund, M.D.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,315</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,315</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gregory K. Hinckley</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,452</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,452</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Karen A. Licitra</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32,897</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32,897</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Timothy B. Petersen</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,936</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,936</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Mark A. Reiley, M.D.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,280</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,280</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Keith C. Valentine</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33,175</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33,175</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:130%;padding-bottom:10px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">27</font></div></div><hr style="page-break-after:always"><div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We did not grant any stock option to our non-employee directors in 2018.  The table below lists the aggregate number of shares subject to outstanding stock options held by each of our&#160;non-employee&#160;directors as of December&#160;31, 2018.</font></div></td></tr></table><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:80.15873015873017%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:78%;"></td><td style="width:1%;"></td><td style="width:20%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Name</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Number&#160;of&#160;Shares<br>Subject to<br>Outstanding<br>Options as of<br>December&#160;31,&#160;2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">David P. Bonita, M.D.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,222</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Timothy E. Davis, Jr.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55,397</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">John G. Freund, M.D.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,222</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gregory K. Hinckley</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,222</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Karen A. Licitra</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,630</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Timothy B. Petersen</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,222</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Mark A. Reiley, M.D.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Keith C. Valentine</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,222</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s11F8689F1551D70DE1AB565655953C0E"></a></div><div style="line-height:130%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Non-Employee Director Compensation Policy </font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have adopted a non-employee director compensation policy, pursuant to which our non-employee directors will be eligible to receive cash compensation for service on our Board and committees of our Board. </font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prior to our initial public offering we paid our&#160;non-employee&#160;directors who are not representatives of our stockholders a fee of $2,000 per month as compensation for their service on our Board. In addition, from time to time we have granted stock options to certain of our&#160;non-employee directors. </font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commencing with the closing of our initial public offering, each non-employee director receives an annual cash retainer of $40,000 for serving on our Board. </font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The chairperson and members of the three committees of our Board are entitled to the following additional annual cash retainers: </font></div><div style="line-height:120%;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:79.16666666666666%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:58%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:19%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Board Committee</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Chairperson&#160;Fee</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Member&#160;Fee</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Audit Committee   </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Compensation Committee   </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nominating and Corporate Governance Committee   </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:130%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All annual cash compensation amounts are payable in equal quarterly installments in arrears, on the last day of each fiscal quarter for which the service occurred, pro-rated based on the days served in the applicable fiscal quarter. </font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Each new non-employee director who joins our Board will receive an option to purchase 22,222 shares of our common stock under the 2018 Plan. The shares subject to this option will vest on a monthly basis over 12 months commencing on the grant date, subject to the non-employee director&#8217;s continuous service with us on each applicable vesting date. </font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On the date of each annual meeting of our stockholders, each continuing non-employee director may receive an option to purchase 12,778 shares of our common stock under the 2018 Plan, vesting on a monthly basis over 12 months commencing on the grant date, subject to the non-employee director&#8217;s continuous service with us on each applicable vesting date. </font></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the event of a change of control (as defined in the 2018 Plan), any unvested shares subject to these options will fully vest and become exercisable immediately prior to the effective date of such change of control, subject to the non-employee director&#8217;s continuous service with us on the effective date of the change of control. </font></div><div><br></div><div><div style="line-height:130%;padding-bottom:10px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28</font></div></div><hr style="page-break-after:always"><div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:130%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The exercise price per share of each stock option granted under the non-employee director compensation policy will be the closing price of our common stock as reported by the Nasdaq Global Market on the date of grant. Each stock option will have a term of ten years from the date of grant, subject to earlier termination in connection with a termination of the non-employee director&#8217;s continuous service with us. </font></div><div><a name="s866a65a415d44e04bf69c9ab7cadaa84"></a></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</font></div><div><a name="s77eb485cab1d492d9a992d3e5787420e"></a></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">RELATED-PERSON TRANSACTIONS POLICY AND PROCEDURES</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our Audit Committee has the primary responsibility for the review, approval, and oversight of any &#8220;related party transaction,&#8221; which is any transaction, arrangement, or relationship (or series of similar transactions, arrangements, or relationships) in which we are, were, or will be a participant and the amount involved exceeds $120,000, and in which the related person has, had, or will have a direct or indirect material interest.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have adopted a written related party transaction policy under which our management is required to submit any related person transaction not previously approved or ratified by our Audit Committee to our Audit Committee. In approving or rejecting the proposed transactions, our Audit Committee will take into account all of the relevant facts and circumstances available. Our Audit Committee will approve only those transactions that, as determined by our Audit Committee, are in, or are not inconsistent with, our best interests and the best interests of our stockholders.</font></div><div><a name="sd9d57f6cb3204d0fa932afb5b0a631f6"></a></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CERTAIN RELATED-PERSON TRANSACTIONS</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following is a description of transactions since January 1, 2017, to which we have been a party in which the amount involved exceeded $120,000 and in which any of our executive officers, directors, promoters, or beneficial holders of more than 5% of our capital stock had or will have a direct or indirect material interest, other than compensation arrangements discussed above.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Sale of Series 7 Preferred Stock </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February and March 2017, we issued and sold an aggregate of 540,874 shares of Series 7 preferred stock at a purchase price of $10.03 per share for an aggregate purchase price of $5,426,717. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes purchases of shares of Series 7 preferred stock in 2017 by our executive officers, directors, and then holders of more than 5% of our capital stock. </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.07142857142857%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td style="width:65%;"></td><td style="width:16%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Shares of Series 7 Preferred Stock</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Purchaser</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Number of Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Aggregate Gross<br>Consideration</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Arboretum Ventures IV, LP</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,495,036</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,000,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Skyline Venture Partners V, L.P.</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">398,676</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,000,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Entities affiliated with Montreux Equity Partners</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">199,338</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,000,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">OrbiMed Private Investments V, LP</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(4)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">179,404</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,800,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Redline Capital Management S.A.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">106,636</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,100,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gregory K. Hinckley</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(5)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44,851</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">450,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Keith C. Valentine</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(6)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,966</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,433,907</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,450,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:1px;"><font style="font-family:inherit;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Timothy B. Petersen, a member of our board of directors, is a Managing Director at Arboretum Ventures, Inc. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:1px;"><font style="font-family:inherit;font-size:10pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">John G. Freund, M.D., a member of our board of directors, is a Managing Director at Skyline Venture Partners. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:1px;"><font style="font-family:inherit;font-size:10pt;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Includes (a) 27,409 shares of Series 7 preferred stock held by Montreux Equity Partners IV, L.P. and (b) 171,929 shares of Series 7 preferred stock held by Montreux IV Associates IV, L.L.C. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:1px;"><font style="font-family:inherit;font-size:10pt;">(4)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">David P. Bonita, M.D., a member of our board of directors, is a Private Equity Partner at OrbiMed Advisors LLC. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:1px;"><font style="font-family:inherit;font-size:10pt;">(5)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Represents shares held by Gregory K. Hinckley and Mary C. Hinckley as Community Property with the Right of Survivorship. Mr. Hinckley is a member of our board of directors. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:1px;"><font style="font-family:inherit;font-size:10pt;">(6)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Mr. Valentine is a member of our board of directors. </font></div></td></tr></table><div><br></div><div><div style="line-height:130%;padding-bottom:10px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">29</font></div></div><hr style="page-break-after:always"><div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Loans </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2013, we loaned Daniel P. Murray, our then current Chief Financial Officer, $200,000 in connection with the exercise of options to purchase 152,106 shares of our common stock, or the Murray Purchased Shares. The loan was evidenced by a full recourse promissory note, accrued interest on the outstanding principal amount at the rate of 1.09% per annum and was secured by a pledge of the Murray Purchased Shares and Mr. Murray&#8217;s personal assets. In November 2016, the loan amount was partially repaid in the amount of $116,000 (including principal of $113,000 and interest of $3,000). The remainder of the principal balance of this loan, together with all interest accrued, was fully paid in December 2017. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2014, we loaned Jeffrey W. Dunn, $437,000 in connection with the exercise of options to purchase 174,110 shares of our common stock, or the 2014 Exercised Options, and Mr. Dunn&#8217;s personal assets. The loan was evidenced by a full recourse promissory note, accrued interest on the outstanding principal amount at the rate of 1.97% per annum and was secured by a pledge of the 2014 Exercised Options. In March 2017, we forgave $231,914 (including principal of $218,500 and interest of $13,414) of this loan. As of December 31, 2017, the outstanding balance of this loan was $231,914, including principal of $219,500, which was forgiven on January 1, 2018. </font></div><div><a name="s14289904beaa49e4b5c6104dbfe33461"></a></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">INDEMNIFICATION AGREEMENTS</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our amended and restated certificate of incorporation contains provisions limiting the liability of directors, and our amended and restated bylaws provide that we will indemnify each of our directors to the fullest extent permitted under Delaware law. Our amended and restated certificate of incorporation and amended and restated bylaws also provide our Board with discretion to indemnify our officers and employees when determined appropriate by our Board.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have and intend to enter into indemnification agreements with each of our directors and executive officers and certain other key employees. The indemnification agreements provide that we will indemnify each of our directors, executive officers, and such other key employees against any and all expenses incurred by that director, executive officer, or other key employee because of his or her status as one of our directors, executive officers, or other key employees, to the fullest extent permitted by Delaware law, our amended and restated certificate of incorporation and our amended and restated bylaws. In addition, the indemnification agreements provide that, to the fullest extent permitted by Delaware law, we will advance all expenses incurred by our directors, executive officers, and other key employees in connection with a legal proceeding involving his or her status as a director, executive officer, or employee.</font></div><div><a name="s97582b9700cb48c6b85af549cd52eef5"></a></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">HOUSEHOLDING AND PROXY MATERIALS</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The SEC has adopted rules that permit companies and intermediaries (e.g., brokers) to satisfy the delivery requirements for Annual Meeting materials with respect to two or more stockholders sharing the same address by delivering a single set of Annual Meeting materials addressed to those stockholders.  This process, which is commonly referred to as &#8220;householding,&#8221; potentially means extra convenience for stockholders and cost savings for companies.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This year, a number of brokers with account holders who are SI-BONE, Inc. stockholders will be &#8220;householding&#8221; SI-BONE&#8217;s proxy materials.  A single set of Annual Meeting materials will be delivered to multiple stockholders sharing an address unless contrary instructions have been received from the affected stockholders.  Once you have received notice from your broker that they will be &#8220;householding&#8221; communications to your address, &#8220;householding&#8221; will continue until you are notified otherwise or until you revoke your consent.  If, at any time, you no longer wish to participate in &#8220;householding&#8221; and would prefer to receive a separate set of Annual Meeting materials, please notify your broker or SI-BONE, Inc.  Direct your written request to SI-BONE, Inc, Attn: Michael A. Pisetsky, General Counsel, 471 El Camino Real, Suite 101, Santa Clara, California 95050. Stockholders who currently receive multiple copies of the Annual Meeting materials at their addresses and would like to request &#8220;householding&#8221; of their communications should contact their brokers.</font></div><div><br></div><div><div style="line-height:130%;padding-bottom:10px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">30</font></div></div><hr style="page-break-after:always"><div><a name="s8518e08d9c614a8b9bf6503f1e1daadc"></a></div><div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">OTHER MATTERS</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Board of Directors knows of no other matters that will be presented for consideration at the Annual Meeting.  If any other matters are properly brought before the meeting, it is the intention of the persons named in the accompanying proxy to vote on such matters in accordance with their best judgment.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:336px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By Order of the Board of Directors</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:336px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:39.48412698412698%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Michael A. Pisetsky</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Michael A. Pisetsky</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Secretary and General Counsel</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">April 30, 2019</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">A copy of SI-BONE, Inc.&#8217;s Annual Report to the Securities and Exchange Commission on Form 10-K for the fiscal year ended December 31, 2018 is available without charge upon written request to: Corporate Secretary, SI-BONE, Inc, 471 El Camino Real, Suite 101, Santa Clara, California 95050.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:130%;padding-bottom:10px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">31</font></div></div><hr style="page-break-after:always"><div><a name="s3e7864d3af6545f99d991dfcd5138387"></a></div><div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;"><img src="a2019proxysiboneincproxy001.jpg" alt="a2019proxysiboneincproxy001.jpg" style="height:869px;width:672px;"></div><div><br></div><div><div style="line-height:130%;padding-bottom:10px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">32</font></div></div><hr style="page-break-after:always"><div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;"><img src="a2019proxysiboneincproxy002.jpg" alt="a2019proxysiboneincproxy002.jpg" style="height:869px;width:672px;"></div><div><br></div><div><div style="line-height:130%;padding-bottom:10px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">33</font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>a2019proxysiboneincproxy001.jpg
<TEXT>
begin 644 a2019proxysiboneincproxy001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;9^(=)O[YK&UO4DG7=\H4@-M.&VDC#8/7!.*=/KFFVVIQZ9+<C[7( 1$J,Q
M/ +8!"CZXH T**Q[?Q9H-T\RP:E&YAC:5CA@"B_>93C# ?[.:K_\)UX9"LW]
MJIA0K']V_P!T]&Z?=]^@]: .@HI 0P!!!!Y!%+0 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6D-Q$Y<[SOW=1CV]>,=\\,.LW<5Y>Q2VL;+'/'#;A).79E!YR.!R23V Z'N
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M5BWFH:E9R?98[V*XDE$#+,8A^[WS+&> >00Q*]_E/)HEO-46>X5+Q-L%[#:
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M@AY!&-SCT)[TMK);W-O#=VZJ4EB5HVVX.PC(^GTJKI=NUI/?PA76 3@PAB2
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M(Z@'I0 M%%% !1110 4444 %%(S*HW,0 .Y-'49% "T444 %%%% !112%@"
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M !1110 4444 %%%% !1110 4444 %%%% !5+5]5M=#TJXU*]<I!;KN; R3V
M'N20/QJ[45S:V]Y T%U!'/$V-T<J!E..>AH \UT"ZDUGXF6E[?:A$TQL7G%O
M'.&2'<2JQ#!Y8*2Q]R?2I+;PWI.H>/X[?1;=X;+16$E[/Y\CB6;.5B&YB.,9
M/XBNML_!^DZ?JE]J5G$(+B[155DC0"VPI7,8V_*3G)SG-6] T&S\.:8MA9>8
MR[V=Y)2"\C$\LQ[G_"@#D_L%U+\7[<3:G<7:V]I)=^6V%CA5B41 HXR,YSU/
M%:/Q-NYK?P;+;6V[[1?31VT00\DLV<#ZA2*V[70K:UU^^UI9)7N;U$C8.1M1
M5&,+QGGJ<DU!XC\,V_B1;03WEW:FSF\^)K9E4AQT/(/2@#C-3M;30O ^KWMK
MH5WI-Y-&MFOVBY,C2AR <?,0._ITKT+2[/\ L_2;.RSG[/ D>2>N% K%OO!4
M.I:-'IEYK.J3B.Y%RL[RH9-P& ,[<8'7&.M:ND:4^E0R1OJ=]J!=MV^\D#,O
ML, <4 <E'8P>,?'>LV^LEIK+1_*CM[(N0A+ DNP'4\<?6G^*;G3?".CP^']'
M>#3)=5F*AVDPMNAP))"2>..![].E;6J^#;#4M6_M6*[OM.OF39)/8S>69%'0
M-D$'_P"L/2G6G@_3(-1DO[IIM1G>".!3>E9?+11VXZD\DG.3]: .6\,:Q!I7
M@CQ,EM=_:(M+N+@6LOF;]R$9C.>^36-X9U*\\+6.K:9$SS:G=I9"RC=LDRS1
M$D_13DGZ5W-UX"TJYCU:%9;BWAU8PF>* HJKY?3:-O&>]6O^$0TS_A*#XBS+
M]L$'DH,C9'QC<!CKCCKWH \OM;>:U\':O!!=2RRZIK$6FPS%R2^PY+#ZG-:^
ML7,]MX]DUJ"5UL=!GM+*1<G;Y;JP<_@6 _&NPL_ >EV=KI-ND]TR:5<-<1[V
M4^8['.7^7G';&*G;P;IKZ7J^GR23R)J\[SSNQ7<K-C&WC  P,9S0!PLNH7UW
M)>"UNI+<^(M>-F+A&Y2WC 7Y3V)R?UK3UO0],\+>(O#/]@0FUO+B]$4JI(Q,
MT/&\MD\XSU]ZZ,>!M('AFVT%C<&&UD\V&<2;9DDW$[PP'7D]JETKPA8:9J7]
MIR7%YJ-\$V+<WTWF.B^B\ #\OYT 97Q2FD/A5-.@1I)M2NXK9$3[S<[L#_OG
M'XUSFB>3IX\1^(=,MCI%G8V<EJVGM*S/]H'.Y@>!V P3W]Z]$U+0[35+_3[R
MY:7?ITIEB56 4L1C+#'..U9U]X(TV^@UB$SW4*:P\<EP(W7@J<_+E3C/?K0!
MSO@+1K2UMK6_O]"N[2XMK;SFU"XNB8W)')V[R!\I/4=O6L6;Q)#JOB;3O$@U
M2,?\36.TM[$3#<EM\RM(R9SEB<\]L5W+>"EETJYTRXU_6)[>X54823(2J@_=
M'R< ]#[58U/P9HFHZ4-/6T2S52A26VC59$VD$88@^E &<KMJ'Q7=0Q\G2]-
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *BNIFM[2:=(FE:.-G$:]7(&<#ZU+534Y+^*PD
M?3((9[H8V1S.45N1GD=.,T <MX+UO6O$HBU.35]/:#<PN-/B@(DAZA1N+9SG
M!Y%1ZUXTOH/$L-OIZ1-I=K>0VE_.PR3)(?NJ?]D#GW-0Q:#XE_MO4?$D.GV.
MGWLUG]F@M8IMP=RP)ED; !Q].<"JU[\,+F+PN]M8ZU?RWQ99C#).HMWFR"S$
M;<^N"3GI0!H>./&.H>'M9L;>QCC>!(_M-]N7)$/F*F1Z=35YM7U;4_%&JZ3I
M5Q;PQ65I"1+)%O E<[LG!&1LSQ4-QX7N]5UK7;O4%C6*]TY+*VPV2N02Q/IA
M\8J/P9X=UK0M#U-[\Q/JUT?D*OD$)&%CR?KF@"+PGJ_B765N-1O-3L$TZTNI
M(GQ;%3*B=6!W?*/SZ&G>'O&&HZOXK$$\,<6E7UO)+I_RD2.$8+N/U&XX^E0Q
M^$-7B\#:9X7A=(4E<_VG.LGS!"Q9E7CDG.,^@]ZEC\#76E>(M#U#3]2O;V&Q
M+QR)>SJPCB*;0$ 4?E["@#=\5^(!X;T5KQ8#<7$DBPV\.<>9(W0?S/X51B_X
M2O3H6U36-4T]K>&)Y;BUAMB-H"DX5RV3R!U%6?&7A^?Q%HJ06<Z0WEM.ES;.
M_P!WS%SC/M@FLW5(O%VN^%]1TZXTNSL[B:$1(R76X2$L-QZ?*-N>.>M &QX2
MO[[5/"UAJ&HE/M-S'YC;%VK@D[>/]W%8%IXTOK[QE:0PI$-"NYIK:";;\TLD
M:Y+ _P!TG@?2GR6GB^X\,_V'#I]GI_[N.V6=+HN4BQACC:.<#CZ^U5I_AY-I
MKZ-+H^IWUR-.O8Y/L]Y.OEI%SOV@*,$_U- !XA\7:E;^)=2L++5--L(--M4D
M;[6FXRR$;MHY!Z$=,UIMXLO+?P-9ZM<V035;Y5CM[0 CS)F)"X!YQ_%]*Q]0
M\!WNHV/B&ZDBMQJ]Y?":QFR-T4:E=OS8RI(!!_"M"\\*ZKXEU]+_ %>\GTZ"
MQB46:V,P#^81^\<D@X]![8H TO!FLWVL:3<'4_*^VV=Y+:S^4,+N0]A]"*V;
M^]AT[3[B^N"1#;1-*Y'7"C)_E7$V>GZ[X,EU*&PB?4CJ=_%]EEN&+D;A^]>4
MJ!@#'7O79:IIZ:KI%WITS%5NH6B9@.FX8R* .9TJY\9>(;&/5X;S3],M[@;[
M>U>W,K%#T+MD<D<\5%XU\8ZAI$\D&C1Q2MI\:W&H.ZY"(S!50?[1R3]!4^A)
MXQT?3H-(FTRQNH[2(QQ7:W17>JJ=@V8SG@ FLP?#:\N-"OI+O6K_ /M74$>2
MYBBF5;>24Y*J1MR5' Z_3% '0>(==NK/5- L-.,9;4[KYRRY_<J,OCWP1S2Z
M]K=Y9^)]!T>R\O-_)(T^Y<D1H 3CTSSS[5AOHOBF#5M"U&.QM+IM-TT6[))<
M[/WI&'8'![ ?G5V;1==O?$K:Y-!;Q20Z0\%O$LVX+<,2>N.G.,T 4= \5ZCK
MNH33?V_I-M;1W<@2R9 9W@0Y)^]G[H/..V:EMM;\6>(-+N->TJ2RL+!-[6D$
M\)=[A5SRQR-N<'I_]>M3P[X/M--\)P:;<VL"W9MFCFG1 7R^=V&QG^(BL:VT
M7QG;>&AX5ABL(H K0_VGYQSY1)SB/&=V#CK_ (T )>^.[RZTKPW+836EA-K!
M<RR7(W1Q!.&/)'&>G-,3QMK0\+:K=$6MQ<V]XEI8W4,9$5R68#(!/..>AQ5V
M/P%$==L8;BWAGT;3]+-M$LN&9I6;YFQCC@YSZU!8^%=<_L7PWI5]Y+1Z7?\
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M[:;3K9X;F4S2HT8(>0]6/^U[]: . UJ:\LEU_1=/U.\%I!-9"*7[0S26S22
M,@<G/3G!/%0:KX@U21-7@ENYX+W3]%\NX6.1E F6?'F#'3<I!!]&KT:#0=(M
MK#[!!IMM':[Q)Y2QC:6!!#'U.0.?:FRZ7H]]=W9ELK::>1%BN2T8)=>"%;U'
M H YRRA'B/Q-K%OJE]=H+ Q);VL-T\(5"@/F?*06))/)Z5<\8AY;[0+3[3<0
M0W-\4E\B=HBR^6QQE2#U K0U+2?#NJPM?:C8VEREJ'5I9(\E A(89ZX!!XJ?
M4;/1]6,=GJ-M;W6USLCE3=A@N3C/L?UH \_O]0U!;>_TRUU&[OK6VUJU@MY_
MM1620./GB,HYX/&>V:WXS=6&O>%[5C<6RR_;#-!)>M<9P@V[G)^;U&>F:Z.3
M0=(ETY=.?3+4V:MN%OY2A ?7'3-02>%_#TEM#9R:19-#"6:*)HAA2<;B![X%
M '*:S=ZC'J?B6^MKNX(T>[L[E85E;:T8B!D3&<8())]Q5;5]2O-3TS4=9L[R
MY-M<ZI;VEFD5PT0:-&"L5(/&]BPS["N_M](TZUCECM[*"))T6.150 .JKM /
MJ O'TICZ%I,FEKI;Z=;FQ0Y6W,8V YST^IS0!PVO+?VC:#:QVNI9D^UO)9PZ
MLYD?:BD?O<Y..H'X4K7VL:;X.T7Q/:ZDVH3K (+A)9&V3"1L(2#_ !(Q4$XR
M1GFNXM-"TJQ\C[)I]O!]G+&'9&!Y988;'ID#FDM]-TB?2([>WM+=K"3$R1A!
ML.3O# ?7F@#.NH[_ ,.^!+HQ7,MY?VUI)(9I"7+28)+<]@>@] !6$J#2#X8O
MM.U6[N[C4[B..Y66Z>5;F-D)=]I) V\'(QBN](!&",@UFV/AS1=,NVN['2[6
MWG;(,D<0!YZX]/PH YOX?+>W"R7]TEW(KO.@N9=0>17Q*0 (B<+@#&?;WJ*V
M6_N_&^N,$O)H;69 CKJ#HD.80<>4#ALFNQM4L;$1V5HD4(;?(D<8P#\PW'CW
M;GZU+#:6UO---# D<EPP:5U7!<@8!/KQQ0!P-MJ=Q<>%?!>+^9YKJ^C2=EF.
M^10KA@QSD\XSGVIR:>;?4?%RQ7VI-_9ENIM%:^F8(6MR3P6YYY&>E=?;>'-$
MLM0;4+;2K6&Z8D^:D0# GJ1Z9]JN1V=M%<3W$<$:RW.WSG"\R8&!GUP.* .,
M&ISRCP2([V1C<VLCS;92?,Q;=6YYPWKWKG_"][JABC:6\OH/,T6>X)GO&F%V
MW0,@).PK]<].*]&L_#NAZ7<O<V>EVEM-("I=(PI(/8>F?05,-$TL1V\8L+<)
M;(T<(V#$:L,,!Z CK0!@?#^*Z.C0W=U%<A[BVA?S9M0>X\[*Y+!2?D^GO[5C
M:9'KU_XJNYK*2^$5MKDBSSR7F8/LX S$(BW7G@A>,]:[32M&T?3#))I5A;6W
MF'8[0QA=VTD8/T.:N6]I;6AE-O D7G2&638,;W/5C[\"@#RGPIJ>L1I:W N+
MT2MI-S<A;F[:=;YUR%VJ20I4CGN:UHV:PT3PYKEGJ]W<ZAJ%S DXDNF=;G?_
M *Q=A.T;><8 QBNYAT?3;?[+Y-C!']BW"VVH!Y6[[VWTSWJ&U\-Z)97YO[72
MK2&Z.?WJ1 $9ZX],^U '&)?W \;_ -BG4[DZ,=0++/O;)G";OLN_/W<\X_X#
M5P6^KCQ>?#'V^4Z<S?VGYWG-YHBW8\C/7&_'?[O%=9_8NE_9%M/L%OY"R^<(
M]@P'SG=]<]Z4G3@[:N1%O1&A:XV\A0W*Y]-PH Y;XA2:E]KT>+3+J>";_2)0
ML4A42F./>%('4$KC!]:S[#7I]7\>V&JQ7LR:3.LT44)D(C(CA5F8CH?F<C/^
MS7H$MI;S7$-Q+"CS6Y8Q.PR4R,''ID<5570=(2"*!--MEBA618T$8 0/]\#Z
M]Z .#\.^)IKKQ4EQ<W=X;376EB2&1)$CM\?ZG:Q 7+*#]T]34Z61MKOQB8[_
M %(_V7;_ .BA[Z5@FZW))P6Y.3D9Z=J[N33;&6W@MY+2)H;9E:%"@Q&5^Z5'
M;':@Z;9%KIC:Q$WHQ<G:/WHV[<-Z\<4 >=3#4;;P$EUMOX9[E[,>9_:KR-,&
M89P2?W><]O7VIUC?:@D5JCWMW%CQ-';FUEN6EDA0(V49S]Y3U[BNXM_#&A6D
M;QV^D6D22,K.J1 !BIRI/T/2K#Z/ILEPUP]C TS2K,SE!DNHPK?4 D9H X%?
M%DG_  FPU/[9=?V>UZ=/\CRY/(\O&T2[L;,^;GOG%=#H,U[>6OBB)+UEG74K
MB*WDE8L(?W:;<9Z $YQ6Z=(TTZ9_9AL8/L0&/L^P;.N>GUYJ!O#.A/>O>MI-
MHUS)N+RF(;FW @Y/N": ,3P3*;6XN]'O8;N+5;>*)[EIKQKA)LY'F*23MR<Y
M&!V]*Z^J.F:)I>C(Z:;806@D(+^4@!;'3)[U>H **8TB(R*S8+G:H]3@G^0-
M/H **** "BH)+VVB<H\RJP)!'N%W'].:F!! (Z&@!:*** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M)P6N)/F8R%MS=,#)XQCH.!SQ5F@ HHHH **** "BBB@ HHHH **** "BBB@
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M6&&2?>R@AT3&XC!SQD=<9[4 9MEI=_;I9-)&2ZR70<JZEHQ+(65L\ X&,X_
M55M_#UT^G);W,<S2Q1P0$2-%Y3HLB,VW8 2,*<;N>3ZFM+4_$(M=-NY8;:X$
M\%JTQW1\1<-L+C/<KT&2!R<5HVM^EW-*D44FR)V0RD#:64X('.>#ZB@#.OK3
M44OY)[,,(I&B#B$H)"BJ^=N_@?,5_#..:J6^BW45F%N;=Y"L0 6"5=X<3%U(
M)P./E//''3M6W>:@EBR&6&4QLRJTJ@%4+' SSGJ>P..]01ZY:O-L*RI'YDD0
MF=<(7CW;@#G/ 1CG&.#S0 [39[W"6M]$WG)"'>7 VDEF ''!; R<<<^A%4-?
MMC<ZE900NFZ[S!<QYY,'#L<>GRE/^VE6;76#>:K!!'#+%#):O./-3!8;D"D<
M^C-P>>F0*MWM_'8E7EAE,9P&E4 JF3@9YSU] : ,J/3;Q9$M3;*%34'N_MF\
M<J79L8Z[L'9TQCOVI^E65_#<:?'/;"..PM7@:3S ?,/R %0.<84]<&KD>MVT
MMRL(CF :9X%E9,(TB;MRCG/16.<8XZYXJ.'Q#930+.R3Q1/")XFDCQYB$@9
MZ]67K@\B@!VH07"ZI:7\-N;I((Y(VB5E# L5PR[B!QM(ZCAOP-)K+5;C6K:>
M97$,%V91\R",1F-E   W%OFYSQUQZ5KR7R*\T<<4D\L.W='&!GYNG)(';UJM
M8ZF+^_=8O]1]F210RX8,7=6!^FW% %?2M*FL1I :-$%IIS6\NT_QGROS^ZW/
M^-3WT-Q'JMM?Q6INDCBDB,:LH9"Q4AAN('\.#SZ4^XUFUMKF:!UE)@C$DC*F
M54'.T>Y)!  R:8==MPRQ?9[G[2TIB^S[!OW;=_KMQMYSG'XT 4CIMX7^R_9@
M =0%Y]LWK]W>'QCKNQ^[]-O?M2)H;+86<$MLLB1VT\4\:,%+;P,@'CJ?>KO]
MOVCQAX8KB<A"\B1Q_-$H8J=P/<,K# R3M. <5%=^)((K>ZEM;::[^S(K,T8
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M,#U)'ZBM.VO(;JT%U&Q\OG.Y2"I!(8$=B"""/:@!;:X>=I@T+1B*38&88$G
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MHUN8S+"\B;1*!C./<9'7&>HR*TJ "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@"C/8S?VC]NM+A(I'C$4JR1;U=5)*]"""-S=^_2LO_A$D/G@W*?O8)X=ZP 2
M,)""6=L_,1CVJ36+J6TURVGE*FSMK*YN70$[B4,?.,X)PW&?4TZYUR]L2L5U
M81>?*BO$D<Y(.9$1E)*\$&1>>_/3% $VIZ++??;%@O?LZ7T'DSCRMQP 1E3D
M8.&P>O0=*FATUX]8DU%Y8\M&8]D46S<"007.3N(Q@' QD^M/OK]]-TE[N>-6
MD15!1"<%R0  <9QDCG'X5BW&OR(\5U<1/&EH\S2"/<%E58"^1N SZ?44 7=3
M\/+J5ZUP\T8#",?/"'=-C;OD8GY0>_%3MHD4D$4$DA9$N9IR,8W>8) 5_#S3
MS[54A\07,D@MOL*_:)'1(CN<1$LKL069 <J(VZ#G*],\)=:IJ=C=WTDR020V
MMBL_DQDY+9?HQ'?;0!<LM+N+>]BN;B^\_P BW-O&HBV<$J=QY.6^49Z#V%0Z
MIX>74[MYVFC >-$^> .T>UB<H2?ESGG@]!TI+C6;ZWCNI#9P,+"(27(68\\%
MBJ?+SA<')QDG''6G1ZS</=#-K&+8W7V8/YAWDXR&QCIGC&: )UTA56W'G']Q
M=RW(^7J7\SC\/,_2H)O#Z2V-O;"Y93;V36JOLSG/ED-CV,8X]Z;I6JW%_';Q
MVUN@1+>&29I9F)&\9VC()8@<Y)[CWQ<OKN>*YMK2V2,RW!8[I,[551DG ZGD
M#'OGM0!1G\/SW<K3W5W!+(TJ2>6UMF([59<%"W(^;/7@@&K.E:,FEG*S;_W0
MCQL"C[[MT'^_C\*QK7Q)<6MJ8C;&>>)9)Y5#.Y(,T@")A3D_(V,XZ#UXG;59
M;*]O'V-*(C/*<R-A8T\C< O0G#$CZ8[F@#3OM%AOTO4E<[;M(U(V@[2A)!P>
M#SC@^E4CHES;S6)LQ9P/',[R/!:"./!C*C<F[)Z]CZ47'B1TNC!!;I)N:7RV
M9FPRQ[5;[JGDN2/3"Y]J<FOW,BS7 L1':0/$LC2.1( ZQL25QQM#Y//:@!\6
M@S6BLUG?^7-,C+<2/#NWDN[[E&1M(:1\=1ST.*D3088=,N[""5DCN H0D9\L
M+&D8^OW ?QJYI]V;ZV-QL"HTCB/!^\H8@-^.,_0BJM]J5Y#>S6UK:12^3;"X
M9I)2F<EAM'!Y^7K0 Y-,E.JQZA-/"72,H?)@*,^0.&.XY .2!V]?6/4M!AO[
M];PI:N_E")UN;83*5!)&.1@\G\^G%4$U\Q7%QY*F0W5R&B$A;")]GB8_=!/5
MAQ[DU._B0J+1A; >=Y(EB._?$9'"\X7  SGYB,^U #KKPS!/<K<C[.\BO(0M
MQ;"6,*^W(VY'(V#!SZU;M=,DL;EWM9XDMY2K20^3P"J!/D((VC"KQ@]*HOXC
MDC0K);QI<-.(4@+/N3(<Y<;<XVH2" 0>F>]:>GWDM_IPN/)\F4EUVN#C*L1G
MD X.,CCH: *MMH2Q6\=O/,)HX[0V8 3;F,X SR><#K_*F-H4UQL-Y?><T,8B
MB98MN!O1B6Y.6/EKR,#KQS531KV_%K;V\<4$UU.DES(\DK*N-P [$Y)/T 'X
M5$NJFYOH;P-)'"[0.T9;[H,<I(XZ\C]* -6XT.*YO'GDD)5Y=[)CJ/*:+&?H
MV:AFT.YN+6WM[B\@N$M7!C$MMN5P%*_O!NPQY!R,8(SBH9/$-U!:175Q91I'
M/!]H7;*6*H"I<-P.0C$\9&1CT)ECU]Y+R6V6!<FX2.W.[_6+N97;_@/ER'Z
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:75)TE^TV]L04\K#9 C!(7'7G/X\5B0:O=.UPGV_%KBV>2=)UF,*NT@8EMH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.<G'8#T ]/KZU/110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% #$ABB9VCC1&D.YRJ@%CTR?6GT44 %%%%
M !1110 4Q(8HY'D2-%>0@NP4 L0,#)[\4^B@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH YS6=:GT/Q-9O=7&-)NK6564J,1RQC?
MNSC/*AAC/:L?3M2U_5[C2=+GU%[&2\LY-1GECC3>$+@)$N5P,!ADD$\5U.N:
M#IWB*Q%EJ<)EA5Q( &*D,,CJ/8D?C2:IX?L-6^SO,LL,UKGR)[:5HI(P1@@,
MO8CM0!R-]JVO1Z!KQ769$NM!E95GCABQ<J55EW@J0",D';BI-6OM;T_4M(L%
MUC4[@74$LTK6UK \I(V8&-F,#)_.NF3PQI4>AW&CK WV6ZW&<F1B\K-U9F)R
M2?6EU+PW8:G/;3RO=0S6J-'%);7+Q,%.,C*D>@H H>,-1OM*\'_:K.XFCN0\
M">;Y:F0[G56^4C;D@GMUK&M=7\1R:/J5S'>2RW&DW@<VUS!''-+ %#,C@#"D
MC)4CKBNNU'1;/5=)&F7?FO -G/FL'RI!!W9SG(!S4=AX>T[3K6ZMX4E;[9G[
M1)+,TDDN1CEF)/3B@"OX6O;_ %:REU>[=D@O7WV=N5 \J'HI)')+?>/)ZC%<
M?I/B3Q-<H]PEU=7,*Q7AN6ELU2*WV;O**.%&XY R.>]>B6-E!IUA!96RE8;>
M-8XP3DA0,#FJ]KHEC9Z1)I4,;"UD$@92Q)^<DMS]6- '(V7C'4;B3PNKPWD8
MN;=WNWE@55NB+<OE3_O#/&.M1?VSKT'A&V\8R:N93)(CR:>(D\GRWD"[%.-V
MX9ZY[5V*:#I\?]E[8F_XE*;+7YS\HV;.?7Y?6J$'@S0X[I9(TF,4,WFK:?:'
M,$<G7<(\X!YSCIS0!RU]XPUJP/B3SKH")99X=.E\M?W4D0#%#QSE6R,Y^Z:T
MK?5]6N_&MU9&]U$6MN;4JEM;1-&-Z!F\QBNX GT/K6]>>$=&O]/O+&YMB\-Y
M<FZE&\Y\PXY![=.WO2GPMIXU9M3CEO89W,9D$-W(B2;  H90<$8'?WH NW6K
M6-E>6]I<W"QSW)Q$A!^<YQ6+XWOM9TW3[>[TRZAMX5GC6?,>YWW2*H SP!@G
M)Z\#%=-534],M=7L_LEXA>+>CX#$<JP8=/<"@##\5^)H[/1]2ATR_2/4K55)
M4IEE!=00H(P6(; 'J16#I_B#5[V2#2/[2NH&N-3>#S9X46[AB6+?AAMVAB>A
MP>/T[K5-,M-8L)+&]C+PR8)VL5((.001R"" :R_^$/T?R6@+7)N'F%S]I-RW
MG[P-H;?G/ X].: .5M_$NNZI ULNI&UFL-/N;F2>.)/](>.4QKD$$!<+D@8Z
MUKZCXYB3P>][:RH-4^QPS-#L)\HR;!G'?!D!Q6G/X*T2:TM[40S0QV\30CR9
MV1GC8Y=6(.6#'DY[UI7FFV%_IKZ3<1*UL\80P@XPHZ8QR,8&#[4 <8^N:DNG
M?9H[S5UDAU!(M1EFM8FN+:-DW JL:LN"<<X)&?I5:R\2ZYK%M';+J,MG+;6%
MU=/.(4#SM%+L0,K*0!QE@ /PKKH_"EA#936T5Q?QO/*)9KA+MQ-(P&!E\Y(Q
MQCI3;CP;HMQ:6UJ(98([:)H4\B9D8QM]Y&(.6#=3F@#*O/'44?@UKV&6/^U1
M8Q3M#L)"-($P?< N#BJ#ZYJ:::UM'>:OY\%_%'J,DUK$T]M$R;MR+&",'CL2
M,UVUSI=E=Z4^ES6ZFS>+RC$. % P ,=,5GQ>%+"&SG@BN+]'N)!)-<K=N)G(
M&!E\YP!QB@#DK#Q'K>LI#8)J4UI)!!>3-=>2@>;RG"H&5EP.OS  =.U3W_B'
M5SI6BZQ%>7ENUXEN9%\A#9IN(#;VQN&<\<]Q723^#=&GLK6T6&6!+5'CC:"9
MD8H_WU+ Y(;OFG7/A+2[N6$RFY-O $V68N'$ V8V_N\XXP/RH VZ*** "BBD
M9@JEF( '))[4 +1110 4444 %%%% !12,P52S$  9)/:EH ***3<-P7(R1D"
M@!:*** "BBB@ HI-PW;<C(&<4M !1110 4444 %%%% !131(A;:'4L<\9YXZ
M_P Z=0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MC#9/ YX-6[_4[E]1EM+.Z1%#6R[E4,4WL^[\=H7&:VH[6WA:1HH(HVE.9"J
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M+]:WZ:(T4Y5%!&>0/7K3J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MYV_85P<!L9VD] <<XZT 8>IZ;<6\EREA 5M66V:1!&7$F'D\P[006.-A;G)
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M%=!110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 8FJ69N]=L%C)"@%KH;3A
MHU8.G/3.]0,=PS4Q-#NVAM[&5X1:VLDCI*K$R/N5U *XP,!SDY.<=!GC>HH
MR=-L;Z*[BFN_LZB*U%N!$S-N((.[D#&<=.WJ:8VGZG#!>VMI)"B7#R213[R)
M$9^2"-ISR2,YX&...=FB@#G8?#]T+CSGD1<W'F[#/),0/(>+&]N3RP/T_6[-
MIUX-%M+."8!X!&L@$K1^8JC! =1E?7(],=ZU:* ,/3-$GLWC>62-BL=RI 9G
M/[V;S!\S<G X)/6J_P#8&H0Z=)80O;,EPL/F22,V49$13@8Y!"#'(P2>M=)1
M0!2U"VFGELIH/++6UQYA5V*A@4=#R >?GS^%9UQX=DN=)BL3,B;8IXV=<_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%R4W$K%&1\B+[!<?4DUPFGZEJ-G:7MBMS,\OB!Y(;-V<GRY1<-$^#VPC*W_
M: /7**\M3493X$T71?M%\TE]=3B:6W5Y9E@CF?<1MRV?NC/N:O:7K=SJ47A)
M9I)5N8+V6TNU;*EF2)OO \Y(VG!]: /1**YGX>W?VGP7IWF7'FS['+[GW-]]
MNO?TKIJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQR-J>F/,+YKQ3*;PR>88U?:1W^4#/W<<8_"NKH **** "BBB@ HHHH ****
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MZ9Y-6M6TV/5M/>SDE>(,5(DCX92#GC^7XT 9MCKUU=6H+11+/-=1K N#AH7
M<,1GJ(]_XJ:MRZ];V]Q-!<031-$AD))0@H& +<,2 -P/.#BI3I$']KQ:B&93
M%#Y0B&-O&=K?4!G'_ C5"W\.Q:?&S8:\5+:2W$*QHC2JY4G<Q(W,=O))&: -
M>"ZCN9)TCW?N)/+8D<$[0>/^^A^.:SM8U26QO[2W2YM[9)XY7:2:%I.5*
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MV;<;,#KZYI] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MDV)&I) +-@GD@XP#T/2HKC6DM+A;:X@;[0T(D6.)MQ=B2-B],]#SP,<G !H
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX#32! 3Z<U'-JVG6QC$]_;1>:H9-\JC<IZ$<]/>@"W15>6_LH;E+66[@CGD
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MC*+CMP2:S+VV\7/>2M9:EI<=L6_=I+:NS >Y#<T ;]%<S]D\<?\ 06T?_P
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M8/\ H)VO_?,'_P 11]B^,'_03M?^^8/_ (B@#T^BO,/L7Q@_Z"=K_P!\P?\
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M^(H ]/HKS#[%\8/^@G:_]\P?_$4?8OC!_P!!.U_[Y@_^(H ]/HKS#[%\8/\
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ML0,9*@TX(@;<% 8C&<<XKS+[%\8/^@G:_P#?,'_Q%'V+XP?]!.U_[Y@_^(H
M].95=2K ,#U!'6FF*,A08U(3[HQT^E>9_8OC!_T$[7_OF#_XBC[%\8/^@G:_
M]\P?_$4 >F[%W[]HW8QG'.*:8(67:8D*YS@J,9]:\T^Q?&#_ *"=K_WS!_\
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M"=K_ -\P?_$4 >FLBNI5U#*>H(R*&1'7:ZJR^A&17F7V+XP?]!.U_P"^8/\
MXBC[%\8/^@G:_P#?,'_Q% 'IGE1[678NUCEAC@GWI#!"Q4F)"5&%)4<"O-/L
M7Q@_Z"=K_P!\P?\ Q%'V+XP?]!.U_P"^8/\ XB@#T^F+#$CEUC16/5@H!->9
M_8OC!_T$[7_OF#_XBC[%\8/^@G:_]\P?_$4 >FA%5BP4 MU(')I/)B.?W:<G
M<?E')]:\S^Q?&#_H)VO_ 'S!_P#$4?8OC!_T$[7_ +Y@_P#B* /2W@BE(,D2
M.1W90:#!"2I,2$J,*=HX%>:?8OC!_P!!.U_[Y@_^(H^Q?&#_ *"=K_WS!_\
M$4 >FLBM@LH.TY&1T-.KS#[%\8/^@G:_]\P?_$4?8OC!_P!!.U_[Y@_^(H ]
M/HKS#[%\8/\ H)VO_?,'_P 11]B^,'_03M?^^8/_ (B@#T^BO,/L7Q@_Z"=K
M_P!\P?\ Q%'V+XP?]!.U_P"^8/\ XB@#T^BO,/L7Q@_Z"=K_ -\P?_$4?8OC
M!_T$[7_OF#_XB@#T^BO,/L7Q@_Z"=K_WS!_\11]B^,'_ $$[7_OF#_XB@#T^
MBO,/L7Q@_P"@G:_]\P?_ !%'V+XP?]!.U_[Y@_\ B* /3Z*\P^Q?&#_H)VO_
M 'S!_P#$4?8OC!_T$[7_ +Y@_P#B* /3Z*\P^Q?&#_H)VO\ WS!_\11]B^,'
M_03M?^^8/_B* /3Z*\P^Q?&#_H)VO_?,'_Q%'V+XP?\ 03M?^^8/_B* /3Z*
M\P^Q?&#_ *"=K_WS!_\ $4?8OC!_T$[7_OF#_P"(H ]/HKS#[%\8/^@G:_\
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M_P#$5)I7CCQ'H6OV^B^-;5$6Z($5V@ &3P"2ORD9QGH1GF@#TNBBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MUBAF49R,(690'.#G*]<$#M6_I.O)>^'9=4FN+8^0)/-95>-8RO4,&&Y2._%
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MZB9BK1I=W%RLD(S.$W+'G(*CN1C@^M ';ZQH;:GXCT6^:.&2VL//,JR<G+J
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MB@;P[,S[1R2!C K6\.>'9/#VK:D(%C_L^[\N2/YRTB.%VL"3R1T(YXYKHJ*
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M///(-)'X5T.*\^UQZ=&LV]W#!F^4N"&P,X&03G%:]% &?-H>F7&BC1I;1&L
MBH("3C:I! ZYX(%0VWA?1;1(T@L558IUN$!=CMD4$!N3V!/YUK44 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=VXGG@D ''6MR-_,B5]K)N .UA@CV/O0 ZBBB@ HHHH **** "BBB@ HHHH
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ME4])_P"0/9?]>\?_ *"*N4 %%%% !1110 53U;_D#WO_ %[R?^@FKE4]6_Y
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M%%-$BF1HQG<H!/!Q@Y[].U #J**C2:.5Y$1PS1-M<#^$X!P?P(/XT 24444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *\[^-?\ R)UI_P!A!/\ T7)7HE>=_&O_ )$ZT_["
M"?\ HN2@#N-)_P"0/9?]>\?_ *"*N53TG_D#V7_7O'_Z"*N4 %%%% !1110
M53U;_D#WO_7O)_Z":N53U;_D#WO_ %[R?^@F@#A_@I_R)UW_ -A!_P#T7'7H
ME>=_!3_D3KO_ +"#_P#HN.O1* "BBB@ HHHH *:RJZE'4,K#!!&013J* .:"
MW%OHD-NUM(!+?3AV,<A\M3)(P8JF&(/ '('S UHZ!+.-*M8;L3_:/+8DRQN#
M@-@9)S@XQP3D^_)K4HH *S]?CDF\.:G%$C22/:2JJ*,EB4. !W-:%% &'KB7
MK"1;7[0 ;"4 Q9X?<FW&/XL9QWZU6?3IH+NX>#[9B*[M?('FR, I9/,(R>1@
MMG\:Z6B@#E+2WN)EM(F2^^V.L@U$R&14;Y&S@GY?O[=NW^'..*@@TUY+!Y(H
MKU'AT>-8>9$83 R''/)8'&!VS[UV5% &!;F\/B+["SR^1'_II?<<89=@C/\
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MQRBGD^M:]C>QW]N941XRKM&\<@ 9&4X(."1^1(JHVB*+>WCANI(GMKJ2Y1P
M<L^_((]/WA%6++3S9* MP[[F>24LH_>.QSGVQT ';UH N50U?4/[-MX9R5"-
M<1QN6!.%8X/2K]5[NT2[6(.Q7RI5E&.Y4YQ0!E+XE@-Y<HN9HT,20K&N'=V#
MDCYB!T7/.. :L1^(;.2"639*IB3<4(&XMO9-@P<%MRXZXY7GFB^T"WOKA[AY
M")2T;IE0RJ4##H1R"'8'Z\8J&;1VEO\ 35\O$=H6DDD151'R<A-HY^^J-T_@
MZ\T 6H]<M))K2("16NP^W*CY"N<JW/!^5O\ ODTP:];YLRT$RQ7H0Q2,4 ^;
M[H*[MWIV[U%<>&[6XBO8S-*GVN0/N4@&+!)(7ZEG)_WS3I/#\,E^UT)BH::.
M8J(USE H"AL9V_*./4GZ4 $7B&.X6$P6%Y(TZL\:@("R+C<W+# RP'/)[ CF
MH#K%RO@RWU7>@GDAA8N\9P-Y4$E1CU/%6QHWDQV@MKN2&2UB:%9-H;<C8SD'
MOE00?:G+HT2Z'!I7FR&.!8U#G&X["",_7;0 W0[^;4+:>25XY42<QQ3QQF,2
MJ ,G:22,-N7K_#FDO;C4&UB.RLYX(5-NTK-+"9,D, !PR\<U9AL/L]Q-+#,R
M+/,)7CP",[=I ],X!^N?4U'=Z;)<7Z7D-[);.L1B.Q%;()!_B!YXH K6^O-)
M"B_89I[H>8)HK;:0FQRA.6(X+*<=SZ4H\1VCMF&"XE@_=;IU5=BB0 H>2"1\
MPZ X[T\:(MOL:PNI+5Q&8W? <R L6W'/\6YF.?5CD&B+0+6"TDM8G=8G\H 9
MSM$84*/R44 )_;:+\D<%Q>2;IBPA11L5)"ASN8=Q@8Y.,XH.OVP6RD,,PAOA
M&8Y"4 !?&T$;MW4@< CFJUWI<UIA[%;N29S/N:$Q 8>0OAMYXP6.",]^*;:>
M%8X8[</<DM']G9\(I):$(  Q&0IV X]23W- %ZSUN*]GCC6VN(EF#F*60*%D
MVG! P21^(&<<5I51@TJ*W^R;9'/V7?MSCG=US5Z@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH R-8_Y"V@_]?S_^DTU:]9&N0WAG
MTRZL[1KLVET9'C5U0[3#(F06('5Q2?VMJ_\ T+=S_P"!,/\ \50 NF?\A_6O
M^ND/_HL5KUCZ+%>F^U*\O+)K3[3)&4C:17.%0 GY21U%;% !1110 4444 %%
M%% !1110!CZ3_P A[7?^N\7_ *)2M&^_X\+C_KDW\C6.#JFG:UJ4T.D2W<-U
M)&Z/'-&O2-5((9@>HI]QJ.L36TL0\.7 +H5!-S#W'^]0!;\/?\BUI?\ UYP_
M^@"M&J6CV\EIHMC;3#;+#;1QN <X(4 U=H **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *\[^-?_(G6G_803_T7)7HE>=_&O\ Y$ZT_P"P@G_HN2@#
MN-)_Y ]E_P!>\?\ Z"*N53TG_D#V7_7O'_Z"*N4 %%%% !1110 53U;_ ) ]
M[_U[R?\ H)JY5/5O^0/>_P#7O)_Z": .'^"G_(G7?_80?_T7'7HE>=_!3_D3
MKO\ ["#_ /HN.O1* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^"G_ ")UW_V$'_\ 1<=>B5YW\%/^1.N_^P@__HN.O1* "BBB@ HHHH ****
M&-#$\1B>-&C;JI4$'\*(XHXAB.-4  &%&.!T%/HH *0J&QN .#D9%+10 WRT
M_N+UW=._K3$MH(\[((UR=QP@&3US^@J6B@!IC0YRBG)!.1U(Z']!2>5'YOF^
M6OF;=N_'./3/I3Z* &^6@0)L78, +C@8Z4V6"*< 31)(%.X!U!P?6I** (Y(
M8I49)(D=7^\&4$-]:A%A$+V.YW-^ZC,<48 "(#C)  SG@#K].IJU10 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 5-0TNSU6...\B9Q$_F(5D9"K8(R"I!Z$C\:I?\(KI'_/.Y_\#9O_ (NM
MBB@"GI^DV6EB46<3)YK!G+2,Y8@8'+$GI5RBB@ HHHH **** "BBB@ HHHH
MS+KP[I=Y=R7<T,OG2XWM'<2)NP,#(5@.@J$^%-'8$&*X(/!!O)O_ (NMFB@"
M.""*VMX[>%-D42!$4=E P!4E%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !44MK;SNCS01R,ARA= 2I]L]*
MEHH **** "BBB@ HHHH **** "BBB@ KSOXU_P#(G6G_ &$$_P#1<E>B5YW\
M:_\ D3K3_L()_P"BY* .XTG_ ) ]E_U[Q_\ H(JY5/2?^0/9?]>\?_H(JY0
M4444 %%%% !5/5O^0/>_]>\G_H)JY5/5O^0/>_\ 7O)_Z": .'^"G_(G7?\
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M M[%:,LLK2"=M\5O(0/+DV$< Y/;\/\ :%-A\2V4NGV]VT=PHFA\YD\AR8T
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MSSB*)(HF)SY:OCWX.<\#'TH77]/96<R2*@0R([1-B500N4X^;D@#'7(QG(H
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M,4L\;3?-;P>>^%)&SV]3TX'/(]127.L6]J\B21SAD1G7]RQ$FWJ%P.>O^<4
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M:7>?;8'D%[9W8#8WVARHXZ'D\U%<ZQ'9WT\-P"(HHH6#*I9F:1V0# ]U'YT
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M[_D3]8_Z\I?_ $$UL4 95MKGG:A%93:9>VDDRLR-.(]K;<9^ZY]16K61?_\
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MKO,L]P+B"2%'5BT9(8YS@)_"1TSSP>3553/;:M=A+G>9M3*@SHI$?^A[@1@
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MS'#<6Z/'^\C\Q2K[200&!SE%.<_SK-Q87?B9&LDMHY;-W,\R[0\TA0KY?'+
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MM3/.96B*QS(R*556SO!QC##\>,5+9ZU-?:A;1Q6A6VGMC,7=AN0@@8(SV/%
M&O16#JVKWMM-J,,=N52VMXI4E0@LQ9V!&#_NX'X^HJ2X\1Q6:E+JW\BX\Y8E
MC>5 I+*6!WDX PK?B.,Y&0#:HK"7Q5;/"UPEO(T$4#3S2AE*QA6=2,Y^8[D(
M&.#ZTL'B>&Y/DPP>;=&146*.9'!RK-DL#@ !6SWR.^1D W**P?[5N;W5+""*
M&6&/=+]H7>H(9"!M/7(YSQU!%;U !1110 4444 %%%% !1110 4444 %%%%
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MRR"3=(5&2$9!PJ@8PYZ=ZTJ* ,:YT19;NQ1$;R8+I[N21GY))9MF/3>5;_@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !7G?QK_P"1.M/^P@G_ *+DKT2O._C7_P B=:?]A!/_ $7)
M0!W&D_\ ('LO^O>/_P!!%7*IZ3_R![+_ *]X_P#T$5<H **** "BBB@ JGJW
M_('O?^O>3_T$U<JGJW_('O?^O>3_ -!- '#_  4_Y$Z[_P"P@_\ Z+CKT2O.
M_@I_R)UW_P!A!_\ T7'7HE !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7G?QK_Y$ZT_[""?^
MBY*]$KSOXU_\B=:?]A!/_1<E '<:3_R![+_KWC_]!%7*IZ3_ ,@>R_Z]X_\
MT$5<H **** "BBB@ JGJW_('O?\ KWD_]!-7*IZM_P @>]_Z]Y/_ $$T </\
M%/\ D3KO_L(/_P"BXZ]$KSOX*?\ (G7?_80?_P!%QUZ)0 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5YW\:_^1.M/^P@G_HN2O1*\[^-?_(G6G_803_T7)0!W&D_\@>R_P"O
M>/\ ]!%7*IZ3_P @>R_Z]X__ $$5<H **** "BBB@ JGJW_('O?^O>3_ -!-
M7*IZM_R![W_KWD_]!- '#_!3_D3KO_L(/_Z+CKT2O._@I_R)UW_V$'_]%QUZ
M)0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 5YW\:_P#D3K3_ +""?^BY*]$KSOXU_P#(G6G_
M &$$_P#1<E '<:3_ ,@>R_Z]X_\ T$5<JGI/_('LO^O>/_T$5<H **** "BB
MB@ JGJW_ "![W_KWD_\ 035RJ>K?\@>]_P"O>3_T$T </\%/^1.N_P#L(/\
M^BXZ]$KSOX*?\B==_P#80?\ ]%QUZ)0 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5YW\:_\
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M^"G_ ")UW_V$'_\ 1<=>B4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>=_&O_D3K3_L()_Z
M+DKT2O._C7_R)UI_V$$_]%R4 =QI/_('LO\ KWC_ /015RJ>D_\ ('LO^O>/
M_P!!%7* "BBB@ HHHH *IZM_R![W_KWD_P#035RJ>K?\@>]_Z]Y/_030!P_P
M4_Y$Z[_["#_^BXZ]$KSOX*?\B==_]A!__1<=>B4 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %>=_&O_ )$ZT_[""?\ HN2O1*\[^-?_
M ")UI_V$$_\ 1<E '<:3_P @>R_Z]X__ $$5<JGI/_('LO\ KWC_ /015R@
MHHHH **** "J>K?\@>]_Z]Y/_035RJ>K?\@>]_Z]Y/\ T$T </\ !3_D3KO_
M +"#_P#HN.O1*\[^"G_(G7?_ &$'_P#1<=>B4 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>
M=_&O_D3K3_L()_Z+DKT2O._C7_R)UI_V$$_]%R4 =QI/_('LO^O>/_T$5<JG
MI/\ R![+_KWC_P#015R@ HHHH **** "J>K?\@>]_P"O>3_T$U<JGJW_ "![
MW_KWD_\ 030!P_P4_P"1.N_^P@__ *+CKT2O._@I_P B==_]A!__ $7'7HE
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !7G?QK_Y$ZT_[""?^BY*]$KSOXU_\B=:?]A!/_1<
ME '<:3_R![+_ *]X_P#T$5<JGI/_ "![+_KWC_\ 015R@ HHHH **** "J>K
M?\@>]_Z]Y/\ T$U<JGJW_('O?^O>3_T$T </\%/^1.N_^P@__HN.O1*\[^"G
M_(G7?_80?_T7'7HE !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MW%ZWD6]Q)%-Y31&1^5VGE<,!D@[0#TQDU9T74-2OKX22R?NF>59(6:/$6UL
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MVNKEI[B,*Y*E#'M8M@H5 (^Z>&R1CJ>I ->BN9N]9U"%[VV20>;8>9)-*4!
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M^67,>X[1C><9!R2/Q%+I\M[<1:=/<W@DFGT^2Y1Y54)'(5C'0 < ,>O/S-^
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M".E6M-TFZ@U$7MRT&XFX)2+) \QHR,$@9P$.3QG- $POM+F :W:UD:)D"DC
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MB@"];3:?=2/';"*1K4F-MJ<1G)!7./;I5*+4M+LQ?72W;W#D--(=N2RKQA,
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M!>?V8+9W@$B:=]C4JQ(8C&&/' ..1SCWH NKJ=DTTTLZ(H@D6.%]A+MNC5\
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M)9K:9(4#$_*SX#'/0OM8G'7DGO5?^P-0>P6R>2V6.#3IK*-U9B7+A0K$8^7
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M[""?^BY* .XTG_D#V7_7O'_Z"*N53TG_ ) ]E_U[Q_\ H(JY0 4444 %%%%
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M*HHPV1OSP1P2"#]14^I6=TVJ7%Q'8)=QSV/V89=00VYC@Y_A.1G&3TX-;=%
M'-Z;8R1:_P#9A.LT%I$D\C \_:"GE<_\!4G'JV:FU>RU.\O=L>\P"6!TVLBH
M D@9MV1N)XXQQTZ5NX Z#K2T 8,%A?+=V<3VP$-M>W$[2EQAE<2[<#K_ ,M!
MG./;-16&C7 @@6XME5H=+^QG<5.6X!QC^$X_Q%='10!S1TF_%M<V9MA(UVT+
MBYWC]R51%.<\Y4H67 /)[<FK$>EW%M%;O%;HTD6H7-TZA@-X<3;>?4[U'M^%
M;M% ','3=0ECM[DV\\5U'<^=.5:+=(2C+\F=R@+D  XXSSGK'=Z'=)IU];6U
MD;C[=I_V=/.D0&)LR'#8XQEQC:#T^AKJZ* ,_5+>:26RN(8?/^RS^8T60"P*
M,N1GC(+9Y([U4T_3+F*\AN98DC7?<.8PP/E^8RD#Z\$G'&2>M;=% ',2:!>O
M864(2,M!:-&Z,WRNWF1/L/LP1@3[U-J-E>WUU'=?9;J.,V\EN\"- 7^8KS\V
M5VG&#@YX'!KH:* ,O3[!].DOI$A\QIIHRA+#<R"*-,D^Q5C_ /KK4HHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!+?_ !NCS-2_Y]+7_P "6_\ C= %RBJ?F:E_SZ6O_@2W_P ;H\S4O^?2U_\
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M!+?_ !NCS-2_Y]+7_P "6_\ C= %RBJ?F:E_SZ6O_@2W_P ;H\S4O^?2U_\
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M5>JC?_\ 'YIG_7TW_HF2@"]1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !7G?QK_P"1.M/^P@G_ *+DKT2O._C7_P B=:?]A!/_ $7)0!W&
MD_\ ('LO^O>/_P!!%7*IZ3_R![+_ *]X_P#T$5<H **** "BBB@ JGJW_('O
M?^O>3_T$U<JGJW_('O?^O>3_ -!- '#_  4_Y$Z[_P"P@_\ Z+CKT2O._@I_
MR)UW_P!A!_\ T7'7HE !5/4_^/5/^OB'_P!&K5RJ>JL%LU9B HGA))Z#]ZM
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MGJ;^T]/_ .?ZV_[^K_C4&A.DFG.Z,&5KJY(93D']\] &C1110 4444 %%%%
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M_P#/];?]_5_QH_M/3_\ G^MO^_J_XT 6J*J_VGI__/\ 6W_?U?\ &C^T]/\
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MY-&OH89GB6(M?.2XD8 'B0XZ@FGP^"/#-U-_HVB7TMN)"AN/MSA20<$@&3)
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M!'@L:7_:2V\[V^S>&2\F;=Z 8;DYXQZU##X,\*?:%@O=(O+!Y$+QF:^<JX!
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MS95?Y420#;@ <,_U_*FW&GWOE:A:0Q/':7BO&(R^_#R,=T@_NK@LQ!/7H!W
M*W_"M/"W_/E/_P"!DW_Q5'_"M/"W_/E/_P"!DW_Q5=710!RG_"M/"W_/E/\
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M$-RL.]$F4>64/?CD=Q@]2>G6NBH Y+_A6'A+_H'R_P#@7+_\51_PK#PE_P!
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MBC_T*EK_ -^'_P#CE'_"6?%'_H5+7_OP_P#\<KT^B@#S#_A+/BC_ -"I:_\
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MBC_T*EK_ -^'_P#CE'_"6?%'_H5+7_OP_P#\<KT^B@#S#_A+/BC_ -"I:_\
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MBC_T*EK_ -^'_P#CE'_"6?%'_H5+7_OP_P#\<KT^B@#S#_A+/BC_ -"I:_\
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MBC_T*EK_ -^'_P#CE'_"6?%'_H5+7_OP_P#\<KT^B@#S#_A+/BC_ -"I:_\
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MBC_T*EK_ -^'_P#CE'_"6?%'_H5+7_OP_P#\<KT^B@#S#_A+/BC_ -"I:_\
M?A__ (Y1_P )9\4?^A4M?^_#_P#QRO3Z* /,/^$L^*/_ $*EK_WX?_XY1_PE
MGQ1_Z%2U_P"_#_\ QRO3Z* /,/\ A+/BC_T*EK_WX?\ ^.4?\)9\4?\ H5+7
M_OP__P <KT^B@#S#_A+/BC_T*EK_ -^'_P#CE'_"6?%'_H5+7_OP_P#\<KT^
MB@#S#_A+/BC_ -"I:_\ ?A__ (Y26?@_Q3XOUJVU/QF\<%I;-NCLD(^;G.,
MG ..23GM]/4** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
)BB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>a2019proxysiboneincproxy002.jpg
<TEXT>
begin 644 a2019proxysiboneincproxy002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MJ*ZN([2UFN921'"C2/@9. ,F@"6BJ6D:K:ZWI<&I618V\X)0LN#P2.GX5=H
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$4&IWFI:IJ+B"^GMX88[EE55X)/'.>?7L*[/2O"F@Z'<-<Z;I<%O,PP9%!+
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M>AR:+ILMU=73VD;37D/DSN<YD3&-I]L4R/0-*B>Q>.RC5M.5EM2,_N@1@XH
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M?/\  W'4'Z54T2)M$T'QEJ>GS7'VVRNYX(@9F;:N5^<J>K#D[CSQ7HNG^$M
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MRMT@$\K32A?XG/5C[\4#2[%=1EU$6R?:YHO*DE[LGH?:@#QOQ/>+XKT_5O%
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MQC@CMM-BC6WG-Q$,D[)" -PR?0#\JM1Z)IL27R)9QJNH%C= 9_>EA@Y^H)H
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M2Z6R9E#M$L/D^NT/@E@,]@,YJ34K6^UN6]NX[":W2/2KBUA2;:KS22;3T!.
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M +Y%17.G65W"89[:-T)5L8QR"".GN!5JB@"+[/!_SQC_ .^11]G@_P">,?\
MWR*EHH B^SP?\\8_^^14%[I5E?VS6UQ!F-OO!&,9/ME2#CV[U<HH A2TMHT5
M$MXE51@ (, 4OV>#_GC'_P!\BI:* (OL\'_/&/\ [Y%'V>#_ )XQ_P#?(J6B
M@"+[/!_SQC_[Y%'V>#_GC'_WR*EHH B^SP?\\8_^^11]G@_YXQ_]\BI:* (O
ML\'_ #QC_P"^13EBC0Y2-%/J% I]% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M: -^BLS6[36+N&)='U2/3Y%;+M);B7<,=,$\5C?V-XW_ .AMM?\ P6K_ (T
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M'Y8;DX^7MQ@?A0!;HKF+G2?&3W,KV_BBVBA9R8XSIZL57/ SGG J+^QO&_\
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M6K_C6KH=EKMHTQUG6(M0# >6([81;.N>AYSQ^5 &O16)K5AXBNKM'TC7(;"
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M7'/M0!H45R?]C>-_^AMM?_!:O^-6;#2_%L-]#)?>)+>YME;,D2V"H7'IG/%
M'1T51U>WU&YL3'I=\EE<[@1*\(D '<8-8/\ 8WC?_H;;7_P6K_C0!UE%<S::
M3XPCO(9+KQ/;30+(IEB73U4NN>1G/&1WK:U6"_N-/>+3+Q+.Z)&V9XA(%YY^
M4^U %RBN3_L;QO\ ]#;:_P#@M7_&I(-(\9I<1M-XIMI(@X+H-.4%ESR,YXH
MZBBJNIPWL^GRQ:==K:73 >7,\?F!>1GY>_&17._V-XW_ .AMM?\ P6K_ (T
M=917*IH_C42*7\5VK*",C^SE&1^==%?Q74UC-'97"VURRXCE9-X0^N.] %BB
MN3_L;QO_ -#;:_\ @M7_ !H_L;QO_P!#;:_^"U?\: .LHJ&[2>2SFCMIA#.T
M;"*0KN"-C@X[X/:N9_L;QO\ ]#;:_P#@M7_&@#K**Y/^QO&__0VVO_@M7_&N
MF9)S9&,3 7'EX$NWC=C[V/KSB@":BN3_ +&\;_\ 0VVO_@M7_&C^QO&__0VV
MO_@M7_&@#K**BM4FCM(4N91-.L:B20+M#MCDX[9/:I: "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>8?8OC!_T$[7_OF#_P"(H^Q?&#_H)VO_ 'S!_P#$4 >GT5YA]B^,'_03M?\
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M,'_03M?^^8/_ (BC[%\8/^@G:_\ ?,'_ ,10!Z?17F'V+XP?]!.U_P"^8/\
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M%\8/^@G:_P#?,'_Q% 'I]%>8?8OC!_T$[7_OF#_XBC[%\8/^@G:_]\P?_$4
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M Y/YU(EI#']HV!E-RV^0AB"3M"Y![< =*\W^Q?&#_H)VO_?,'_Q%'V+XP?\
M03M?^^8/_B* .^M-#M;*T-K!+=+%M"JOVE_D ].>*5=&M4@:..2Y0O)YCRK<
M/O=L8Y;.2,8&.G K@/L7Q@_Z"=K_ -\P?_$4?8OC!_T$[7_OF#_XB@#T/^R;
M'^SVL?(!@9&1@222&SN.X\Y)).<YR:?/IUI<1+%+ A571QQCE&#+^JBO.?L7
MQ@_Z"=K_ -\P?_$4?8OC!_T$[7_OF#_XB@#T^BO,/L7Q@_Z"=K_WS!_\11]B
M^,'_ $$[7_OF#_XB@#T^BO,/L7Q@_P"@G:_]\P?_ !%2:5XX\1Z%K]OHOC6U
M1%NB!%=H !D\ DK\I&<9Z$9YH ]+HHHH **** "BBB@ JKJ;M'I=W(APRP.0
M?0A35JJ>K?\ ('O?^O>3_P!!- '"_!.)!X4O90HWM?,I;N0$0@?J?SKT:O._
M@I_R)UW_ -A!_P#T7'7HE !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7G'QLB0^%;&<J/,2^
M55;N 4<D?^.C\J]'KSOXU_\ (G6G_803_P!%R4 =WILC3:7:2N<N\*,Q]25%
M6:IZ3_R![+_KWC_]!%7* "BBB@ HHHH *IZM_P @>]_Z]Y/_ $$U<JGJW_('
MO?\ KWD_]!- '#_!3_D3KO\ ["#_ /HN.O1*\[^"G_(G7?\ V$'_ /1<=>B4
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %>=_&O_ )$ZT_[""?\ HN2O1*\[^-?_ ")UI_V$
M$_\ 1<E '<:3_P @>R_Z]X__ $$5<JGI/_('LO\ KWC_ /015R@ HHHH ***
M* "J>K?\@>]_Z]Y/_035RJ>K?\@>]_Z]Y/\ T$T </\ !3_D3KO_ +"#_P#H
MN.O1*\[^"G_(G7?_ &$'_P#1<=>B4 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>=_&O_D3K
M3_L()_Z+DKT2O._C7_R)UI_V$$_]%R4 =QI/_('LO^O>/_T$5<JGI/\ R![+
M_KWC_P#015R@ HHHH **** "J>K?\@>]_P"O>3_T$U<JGJW_ "![W_KWD_\
M030!P_P4_P"1.N_^P@__ *+CKT2O._@I_P B==_]A!__ $7'7HE !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M ")UI_V$$_\ 1<E '<:3_P @>R_Z]X__ $$5<JGI/_('LO\ KWC_ /015R@
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MG_D#V7_7O'_Z"*N53TG_ ) ]E_U[Q_\ H(JY0 4444 %%%% !5/5O^0/>_\
M7O)_Z":N53U;_D#WO_7O)_Z": .'^"G_ ")UW_V$'_\ 1<=>B5YW\%/^1.N_
M^P@__HN.O1* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH C
MGGCMK>2XF<)%$A=V/0 #)-<QX/\ 'UEXON;JWAM9;66W4.%D8$NI.,C'IQ^8
MJE\6-:;3O"O]GP$_:=3?R55>NSJV/T'_  *N,77]*T7Q;H&HZ9!>6]K# MC>
M&X@,89>F[W/.?^ B@#VNBO-/$M@=8^+UAILES/%:S:=F989"A=09#MR.QP,^
MU,\-V_\ 87BWQ9H%G+(-/AM/.BB=RVQB@/&?]XC\!0!Z=17B6F>&[>_^%5SK
MUW<W4E[;;VM6\YL0A6Z 9QR<G/O6SJM_<W4'PYN9YW:2:>,RN6^^<Q\GUH ]
M4HK@M8F/_"ZM!A60X^PR%D!X^[+U%<WKJ:5K\.MZOI>A:C>FW:1CJLEZ(EA9
M1GY$+<J..,9Q0!WOBOQ-<>'[[1;>"WCE74KQ;=RY.4!*C(QWYKI*\EU6]GU#
M1?A]=7,AEF>]CWNQR6(91D^_%>M4 <7X4^)-EXIU@Z:EA-:R&-I$:1P0^",@
M8_$_A3_%_P 1;/PEJ4=A)8RW<C0B5C&X 0$D#/Y?RKSGP^ITKP]I'BF,8_L_
M6'BN".OE.J _U'_ JE\2_P#$ZTKQ+XH/S1RW\5I:M_TS3J1['"G\Z!GM\4@E
MB20# =0V/K3Z\L\87,^H^+]+T.>QN]0L([!9S8VTOEF=CD9)R,@8_G4=E/X@
M\+Z%XE>'3KW3]/6!9+!+EPYMV)"L <G^]G_@/UH$>KUFW6OZ=::[9Z)+*WVV
M\5GBC"$C: 223T'W37DMII>J+IFG:KH7A_5EU;*3/J#7(=;D$9(*Y^Z<_EUK
M5\0^&M,N/BSI-K)%*(M2ADGN%\Y@2^)#P<\<@<"@#T%+_53XF>Q;3,:8(=ZW
MN_J_'R[?S_*M:O/[(&'XT36R,WE1Z6H52Q(XVBN4\+^&K?7O >M:EJ%Q<R26
M;S?95\Y@L3*@;=CH220.>PH ]KHKQV^UC4-0\!>$;"XOI8X]4N6@N[@-ABBR
M; "?H<^^VKVJ:%9^&?B!X6LM+GG2VEE+&V>9G"G(!89/&[_V6@#U2BLKQ1J$
M^E>&-2O[49G@MW>/C.#C@_AU_"O-T\,6;_#@^+6U&[.M>2;G[;]H;(8-]SK^
M'KG\J .Z\;^*)?"NC17-M;+<7-Q.L$*.<+N()R?R_6M71WU233(VUF*WBO23
MYB6Y)0<G&,^V*\I\9PIK/A+PUK]XC_;[R2*"9MY 9<-SMZ D\Y'K7K&E:9:Z
M-IT6GV:NL$6=H=RYY))Y//4F@#G-5\>_9M>ET72-%N]7N[=<SB$A5C_'!]16
MN?$<%KX9_MW5K>?38E7,L4J$O&=VT# '<X_.N7UWPGKVD:[>^)_"M_$LEPN^
MYM)UX?')P??&>W?FL?Q+J5OXU^%,GB&YMC#>V+B,*CL$#-)&&..X(QUZ4 >I
M6=U'?64%W#GRIXUD3(P<,,C^=35Y1KD?_"-_#_1;729YK-=9DA^U7'FL2NZ,
M9P2?E!]NP-2^(M%MOA_J&B7_ (?FN(I+BZ$%Q TQ<7*G&20>_P#B* /4JYN\
M\37%M\0+#PVL$9@NK5IVE).Y2-_ [?P#\ZY2STN#QUX^U^+7I9I+?2W$5M:+
M*44#)&[C_=S_ ,"JGXWNKGPWX\TV72;<S2V6BE8E8YVJ/,&X^NT<^^* /1_$
MNJR:)X=O=3AC622VBWJC]#]:?H&HR:OH%CJ,J+&]U LK*O0$C.!7!6]C9Q?!
M[4]0@O&OKF_MS+=7#DEB^>5YZ8.?U/>L/5= BTOX;:3XF@NKH:JGDLD_G-\B
MGH@'0 #'Y4 >U4R5S'$[@9*J37G.N%_%/Q$L?#NHSRQ:8MD+AH(W*"=R">2/
M\\'UI-&1O#7Q%O?#6GSRR:7-9&86\CEQ;MC/!/3_ .R'I0!U'@;Q)<>*O#W]
MI7,$<#^<T>R,G&!CU^M-\7^)KCPY)I2P6\<WVZ\6W?>3\H/<8[UY?!J5W8?!
MJ*.TF:#[7JC0RR*<$(5R1GWP/PS6KXO\*:=X8OO#2Z;/,(YKY!)$\I978%?W
M@!Z'GG''(H&>OT5Y)K,DGB#Q_JUKJ&CW^L6U@JQP6EO/Y:Q9'WSR,DG_ #TJ
M/4%UVQ^%&J6NJPW5OY%W&+0SOF3RBZX!(/;G\Z!'K]%>::EX+U4>"I9M%O+F
MXU35/(FOB\P!E4*Q*KTP,OTST&*O?#F;0XKR_P!/LM'NM(U*)$^U6T\K2 @?
MQ D_[7H.HH [VBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M\[^-?_(G6G_803_T7)7HE>=_&O\ Y$ZT_P"P@G_HN2@#N-)_Y ]E_P!>\?\
MZ"*N53TG_D#V7_7O'_Z"*N4 %%%% !1110 53U;_ ) ][_U[R?\ H)JY5/5O
M^0/>_P#7O)_Z": .'^"G_(G7?_80?_T7'7HE>=_!3_D3KO\ ["#_ /HN.O1*
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%V60@G9P.3P?RKGM9\+V?A3P1K4NG7%X99+4!Y)9RQ)!ZCT//:N4\9Z?'/\
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M]ATB*^MI(90+FUO7+/$V".YZ<'\0>*[&@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KSOXU_
M\B=:?]A!/_1<E>B5YW\:_P#D3K3_ +""?^BY* .XTG_D#V7_ %[Q_P#H(JY5
M/2?^0/9?]>\?_H(JY0 4444 %%%% !5/5O\ D#WO_7O)_P"@FKE4]6_Y ][_
M ->\G_H)H X?X*?\B==_]A!__1<=>B5YW\%/^1.N_P#L(/\ ^BXZ]$H ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MMK(@VUK=3!HTQTXQS6H?"5I/XGEUZ]F>[E:$P10R@>7"A&" /<$]?[QK>HH
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MUJUJ'@O3=2\)V_AR>28V]LJ"*4,/,4J, ],=,]N]=#10!RUQX$M;[1[:RO\
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M_>S>^^R1&UNEF @9FW (RGJ!C[PH ;HFKW6KR2R%+6.&-W1H1(3/$02!O&,
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M2>!,YWM"Z@*"?4#C/? -+I6D7^GK#!)!I<B6Z;5N5C(E? PI*XP#TS@GOTH
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M*^1=7M_) D<2(QCA .TYZ$@ EB>.AZ=* .CHHHH *\[^-?\ R)UI_P!A!/\
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MO=0X<Y^8%2QYZ8R,8JM=01Z3IOBFZTZ)8)TO4B\Q6*E(VC@WG=SMP"QSVZT
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M9#&P,DZM&O'3!+@@#)'O6=X?O;R[M]0\F\&H6\<FVQNY5"B;Y1D$J &4-QN
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MO[33;5KJ]N([>%< O(V!STH P;VPU'6)KZ\:Q>U_XEDUG;PRNA>1I,$D[25
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M;B%'! P<\],[7B*WO;FVMEM5FDB6X#74-O*(I)8MK?*K$C'S;2>1D C-:]%
M''#P]>2:;XD@@L/L:ZC:B.VCDE#,6\ME^8@G!R1W/6NKM)I+BV666UEM7/6*
M4J67\5)'ZU-10!RUCINH_P!EZ'9RV+Q/IETOFLSH5=5C==ZX8G&2.#@\]*DU
MW0;O5+C5?*"JMQ96R0L7VAI(Y97*DCD#E>??CI6]!>0W%Q<V\9)DM7"2 CH2
MH8?H14] &#H^GPK?K<OH]_:S11%5EN[WS@-V,JH\QO0<X'04YXKW3-=O+V"P
MEOH+Y(\B%T5XW0$<AV4%2,=#P<\5M,Z*RJS %SA03U.,\?@#3J .9@T6_2VL
M'DC3SSJK7UPBN,1*V_@'OC<HXZG)J\+"Y_M?5[CR_P!W=6L4<1W#YF429'M]
MX5L44 <Q86&I:+-:7:V+W:R:;!:W$44B"2)X]V"-Q (.]@>>PZU'=Z7.^MRZ
MI+I=_/%>6\8,5O>B*2!UW<,!(JL"".03@@^M=710!RNI:24TV"WTS0[N*[BM
MR;6YBN44VTC$DJSE]Q /)&&!]ZT]9L+R[TZU:+9+=V<\5QL)VK*5^\N>V03C
MWQ6O10!AQ17NIZ]:7\]C)8P644@59G1GD=]HZ(S * #U/)(XXJUX>M)[#0;.
MUN4V2Q1X9<@X.?45<O+J*QLI[N<D101M(Y R0JC)_05(CB2-77[K $4 85LF
MHZ#+<6\.FRZA92SO/";>2-7B+L6965V48W$D$'H<8XIUU%?_ -IV&MPZ?([)
M!)!/:>8GF*KE6!!W;204&1NZ'VK=JA#K%G.UN(W8FYEEBCRIY:,L&_\ 030!
MASZ/J=Y<7&L?9A#<_:;>6"TDD7+)$&!#,"5#-O?') PO-6+NTU#6;TW3V$EG
M';V<\423.A>620*/X6("@+W/)/M71T4 <@=!N+:]BNI;&\NXY+&"&1+.\,+Q
M21@]?G0,#N]3@CWI-<TV2RTK3#I,#6=PTC6@C>3<R+<9W_-DY*MM?J?NFNPJ
MO)86LM]%>R0AIX01&Y).W.>@Z9Y(SUYH J:IIQ;PM>:98QC)LG@@CR!_ 549
M/X5EZBNJ:KX6OM*&BW-O-)8O$C2RPE6?;@#Y7)Y]^*Z5'21=R,&7)&5.13J
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M>=_&O_D3K3_L()_Z+DH [C2?^0/9?]>\?_H(JY5/2?\ D#V7_7O'_P"@BKE
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M#5/M.I:66EOKB,PZXD*^7M'R_:4"]0?N]OUS5K4]6OM,FU2**<R&WM+-83,
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M;7^TKBUM8;:!U2#:&WOOR<D'CY1Q52SU#4-6&C6+WKP&>WGFN9X0JO+Y3*@
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MFT]Q)8Q R2L&"#M\HZDX]ATJ>.[UJ=-+LY;BXM&FO9H6F>)5EDA5'93C& Q
M SCKDXK7;PY9B"T2"6XMI+,,L,\4F'56Y93D$$' X(/05832X@;-I9IYY+-V
M>.25\L2P8'/'HQ_2@#FM:6Z/A[Q3ITNH7$B6=JTD<C%=Y5H6)1CCD9!]\'K5
MO4EOM/6U::\U%M,C@8S3VX1I4?((9P%R4 S]T?6MJ;2+2<7XE1F74(Q%.-W!
M7:5P/3@FJ\F@>=:K;/JVHF,(8WQ*H,B^A(7TXR,&@#2@=)((Y(Y/-1E!5\@[
MAC@\>M25'!!';6\<$*!(HD"(HZ* , 5)0 5YW\:_^1.M/^P@G_HN2O1*\[^-
M?_(G6G_803_T7)0!W&D_\@>R_P"O>/\ ]!%7*IZ3_P @>R_Z]X__ $$5<H *
M*** "BBB@ JGJW_('O?^O>3_ -!-7*IZM_R![W_KWD_]!- '#_!3_D3KO_L(
M/_Z+CKT2O._@I_R)UW_V$'_]%QUZ)0 4R:5((7FD)"(I9B 3@#V%/HH YEO%
MD-UHT&HVSB!?ML<4WF X5#)M)R0.H&?:MFSU>PO_ #?L]P"8 #(KJ4*@]"0P
M!P<'GIQ7-0I]HT"UL#!(TUKJR&:-HF&T?:"P/(Y&.<CC%6/$NGWE]=:G%:1N
M7GT=HU(& [;S\N>F2"1^- &U9:YIFH2&.UNED8)O VD;E_O+D?,O3D9'(ID?
MB/2);62Z2^C:",)ND .T[ON@'')/3 R<\5D:<D&HWUM<'5-0GFM(G*P368A"
M;EVE6(C&#R.,]O:J;6-S;^%?"LB"XMX[)8FN!#"'DBS"5W;"#G#-SQD9)[4
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M(4-O8*I(& Q&, G)S[U+<RBV\86TDJN(Y[-H4<(2I?S%."0../7T-9JV<J>
MV@6V<2FY+[ AW9^T[LX_6@#>O=;T[3I?+N[CRB%#,=C%4'JS 84>Y(J!O$5H
MOB)=&.[S#%OW[6QG( 7ICH<YSBL/7KN^N7UBSEN;ZWVQF.TM;6U#"Y4Q@[BY
M1OXBR\$8QSZU=MG-IX@TQ[A)%6;3!"K>6Q'F;E.TD#@_7WH T=<UVWT*&"2=
M6;SYXX@ #P&=5)X!Z!LX[]*JGQ';P:W<PW%QBW^R6\T"K$S.=QEW' &[&%7M
MQ^-2^*0PTJ&4([K!>VTLFQ2Q"+,A8X')P 3^%-T]%F\57]\D;&.6PM1'*4(R
M-TQ(&?JN1]* +LVLZ=!90WCW:&"XQY+)ES+D9&T#);CGBI[.\M[^V6XM95EB
M;(#+Z@X(/H0>"#7%16UW:)HUW))=V=O#]LB>2*W$AA+R@H2I4X4A2,XXR.QK
MIO#UM#!:W$T%W<70NKAIFDGB\L[L*IPNU>/ESTY)- %\7ML8[B03+MMF*S'^
MX0 3G\"#5:XU[3+5D66Z&^2,2(B*SLRG."% )(X-85S=_8(O$-C);W+W-U(\
MELD<+-YP:)0,$#'4$')XQS5O2+9UUR&9X&7;H\$8=EQ@[F)7/KTX^E &I)K6
MFQ:=%J#7D9MIB!$ZY;>3T"@<D]>!SP:HV&OP76I:HQNXQ8VD,+[F&SRR=^_=
MGD?='!Z5D6\4MBUA?7%O-]FM=4O]X6-F,8>238^T#.WMD=FSTJMJ$<^JS:]=
M6%I<K&SV,@80$-<+&Y+E58?,<# !'.!U!% '5PZ]ID]M<7"70$=K'YDV]&0H
MF"=Q! ., \]#@TUO$6DB+S!=[U,AC79&S%V R=H RP [C(KG;ZWCU#2M:O(-
M2OM1N?[(GMU22U\L8920.$7+9'3J,GCFM;68K*VM[&1KJ?3[BWC9;:6"$R;1
M@ J5VD$'"\'!XXZ4 :4=['+>+MNH_*:V\T1%"&QG[^3T';&*@M_$NCW<\4$-
MZK23G$(*L!+QG*$C##CJ,BL&XM]6UNUF,MLUM>7F@O&1M*A9&/3GI]#R*EN]
M3M[Z^\.PPV-S"T=Z"PFMVC$/[F0;,L!D_3(P,^E &R?$FCB<0_;DW>9Y1(5M
MJONV[6;&%.>,$C-27VN:9IT_DW=VL;[=[#!.Q?[S8'RCKR<#BL#['*/ 6J1"
MV<327%XX0(=S$W#E3CJ>,8_"F7,<EIKNLK>ZA>6<-ZZ/$8K194E3RE0KG8QR
M"K?+[@XY- '27NLZ?I\D<5S<A9)%+*BJ7;:.K84' ]^E1>']0?4].DN7D64?
M:[B-'3&"B3.JXQU^4#FLBR6'PWJS?:?M+VTFGVT-O<&%G)\O>"K;1PQW XP,
MY/I5[P>CQZ!A[5[7==W3"&1=I13.Y Q]"* +\FL:=%IR:C)=QI:2%0LI. 23
M@#\ZFEO+:"80RS(CF-I<,<81<;F/H!N'YURW]D/>ZI<Z!<02#3HGGN5DV_*P
ME7 4'U#23'';:M0"TU36M!U2XN;63[8((K01.-IE\O#2XSV=BR^X H Z>RUW
M3-1G$%K=!Y&7>BE67>O]Y<@;A[C-3#4K-K*.]%PIMY2JI)V)9@J_F2!6)<WL
M6N:GHZZ?#/NM;DSS220/'Y*>6ZE26 Y)8#;]3VK,CN63PM8Z+]ENC?07=NDT
M8@?$82X0EB<8VX&00><_6@#?M=96,ZS+J-PD5O97GE(S<!5,4; >YW.??G%)
M9ZY'J'B'[+:S!X%M#(Z%"KJ^\ 9! (X/>LBZMKA)[V[:VE>&WUZ.Y=%C)+QB
M"-=R@<MM8YX_NFKUC<Q:AXT>\MK>7R!I_EFY:)D5V\P':"0,XS^I]#0!K7NK
M6&G2)%=7 CDD4LD84LS@8S@ $GKT%(-:TPZ:=1^V1"U!VF0G&&SC;CKNSQCK
MGBLG5;N"Q\::?<7$3M&+"=?,2,OY67CY('(';/O6=Y,QN#K8M)S8?VS]J\D1
M-O,?V?RO-V8W??\ FQC..: .EAUW3)[>XN%NU5+89G\P%#&.H+*P!&>W'-)_
M;^F_9#=-.R1!PGSPNK,QZ *1DD^PK$NOL6LZM<WKQS_V8EA]GFF$3J9',BLN
MWC)V8)R!@;OK3$N5N[29=1O;LV]I<H;#4EMBDI?8<D@+@XR1NV[3G'6@#H)-
M:T^&RCNY)RD4S;(P8VWNW/ 3&XG@\8[4U]>TM+.*[^UJT4S%(]BEF9AG*A0,
MY&#D8XQS7+O/JEQ<:7JM[-=6T,0N;?[5#:<D%E\N1HV5BH94/....@-6OL>F
M6]F+TZM?K/+=27$-Y]E(97*JC#8$QM(7H1SR0>] &]-K^F6XB\RX;,R>8J+$
M[-M]2H&0/<XJQ?S?9]-N9Q.EOY<+OYTB[ECP"=Q'<#KBN4N;ZX%A!JS-<6FO
M&TP($M'=+I0S;$9,'&3S@$,N[DXK>\0+-<>#]37R6\^33Y1Y2_,=QC/RC'7G
MB@"I=:T'\4VFE1WKPJ(C)*$ASYK;EVKDJ0%P3DCVY%;%]J-GIL227MPD".VQ
M2YZM@G'UPI_*L](I/^$IMY/+;8-.92V. =Z<9]:K>+I$ADT.62!YDCU16*(N
MX\12G( Y..O'/'% &I:ZQI]Y#/+#=+MMN9O,!C,0QG+!L$#'.33+;7M,O$F>
M&Z!$,?FON5E(3^\ 0"5X/(XKFM:@GUUM6N]+BF:+[%##N\LJ9V64NRJ&'S87
M(],MCUJ9H8M1CNKN/4[^]N8M/GC6.6T\H .!D'"+SE1QG/M0!N?\))I!A\Y;
MP.GF>6I1&8NV,X4 9;@'IG&#4L^M:=;6\,\MQM6X_P!4NQB[^N$ W<=^.*RK
MF"RM]"TGSY[C3YK:)?L\L,18QG8 01M(P1Q@CZ<U5LKZ[BU&RUK6;:2-9K%H
M#(D#8B<29RR\E-Z[3STQ@]J -\ZYI8L$OS?1"V=M@E)P-W.0?0\'@^E.M-8L
M+Y)W@N ?L_,JNI1D&,@D, 0, \US0M9;RX:]6TE6UNM;AGB1XRIVK&%,A4C*
M@LN>?0'O5S5WO[/6-3O;"V:24:7$(SY98%A))V'WB <XZ_G0!I#7+*[@NA9S
MYGAA,FQXV0XP<, P&1GN.*HV>O2+<6C7TZ);OI<=S(Q7 \QF S[#FLV(2W.O
M":.\O]0C_LNZ0S3VXC0.6B(5<(O/!X.?YU/9:6;V2WM+J"00S: EO(2I&"2
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M/7@<\5/9WMMJ%N+BUE66,DC([$'!!!Y!![&N,-M=VRZ7=M)=6EO;W6H)))#
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M?W'(!*_@>*L4 %>=_&O_ )$ZT_[""?\ HN2O1*\[^-?_ ")UI_V$$_\ 1<E
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M -H64LSDQDI#L,>-JAAD?.1C(['/&#KZ+?7-W'=0WHB^T6=P8'>$%4?Y58,
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M5;/_ (Z*GCECE4M&ZN Q4E3G!!P1]0017,QSZI/X@T1H;FVAMI].DE-N(&P
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M[""?^BY* .XTG_D#V7_7O'_Z"*N53TG_ ) ]E_U[Q_\ H(JY0 4444 %%%%
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M[_["#_\ HN.O1*\[^"G_ ")UW_V$'_\ 1<=>B4 %5]0-PNG7+6@S<"%S$/\
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MXC'U(W+CT/TKI/%\2SZ 8GSMDN[53@X.#<1]ZTCIUB;S[8;*W^T_\]O*7?\
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M G\30 ^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MBKE !1110 4444 %4]6_Y ][_P!>\G_H)JY5/5O^0/>_]>\G_H)H X?X*?\
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M:^UN_NKJY@G+P>?^X7AEV^7TXQGZT =GHFL6^OZ/;ZI:)(D%P"464 ,,$CD
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M* .XTG_D#V7_ %[Q_P#H(JY5/2?^0/9?]>\?_H(JY0 4444 %%%% !5/5O\
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M]G8B=[+[-_J0 "7W]6R.U-M/B#X<OKRUM8+R0M=D+#(T#JC.?X=Q&,\]/PH
MNV?A/0K'1YM(@TZ/['.<S1N2WF'U))R3P/IVJ/3/!^AZ2\KVEK(&FA,#%[B1
M\1G&5&YC@<#I6M>7<-A9S7=RY2&!"\C!2<*!D\#DUDZ5XNTG6-0-A \\5T$\
MQ8KB!XBZ>HW#D4 3_P#"-:1_PCW]@?9/^);MV^1YC]-V[[V=W7GK6!XN\-WW
MB2;3M$33HH])MI8Y7O6GRP4 @H$ZY([YK6L/&>BZIJK:=8S2SNK,IF2%O)RH
M)(WXQT%&F^--$U>^DM;&>641ALS^2PA^7K\Y&* -U55%"J JJ, #H!6)JG@W
M0=8OFO;NS;[0ZA7DBF>(R#T;:1G\:K6OQ \.7E]':Q7KCSG\N*9X76*1_17(
MP34]SXTT.TUAM(EN6^VK-'"8A&Q.YQD=NG(R>V: +</AW28-0@OX[0?:+:W%
MM"Q=F$<8XVA2<#ZXS5=?!OA]=)ETH:<OV*67SC"9'(5_5<G*_P# <5S7B[XB
MZ<F@:C'HFH2+?0LJ13K"3&7#KN4,1M)VY_I70WGBS3]'@M4OOM,D\ENLS""V
M>3"X^\2HP!D&@"?3O"FBZ9;W4%O:%DO%"7'GRO+YBC. =Q/')_.H+#P1X>TZ
M&Y@M[ ^3=1F*6-YG=2A.< $G'/I3KKQIH%EI]E?S7P%K?Y\B548AL=>@R#VQ
MZ\4_2?%NC:Q'>/;W+1_81FX6>,Q-&N"<D-VX- $.G^!?#>EW-M=6FG;9[5BT
M4K3.S+D8QRW(QV/ JS_PB^C_ -NMK8M-M\X(=Q(P5_EV_,N=IX)ZBJ^G>-M#
MU1+B6WGE6WMHVE>XE@9(RH."0Q'/\Z=I'C+1=;O%L[2:59G0R1+- \?FI_>7
M<.10 VS\#^'M/OX[VUL6BDB<R1J)Y/+1O4)NVC\J9>^ O#.H7T][<Z8KRW&3
M+B5U5R?XBH(&>>OX]:T]0UJQTN[LK:\D:.2_E\J#Y"0S\<$]NO>H8/$NE7'B
M&?0(KG-_ F]X]AQC /!Z$_,.* *L/A*U@\0V&IQRE8--LOLMK:[21'VW;B22
M=O']:VKBWBN[:6VG020S(4D0]&4C!'Y5S-SXGM=0O-&DT[66MX)[UX#&;4L+
MHKC*@D?*/>J^F?$&WU;7M1TJ.VFB6%!]GD,3Y<[2S%@1\F,<9ZT ;"^#M 70
M&T$:>HTYGWF'S'Y;.<[L[NH]:L3^'-)N;"QL9;0&WT]TDMD#L/+9!A3D')P/
M7.:Y+P?\1+!O#VG)KFH2/?3R-'),83L5B[;0S ;0<8_#DUVVIZA#I6G37TX=
MHX1DB-"['G'0<]Z *K>&](=M39K3)U90MX?,?]Z "!WXX)Z8J]9VD%A906=L
MGEP6\:QQIDG:H& ,GD\5YSJ'Q#NM4^'5UJUAYEAJ$,B;MJ$JH,FT89AAN!SC
MI77:7XRT35]3_LVUN7:Y,?F)OB9%E4=2A(^84 5I/AUX4E<NVE#+2&1_W\F'
M).?F^;GGM6AJWA71=:,#7MF#);KMBDB=HG1?0%2#CVJH/'?AXZC]B%V_,WD>
M?Y+>3YG]W?C&?TK1\0WTVF>'=1O[?;YUM;22IN&1N"DC(H FTS3+/1[".QL8
MO*@CR54L6.222<DDGDFJ^I^'-(UB]M+W4+-9Y[)MT#EF&TY!Z X/('!S7$Z5
MXT\0_;- -W<Z9?Q:PZJUO;J1- #CYCST&<GZ5T^I>._#^E7\EE<74C208\\P
MPO(L.?[Q P* +VM>'-)\0)$NIV@E:$YCD5F1T^C*0:=IOA_2M(TU].LK*..V
MESYB'+>9D8.XG).1ZU%J/B?2]-MK6X=Y;A;Q2T M86F,B@ DC:#QR/SJ$>,]
M".BQZQ]L_P!#>80;RC I(?X6&,C\: (XO OAR+3)-,&G[K6202>6\SML8="I
M)RO4]"*L6?A+1+&QN[.*S+PWH N!-*\AD Z9+$GC/:J4GQ!\.I90W0NI76XE
M:*%$@<O*5QDA<9QR.:J^"_$4VOZ[XA(NVN+*"6+[*"FW8I#9&, ]1W]* +VG
M^ _#6F7=O=VNG%9[9MT4C3R,5XQCENGMTK7U32[+6M.ET_4(?.MIL;X]Q7."
M".00>H%4M;\4:3H$D,-[,YN)P3'!#&TDC =3M Z>]9&O^.;&+P7<:QH]R978
M-%"PB8^7+C^,8^7'7GCIZT =!%H>G0ZJNJQV^+Q;<6PDWMQ&#G;C..O?&:=I
MFCV&C1SQV$'DK<3M<2C>S;I&QD\DXZ#@<5D^!;J2]\-17$VH75]+(=SR7,6P
MJQ52548&5!Z'WK%M]9\8ZOK>N0:3<::L>F7/E)%<PM^\'.!N!]J .GUGPSI&
MOR02ZC:F26V)\J1)&1ESU&5(XJ2/P]I4(U$1VN!JA)N_WC?O<@@]^.">F*Y0
M^-I=3\'W%Y+=G0+^SNUMKEA!YX1\] OH>GM@_6M_4O&FAZ3J+Z==W3+=)L_=
M+&S$[NF,#GW]* )+KPAH5YIEKITUB#;V0Q;8D</%]'!W?K5O2-&L-#M&M=/B
M:.-W,C[I&<LQ !)+$GH!69/X[\/6^H/9R7;_ +J7R9)Q"QACD_NE\8!J;6/&
M&C:)?+87,TLETR;S#;PM*RKZD*.* +ZZ/8)K3ZRL&+Z2'R&EWMRF0<8SCJ!S
MC-4E\(:"NC1:.+#%C#+YT<7G/P^2<YW9ZD]ZRE^(%JWC7^P!:S"()M\[R7W&
M7>%QC'"]?FZ5;O/'_ARQOY;2:\<F!]DTJ0NT<3=,,P& : )[[P5X>U'4);^Z
MT\/-. )<2.JR8X!90<$CUQ5BW\,Z/:W%A<0VFV338C%:MYKGRT(P1R>>#WS4
M&K^,M"T29(KZ\VO)!Y\81"_F*3@;<=234?\ PF^B'4ET^*2XGF^0/Y-N[K$6
M^Z&(&!U_"@"S-X5T2XAU&&6RW)JCJ]V/-<>8RG(/7CGTQ4\VAZ;/=V%W+;;I
MM-#"U;>P\L$ 'C.#P!US571[[5;G7=9M[ZW:.TMI(Q9R&(J)%*DL03][GTI-
M:\7Z+X?NOLNHW+1S&'SE01LQ9=VWC Y.>U $5SX%\.75_)>R6!$DK[Y1',Z)
M(W7)4$ G\*TX='L(-7N-6B@VWMRBQRR[V.Y1T&,X'3L*R;WQYX?L+DP37,I,
M:JTS1P.ZP!AD;R!@=:L:OXNT;1?LRW-RTDEVN^"*WC,KR+_> 7M[T :=[96V
MI64MG>0K/;S+M>-NC"L;3_ ?AO2[NWO+33BMQ;$F*1IY&*Y&,<MR,=C3]0\9
MZ+ID=J9YI3+=Q":*WCA9I2A&<E0,C\??TI7\::!'HD6LF_!LI91") A^5SV8
M8RO3O0 ]_"&@R:?<V#V&;:ZN3=3)YS_-*<?-G=D=!P.*L:SX?TO7XHX]2M1-
MY+;HW#%'C/J&4@BL@?$?PT?.47,_FPX_<FVD$C@C.57&2,<YJU+XV\/PZ39:
MK)?8M+YRD,GEL?F&<@C&1C!H FA\)Z'#HT^D?81)9W#^9*DLC.7;@;MQ.<\#
MOVIEKX.T*STJZTN.S9K2[QYT<DSONQTP2<C';%4/^%D^&O)FD^TW&^%L20_9
MG\Q1_>*XX'N:T;WQ=HMCIUG?/=-)'?C-JD,;.\W&>% S]?2@")_!/A^32X-.
MDLF>&V8O"3,^^,GKA\[A],XXJ5/"&A+HLVCFQ\RSG?S)$DD=BS\?-N)SG@=Z
MC_X3301HC:R;LBT27R9"8V#1OG&UEQD&ETGQCHFM:DVGV5Q(;@)YBK)"R>8G
M]Y<@9% !I?@OP_HU['?6-B8[J-2@E:9V;!ZYR3FM#5-'L-:@B@U"#SHXI5F0
M;V7#KT/!'K7'>+/B+IJ:%J46C:A(M]"0D4ZPDQEPPW*&(VDXS_2MRX\7Z?I%
MI:)?FYDG>T2>3R;9Y-JD?>8J, 9!_*@#4?1[!]976&M\WRP?9Q+O;_5Y)QMS
MCJ3SC-9MOX&\.VFH)>V]@8I(Y?-1%F<1J_7<$SM_2L_Q%\0K'2;33+BR1KQ-
M0D3;($?:(R2"1@<L,?=ZU<M];6\\76\46JNL$VF_:%L'M2I/S$>87(R/3;0!
MK66CV&G75Y<VMOY<M])YEPV]FWMZX)P.O:LVW\#>';34$O;>P,4D<GFHBS.(
MU?KN"9V_I44?Q!\-2WJVRWS;6D\I;@Q,(6?^Z'QC^E2ZGXWT/2+^?3[J>4W4
M"JS0QP.[$$9R,#TZ^E %B;PGH<]OJ,$MENCU.02W:^:X\Q@<@]>.?3%69]#T
MZXO+"\EM]T^G!A:OO8>7N !XS@\ =<U0F\:Z#!H]IJOVPR07K;+=8XV9Y&Z%
M0H&<@UIZ;J,.JV*7ENLJQN2 LT9C8$'!RIY'2@!FEZ/8:-%/'I\'DI<3M/*-
M[-ND;&3R3CH.!Q0NC:>FMMK2V^+]X?(:;>W*9!QC..H'.,U>HH I:5H]AHEH
M;33H/(A+F0KO9OF/4Y8DT2Z/83ZO!JTD&Z]MXS'%+O8;5/48S@]>XJ[10!EI
MX;T=$U!/L*,FIOYEVKLS"5O7!/'X8JOH_@W0-"N_M=A8[)PNQ9))'D*+Z+N)
MP/I6Y10!1U;1[+6[06M_&[QJX==DC(0PS@@J0>YJE'X.T"+1)M&73D^Q3MOE
M0LQ9V_O%B=V>.N:VZ* ,/2_!N@:/>1WEC8>7<QH4$IE=F(/7.3S^-1VW@?P[
M9Z@]];6!AE??E4F<)\RE6^0' X)'2N@HH QV\*Z(^B0:*UEFPMW#Q0^:_P K
M D@YSD\D]36LZ))&T<BAT8$,K#((/8TZB@#F(OAUX4AD61-+Y202)F>3",#G
MY1NXY[5I2^&M(FEU*62TR^JHJ7A\Q_WJ@8 Z\<>F*U:* ,VY\/Z5>:+'HUS9
MI+8Q(J1Q,2=H487#9SD#OG-0Z;X4T;2X;J&WM"RW:A)_/E>7S%&< [B>.3^=
M;%% &'I7@[0M%:<V-F46>,Q.CRNZ[#U&UB0!4=OX&\.VMJMK%8MY"7*W*(9Y
M"$D7.TCYNV3QTKH** ,+5_!?A_7+PWE_8;YV7:[QR/&9%]&VD9_&K3^'-(?^
MS_\ 0D4:8VZT5&*B(_0'!_'-:=% %*#1["VU:YU6*#;>7:JDTN]CN"C XS@=
M.PHO-'L-0OK.]NH/,GL69[=][#83@'@'!Z#KFKM% &%9^"] L=374H;(FY0E
MHVDF=Q&3U*AB0*T-6TBPUS3WL-2@\^VD(+)O9<D'(Y4@]:NT4 46T>P;68]8
M,&;Z.#R%EWMQ'DG&,XZD\XS5"3P7X>ETQM.;3Q]G-P;D 2ON64]6#9R#]#BM
MVB@#%LO"&@Z?]H^S:>J_:HO)GW.S^:GHVXG)Y//6JMG\/_"]A<P7-OII$MO(
M)87:>1BA!R,9;I[=*Z2B@# U#P1X>U.^DO;FQ/G3?ZXQ3/&)?]X*0#4MMX;C
M@\5SZ\T_F,UJEK!#LP(4')YSSD^PK:HH J:GI=EK.GRV&H0+/;2@!T)(S@Y'
M(Y!S5*R\*:-I\UE/;VK"6P1TMW>9V*!R2PY//4]:V** ,>;PIHD\.HPRV6Z/
M5'62['FN/-8'(/7CGTQ4-_X)\/ZG<K/>632LJJI7SY C!1A<J&P<5O44 -55
M1 B*%51@ #  IU%% !7G?QK_ .1.M/\ L()_Z+DKT2O._C7_ ,B=:?\ 803_
M -%R4 =QI/\ R![+_KWC_P#015RJ>D_\@>R_Z]X__015R@ HHHH **** "J>
MK?\ ('O?^O>3_P!!-7*IZM_R![W_ *]Y/_030!P_P4_Y$Z[_ .P@_P#Z+CKT
M2O._@I_R)UW_ -A!_P#T7'7HE !4-W_QYS_]<V_E4U-=%D1D;E6!!^E 'C&E
M'4]5^%D/ANR\/W4LEY,3'>*H\G:)<EF;/!!4K@CI7;Z+HMW:?$6_O9K=S -.
MAABN67AV 4-@_A72Z/I%GH6F1:;I\9CMH=VQ2Q8C))/)]R:NT >6V]KK6A^&
MM8\)GP[>7MQ>2RBWNXD!AD$@P'=B?E(Z\^@Z58UOPEJNL:9HGA9(?+73[3S)
MM293M#A-HC0]P3C/L!Z5Z510!YQJ&GWVH?"E4GTY].U+1 LL:%<#,7\2^H*Y
M_&MCX=P37&EW?B&\0+=:U<&<C^[&.$7Z 9Q[&MO7/#]CXAMX[>_,_E(Q)2*9
MD#@]0V.HK0@ABMH(X($6.*)0B(HP% & !0!Q7Q!TS5EO+'6]"M)+F\2*:TE2
M,9.QT.UO^ MD_4BL/4_!FJ6=_;:-IUH[Z9J=O:1:A,G1&B;YF/U KU6B@#AK
MW1[]O&NMW,5G)]FFT)K>)U7Y6?C"CWK/L-"U6.'P('L)E-@TQNLK_J<XQN]*
M])HH Y3XE:=>:KX+N;2PMGN)VDC(CC&20&&:R)8-5\3>+]%D_L2[TF'2H91/
M-,H4%F7:%0@_, 1P?<UZ%10!Y#IWABZCTR+P[J]IXF+1SX M&C-GC?D.&(XZ
MY/?^5>J:E80ZIIES83C,5S$T;>P(QFK5% 'F_@G0-<EOS)KUO);?V58FPLW/
M\66;,B_1<#Z8JA%9:Y9^!I_!!\-W<MX\C(EVJK]F92^[>7SP1_0?2O5Z* .!
MU73]0T/Q)X:U);"[U.WL+)K68VB;WW;< XR.#G^=8]QH%[I^I:Y:7UOXCGMM
M1NI)HSI11HID?L^1P>W/_P"OU:B@#SM=/OO"?BVTU.'1[_4K%]*CLU$(626%
MEQ@-T'\(YX'-:?PWT_4+#3]5_M&P>QDN-2DF6)N@4A>GJ.H_"NQHH X/4=(U
M&7Q7XHN4LY6ANM%,,+A>)'VXVCWJI<Z#J7_"$>$;./3Y?M%GJ$$D\87F-1N+
M$^G)KT>B@#'\6-JZ^&;TZ$,Z@$'E  $]1NQGC.W.*XG3])U.^\6:==_9M<2V
M^R3PR7.J-ET=D(R /NC)&/4UZ=10!YYX534['PXW@R\T2^MK@I/%]O2,&W^8
M,0Y?/N!T]*-!34W\(/X+N=#OK&Z^RS0?:_+'V;)#$'>#W)[#O7H=% 'E5Q9:
MWK'A#3?!P\.WEI=6\D:S7<B@01JA.75P>2?;U/6NET;1[I/'OB>]FMI(HKJ.
M%+>X*_>&S#8/U _*NPHH \?DL-=A^'=SX._X1F\DNXIBWVE$!B9?,W;E;/+=
ML#M6_JJ^(1K<=O+;ZRVG_8HUM4TQ@@,N!N\UNJC.?:O0:* /+-+\.ZLFC>"[
M>?39@UAJ$KW"LG^K7S"0Q]N]:.K>&M3U/Q%XM6&!XX[^PBCMYFX21U"_+G\,
M5Z%10!YVRZGX@\ S>%ET*_TZ]@L47S)HPD,C1LGRJV>=V#[=>:/#FF-=:[I<
M]Y:^)UN;!6(:_,8@B)7!"D#+ ].*]$HH YOQYI%QJWAES8QE[ZSE2ZM0!SO0
M]!^&:XZYT3Q!;:1;>);3393KDU[=2S6X'SHDRE0#[*%4CZUZK10!Y]+X8O-/
MC\$6EM:O(NGS;[ID&1&2 6)_X$35BU@O]+\?Z^9-+NY;?6(XO(N88]T:;8R#
MO.>.>*[FB@#RT^'-4'P;M=,739OMZW.]X-GSC]Z3G'^[C\*]/E0R1.@ZLI%/
MHH \C&F:R_PJN?#!T._2^M)0<F+Y)09MWR'/S8'6NLU;2;N7Q_X=NK>VD%K;
MVT\<DJ+\L64(4'^E=A10!Y!I_AB[ATM?#FK6GB9RLY %DT?V-AOR'W$?+ZG/
M/\AZ5XHMYKOPIJMM;QM+-+9RHB*,EF*D "M6B@#R32-$U3=H$6F>&;K2+ZSD
M0WVH/B-9$'WP0#\^??\ K6E!%J_A@>(M+?P_>:D=4N)9K:YMT#HXD&,2'/RX
M_J:])HH \S&F>(]!T[0-,E75'T^&W?[5_9)!E$Q8L%)Z[0"!D''!K/;PUK4G
M@K4+*72[KSIM>^T"*0[W:,@98G^+W/>O7** .*\3VM]IWC72/$5OIEQJ%I;V
M[V\L5J@:2+.<,%_''X4>!+/48]>\2:A?:7+IZ7\\<L*2 9(^?TXSR,^YKM:*
M .)UB#4-$\?KXD32[K4[*>Q^S,MH@>6%@V<A<C@X_4_CE1^']8F\)>++N33Y
M()]:F,MO8]75<]P.A.>GM7I=% %'0XI+?0=/AE0I)':Q*ZGJI"@$5Q&G7.M^
M'?$/B-XO#5_??;[OS+=TPL9 SU8]!S7HM% 'E=[X/UR+P+J!N+<SZMJFHK=S
M00?-L^;../J3^-=/8Z5=)\4M3U22T<6SV"1Q3E?E+97(!]>*ZVB@#R*/PU>6
M=I>Z%J=IXEN$EN&9!I[1FVG4MD,21\IZ9SZ5O+#?^$?&VI:@='O]5LM0@A6*
M:T0221E%"[6&1C..OT_#OZ* .)NTO[#XEVVM?V5>7%G>:<MKN@CW&%S(#\_/
M  ZFL.WM=:T/PUK'A,^';R]N+R646]W$@,,@D& [L3\I'7GT'2O4J* .!T[P
MU?V'C#PV9H&FAT_2?)DN ,HLGS#&?QXJIK-CJ-OXM>X\+V&LVE]/=K]J=E'V
M*=!U8DG_ #SBO2:* "N2OM+NIOBGINI?9'>U@T]T,VWY4<EN,^N#^M=;10!Y
M9>:#>V&LZ[#>V_B*:TU.X>:,Z24:.57SE7!'!&<<]OUN_P!F7WA7Q/INL0Z1
M?ZC8+I261CB"RSVY&#R!@'IC(P.3^/HU% ' 2-J.E>-&\4G0M0O+/4K%(S%#
M&&GMG&/E9,^W//4UC3^%]:F\,W$TFFR)+J.NK>_8E&XPQ'/WAVZ\_A7K%% '
M)0:9=#XJW6I/:O\ 9&TL1+.5^4OO7C/KC-<KI?AO5X_#7A.VFTV<26NL^=<(
MR<QQ[\[C[5ZO10!PR:/??\)1XTN392>7>V:1VS[>)3Y6"%]>:P?^$;UBTTWP
MOJ#6VIJ+&VDAN8K J+F'<3@J&SG.<'VKU>B@#RS4_#<]UX+U,Z=8:U)<7M]$
M[QZB%,LFWJ^U0,#D]>>*Z74]*NYOB1I5Y#;R"TBL)8GF5?E0G=@?K7744 >0
M'3]=M?A[>>#O^$9O);M)BPN40&%U\P-N#9Y;C&!V_*MG4(O$1U06DUOK+67V
M&)+--.81IYFP!O.;J.<]>U>C44 >7-H6L0_#+P[&-,N'NM,U$7,]JJ_O-@DD
MZ#N?F'YUJW.G7^N^-3?I975G;7>@/;B2>/:8I&9N&'8C.<5WE% 'E$EEKEUX
M$A\#_P#"-W<=ZL@1KME7[,JB3=O#YY..WN?I73Z-H]W:_$;5;V:WD-NUC##'
M<LO#D!=P!_"NPHH \IL- :V\"Z;;ZKH^M"\M[J:2%]-3]];G.0<9Z'C\JZ?P
MYJ'B:RT+2HM9TVXO+JYG,<LF0&@BS\K28'7'_P!?FNOHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH *\[^-?_(G6G_803_T7)7HE>=_&O_D3K3_L()_Z
M+DH [C2?^0/9?]>\?_H(JY5/2?\ D#V7_7O'_P"@BKE !1110 4444 %4]6_
MY ][_P!>\G_H)JY5/5O^0/>_]>\G_H)H X?X*?\ (G7?_80?_P!%QUZ)7G?P
M4_Y$Z[_["#_^BXZ]$H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M4]6_Y ][_P!>\G_H)H X?X*?\B==_P#80?\ ]%QUZ)7G?P4_Y$Z[_P"P@_\
MZ+CKT2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@F@#A_@I_P B==_]A!__ $7'7HE>=_!3_D3KO_L(/_Z+CKT2@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ KSOXU_\B=:?]A!/_1<E>B5YW\:_P#D3K3_ +""?^BY* .XTG_D
M#V7_ %[Q_P#H(JY5/2?^0/9?]>\?_H(JY0 4444 %%%% !5/5O\ D#WO_7O)
M_P"@FKE4]6_Y ][_ ->\G_H)H X?X*?\B==_]A!__1<=>B5YW\%/^1.N_P#L
M(/\ ^BXZ]$H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *\[^-?\ R)UI_P!A!/\ T7)7HE>=
M_&O_ )$ZT_[""?\ HN2@#N-)_P"0/9?]>\?_ *"*N53TG_D#V7_7O'_Z"*N4
M %%%% !1110 53U;_D#WO_7O)_Z":N53U;_D#WO_ %[R?^@F@#A_@I_R)UW_
M -A!_P#T7'7HE>=_!3_D3KO_ +"#_P#HN.O1* "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O
M._C7_P B=:?]A!/_ $7)7HE>=_&O_D3K3_L()_Z+DH [C2?^0/9?]>\?_H(J
MY5/2?^0/9?\ 7O'_ .@BKE !1110 4444 %4]6_Y ][_ ->\G_H)JY5/5O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %>=_&O_D3K3_L()_Z+DKT2O._C7_R)UI_V$$_]%R4 =QI/_('LO\
MKWC_ /015RJ>D_\ ('LO^O>/_P!!%7* "BBB@ HHHH *IZM_R![W_KWD_P#0
M35RJ>K?\@>]_Z]Y/_030!P_P4_Y$Z[_["#_^BXZ]$KSOX*?\B==_]A!__1<=
M>B4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %>=_&O\ Y$ZT_P"P@G_HN2O1*\[^-?\ R)UI
M_P!A!/\ T7)0!W&D_P#('LO^O>/_ -!%7*IZ3_R![+_KWC_]!%7* "BBB@ H
MHHH *IZM_P @>]_Z]Y/_ $$U<JGJW_('O?\ KWD_]!- '#_!3_D3KO\ ["#_
M /HN.O1*\[^"G_(G7?\ V$'_ /1<=>B4 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>=_&O_
M )$ZT_[""?\ HN2O1*\[^-?_ ")UI_V$$_\ 1<E '<:3_P @>R_Z]X__ $$5
M<JGI/_('LO\ KWC_ /015R@ HHHH **** "J>K?\@>]_Z]Y/_035RJNIHTFE
M7:(,LT#@ =SM- '"_!3_ )$Z[_["#_\ HN.O1*\Y^"<B'PG>QAAO6^9B/0&-
M,?R/Y5Z-0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^$L^*/\ T*EK_P!^'_\ CE'_  EGQ1_Z%2U_[\/_ /'*]/HH \P_X2SXH_\
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M6O\ WX?_ ..4?\)9\4?^A4M?^_#_ /QRO3Z* /,/^$L^*/\ T*EK_P!^'_\
MCE'_  EGQ1_Z%2U_[\/_ /'*]/HH \P_X2SXH_\ 0J6O_?A__CE'_"6?%'_H
M5+7_ +\/_P#'*]/HH \P_P"$L^*/_0J6O_?A_P#XY1_PEGQ1_P"A4M?^_#__
M !RO3Z* /,/^$L^*/_0J6O\ WX?_ ..4?\)9\4?^A4M?^_#_ /QRO3Z* /,/
M^$L^*/\ T*EK_P!^'_\ CE'_  EGQ1_Z%2U_[\/_ /'*]/HH \P_X2SXH_\
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M6O\ WX?_ ..4?\)9\4?^A4M?^_#_ /QRO3Z* /,/^$L^*/\ T*EK_P!^'_\
MCE'_  EGQ1_Z%2U_[\/_ /'*]/HH \P_X2SXH_\ 0J6O_?A__CE'_"6?%'_H
M5+7_ +\/_P#'*]/HH \P_P"$L^*/_0J6O_?A_P#XY1_PEGQ1_P"A4M?^_#__
M !RO3Z* /,/^$L^*/_0J6O\ WX?_ ..4?\)9\4?^A4M?^_#_ /QRO3Z* /,/
M^$L^*/\ T*EK_P!^'_\ CE'_  EGQ1_Z%2U_[\/_ /'*]/HH \P_X2SXH_\
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M6O\ WX?_ ..4?\)9\4?^A4M?^_#_ /QRO3Z* /,/^$L^*/\ T*EK_P!^'_\
MCE'_  EGQ1_Z%2U_[\/_ /'*]/HH \P_X2SXH_\ 0J6O_?A__CE'_"6?%'_H
M5+7_ +\/_P#'*]/HH \P_P"$L^*/_0J6O_?A_P#XY1_PEGQ1_P"A4M?^_#__
M !RO3Z* /,/^$L^*/_0J6O\ WX?_ ..4?\)9\4?^A4M?^_#_ /QRO3Z* /,/
M^$L^*/\ T*EK_P!^'_\ CE'_  EGQ1_Z%2U_[\/_ /'*]/HH \P_X2SXH_\
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M6O\ WX?_ ..4?\)9\4?^A4M?^_#_ /QRO3Z* /,/^$L^*/\ T*EK_P!^'_\
MCE'_  EGQ1_Z%2U_[\/_ /'*]/HH \P_X2SXH_\ 0J6O_?A__CE'_"6?%'_H
M5+7_ +\/_P#'*]/HH \P_P"$L^*/_0J6O_?A_P#XY1_PEGQ1_P"A4M?^_#__
M !RO3Z* /,/^$L^*/_0J6O\ WX?_ ..4?\)9\4?^A4M?^_#_ /QRO3Z* /,/
M^$L^*/\ T*EK_P!^'_\ CE'_  EGQ1_Z%2U_[\/_ /'*]/HH \P_X2SXH_\
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M6O\ WX?_ ..4?\)9\4?^A4M?^_#_ /QRO3Z* /,/^$L^*/\ T*EK_P!^'_\
MCE'_  EGQ1_Z%2U_[\/_ /'*]/HH \P_X2SXH_\ 0J6O_?A__CE)9^#_ !3X
MOUJVU/QF\<%I;-NCLD(^;G., G ..23GM]/4** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
<H **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
